Pesticidally active pyridazinone compounds

By developing pyridazine-3-one compounds and their compositions, the problem of difficulty in effectively controlling arthropods and acarids in the prior art has been solved, and effective pest control and plant protection for the agricultural and horticultural environments have been achieved.

CN118891256APending Publication Date: 2024-11-01SYNGENTA CROP PROTECITON AG
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202280079317.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2021-12-10
Filing Date
2022-12-05
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

When used in agriculture and horticulture, it is difficult to effectively control pests such as arthropods and acarats, and the protection effect on plant reproductive materials is limited.

Method used

A new pyridazine-3-one compound and its agrochemical composition have been developed to achieve insecticidal, acaricidal, nematodeic or molluscicidal effects by applying it to pests or sites thereof and to Plant propagation materials and planting sites to prevent attacks.

Benefits of technology

This compound significantly reduces or eliminates the number of pests, protects plants from pests, and improves the safety of plant propagation materials and the health of the planting environment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118891256A_ABST
    Figure CN118891256A_ABST
Patent Text Reader

Abstract

A compound having the formula (I), wherein Q is Qa or Qb; and R4 is R4a or R4b, and wherein the substituents are defined as in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds can be used as insecticides. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to pesticidal pyridazinone compounds, for example, as active ingredients having pesticidal activity. The present invention also relates to the preparation of these pyridazinone compounds, intermediates useful in the preparation of these pyridazinone compounds, the preparation of these intermediates, agrochemical compositions comprising at least one of these pyridazinone compounds, the preparation of these compositions, and the use of these pyridazinone compounds or compositions for controlling animal pests in agriculture or horticulture, including arthropods and, in particular, insects or representatives of the order Acarina. In particular, pesticidal pyridazin-3-one compounds are disclosed.

[0002] WO 2021 / 083936, WO 2021 / 148639 and WO 2021 / 177160 describe certain quinazoline, quinazolinone and quinoline compounds.

[0003] It has now been surprisingly found that certain novel pyridazinone compounds, in particular pyridazin-3-one compounds, possess pesticidal activity.

[0004] Thus, in a first aspect, the present invention provides compounds of formula (I), and agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides thereof:

[0005]

[0006] in:

[0007] A 1 、A 2 and A 3 N or CR independently of each other Y ;or

[0008] A 1 =A 2 -A 3 Together is NR-C (=X 0 )-N; where X 0 is O or S;

[0009] A 4 and A 5 N or CR independently of each other Y ;

[0010] Q is wherein the staggered lines represent the connection of Q to the remainder of the compound of formula (I);

[0011] R is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy;

[0012] R1 is hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, aminocarbonyl C1-C6 alkyl, hydroxycarbonyl C1-C6 alkyl, C1-C6 nitroalkyl, trimethylsilyl C1-C6 alkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl C1-C6 -C2 alkyl-, or C3-C4 cycloalkylC1-C2 alkyl-, wherein the C3-C4 cycloalkyl group is substituted by 1 or 2 halogen atoms, oxetan-3-yl-CH2-, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl, benzyl or benzyl substituted by 1 to 3 substituents independently selected from halogen, C1-C6 alkoxy and C1-C6 haloalkyl;

[0013] R 2a and R 2b each independently selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, substituted by one to three independently selected R x C3-C6 cycloalkyl, C3-C6 cycloalkylcarbonyl, phenyl, substituted by one to three independently selected R x substituted phenyl, heteroaryl, substituted by one to three independently selected R x Substituents substituted heteroaryl, OR 6 , piperidin-2-one-1-yl, one to two independently selected from R x Substituents substituted piperidin-2-one-1-yl, pyridin-2-one-1-yl, substituted by one to two independently selected from R x substituted pyridin-2-one-1-yl, azetidin-1-yl, substituted by one to two independently selected from R x substituted azetidin-1-yl, pyrrolidin-1-yl, substituted by one to two independently selected from R x substituted pyrrolidin-1-yl, C3-C6 cycloalkyl C1-C4 alkyl, substituted by one to two independently selected R z C3-C6 cycloalkyl C1-C4 alkyl, C3-C6 cycloalkyl C1-C3 alkoxy, substituted by one to two independently selected R x C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, substituted by one to three independently selected R xC1-C4 alkylsulfanyl, C1-C4 alkylsulfonyl, substituted by one to three independently selected R x C1-C4 alkylsulfonyl, C1-C4 alkylsulfinyl, and one to three independently selected R x C1-C4 alkylsulfinyl substituted with a substituent;

[0014] R 3 is C1-C3 alkyl or C1-C3 haloalkyl;

[0015] R 4 yes The interlaced lines represent R 4 With Q a or Q b connection;

[0016] A 14 、A 24 and A 34 are independently N or CH;

[0017] R 4c is C1-C3 alkyl, C1-C3 haloalkyl, allyl, propargyl or C3-C6 cycloalkylC1-C4 alkyl;

[0018] R 5is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, C3-C4 alkoxyC(O)-, (C1-C3 alkoxy)2CH-, halogen, CN, NH2C(O), amino (i.e., NH2), (C1-C3 alkyl)amino, di(C1-C3 alkyl)amino, hydroxy, C3-C4 halocycloalkyl, C3-C4 cyanocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C3 Alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)sulfonylamino, (C1-C3 alkyl)sulfonyl(C1-C3 alkyl)amino, (C1-C3 alkyl)NHC(O), (C1-C3 alkyl)2NC(O), (C1-C3 cycloalkyl)NHC(O), (C1-C3 cycloalkyl)(C1-C3 alkyl)NC(O), (C1-C3 alkyl)C(O)(C1-C3 alkyl)N, (C1-C3 alkyl)C(O)NH, (C1-C3 alkyl)C(O), (C1-C3 alkoxy)C(O), HC(O), diphenylmethanamine, C1-C3 haloalkoxy, phenyl, or a 5-membered heteroaromatic ring; or

[0019] R 5 is phenyl substituted with one to three substituents selected from the group consisting of C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN, and hydroxy; or

[0020] R 5 is a 5-membered heteroaromatic ring substituted with one to three substituents selected from the group consisting of C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN, and hydroxy;

[0021] R 5a and R 5b are independently selected from hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, and C1-C3 haloalkoxy;

[0022] R 6 is phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl; or

[0023] R 6is phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl, each of which is independently substituted by one to three independently selected R x Substituents substituted;

[0024] R x independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, NO2, SF5, CN, C(O)NH2, C(S)NH2, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl and C1-C4 alkylsulfonyl;

[0025] R Y is selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, hydroxy, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, CN and cyclopropyl; and

[0026] R Z is selected from the group consisting of oxo, halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy and CN.

[0027] The present invention also provides a method for preparing the compound of formula (I) and an intermediate compound that can be used in the preparation of the compound of formula (I).

[0028] In a second aspect, the present invention makes available a composition comprising a compound of formula (I), one or more adjuvants and diluents, and optionally one or more other active ingredients.

[0029] In a third aspect, the present invention makes available a method for combating and controlling insects, acarids, nematodes or molluscs, which method comprises applying to the pest, the locus of the pest, or a plant susceptible to attack by the pest an insecticidally, acaridically, nematicidally or molluscicidally effective amount of a compound of formula (I) or a composition comprising such a compound.

[0030] In a fourth aspect, the present invention makes available a method for protecting plant propagation material from attack by insects, mites, nematodes or molluscs, which method comprises treating the propagation material or the site in which the propagation material is planted with an effective amount of a compound of formula (I) or a composition comprising such a compound.

[0031] In a fifth aspect, the present invention makes available a plant propagation material, such as a seed, containing, treated with, or having adhered thereto, a compound of formula (I) or a composition comprising such a compound.

[0032] In another aspect, the present invention provides a method for controlling parasites in or on an animal in need thereof, the method comprising administering an effective amount of a compound of the first aspect. The present invention further provides a method for controlling parasites on the body of an animal in need thereof, the method comprising administering an effective amount of a compound of formula (I) as defined in the first aspect. The present invention further provides a method for preventing and / or treating a disease transmitted by parasites on the body, the method comprising administering an effective amount of a compound of formula (I) as defined in the first aspect to an animal in need thereof.

[0033] Compounds of formula (I) with at least one basic center can form acid addition salts, for example, with strong inorganic acids (such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrous acid, phosphoric acid or hydrohalic acids), strong organic carboxylic acids (such as unsubstituted or, for example, halogen-substituted C1-C4-alkanecarboxylic acids, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid), or organic sulfonic acids (such as unsubstituted or, for example, halogen-substituted C1-C4-alkanesulfonic acids or arylsulfonic acids, for example methanesulfonic acid or p-toluenesulfonic acid). Compounds of formula (I) having at least one acidic group can, for example, form salts with bases, for example mineral salts, such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts; or with ammonia or organic amines such as morpholine, piperidine, pyrrolidine, mono-, di- or tri-lower alkylamines, for example ethylamine, diethylamine, triethylamine or dimethylpropylamine, or mono-, di- or trihydroxy-lower alkylamines, for example monoethanolamine, diethanolamine or triethanolamine.

[0034] In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form (such as N-oxides), or in salt form (eg agronomically usable salt forms).

[0035] N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen-containing heteroaromatic compounds. They are described, for example, in the book "Heterocyclic N-oxides" by A. Albini and S. Pietra, CRC Press, Boca Raton, 1991.

[0036] The compounds of formula (I) according to the invention also include hydrates which may be formed during salt formation.

[0037] As used herein, the term "C1-C n“Alkyl” refers to a saturated straight or branched chain hydrocarbon radical having 1 to n carbon atoms, attached via any carbon atom, such as any of the following: methyl, ethyl, n-propyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, n-pentyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, or 1-ethyl-2-methylpropyl.

[0038] As used herein, the term "C1-C n “Haloalkyl” refers to straight-chain or branched saturated alkyl groups (as mentioned above) having 1 to n carbon atoms, attached via any carbon atom, wherein some or all of the hydrogen atoms in these groups may be replaced by fluorine, chlorine, bromine and / or iodine, i.e., for example, any of the following: chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoro In some embodiments, the present invention relates to a C1-C2 alkyl radical having 1, 2, 3, 4 or 5 fluorine atoms, for example, ...

[0039] As used herein, the term "C1-C n"Alkoxy" refers to a straight-chain or branched saturated alkyl group (as mentioned above) having 1 to n carbon atoms, which is attached via an oxygen atom, i.e., for example, any of the following groups: methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy. As used herein, the term "C1-C n "Haloalkoxy" refers to C1-C n Alkoxy groups wherein one or more hydrogen atoms on the alkyl group are replaced by one or more identical or different halogen atoms - examples include trifluoromethoxy, 2-fluoroethoxy, 3-fluoropropoxy, 3,3,3-trifluoropropoxy, 4-chlorobutoxy.

[0040] As used herein, the term "C1-C n Alkoxy C1-C m "Alkyl" refers to an alkoxy group (as mentioned above) having 1 to n carbon atoms, which is attached via an oxygen atom to an alkyl group (as mentioned above) having 1 to m carbon atoms, which is linked to the rest of the molecule.

[0041] As used herein, the term "C1-Cn cyanoalkyl" refers to a linear or branched saturated C1-Cn alkyl group having 1 to n carbon atoms. n Alkyl groups (as mentioned above), wherein one of the hydrogen atoms in these groups is replaced by a cyano group -CN: for example, cyanomethyl, 2-cyanoethyl, 2-cyanopropyl, 3-cyanopropyl, 1-(cyanomethyl)-2-ethyl, 1-(methyl)-2-cyanoethyl, 4-cyanobutyl, etc.

[0042] As used herein, the term "C1-C n "Nitroalkyl" refers to a straight or branched chain saturated C1-C n Alkyl groups (as mentioned above), wherein one of the hydrogen atoms in these groups is replaced by a nitro-NO2 group: for example, nitromethyl, 2-nitroethyl, 2-nitropropyl, 3-nitropropyl, 1-(nitromethyl)-2-ethyl, 1-(methyl)-2-nitroethyl, 4-nitrobutyl, etc.

[0043] As used herein, the term "C3-C n The term "cycloalkyl" refers to a 3-membered to n-membered cycloalkyl group such as cyclopropane, cyclobutane, cyclopentane and cyclohexane.

[0044] As used herein, the term "C3-C n "Cycloalkylcarbonyl" refers to a 3-membered to n-membered cycloalkyl group attached to a carbonyl (C=O) group, which is linked to the remainder of the molecule. Similarly, the term "C1-C n Alkylcarbonyl", "C1-C n"Alkoxycarbonyl," "phenyloxycarbonyl," and "benzyloxycarbonyl" refer to alkyl, alkoxy, phenyloxy, and benzyloxy groups attached to a carbonyl (C=O) group that is attached to the remainder of the molecule.

[0045] As used herein, the term "C3-C4 cycloalkylC1-C2 alkyl" refers to a 3- or 4-membered cycloalkyl group with a methylene or ethylene group attached to the remainder of the molecule. In this case, the C3-C4 cycloalkyl-C1-C2 alkyl group is substituted, and one or more substituents may be on the cycloalkyl group and / or the alkyl group.

[0046] As used herein, the term "C3-C6 cycloalkyl C1-C4 haloalkoxy" refers to a 3- to 6-membered cycloalkyl group attached to a 1- to 4-membered haloalkoxy group, which is attached to the remainder of the molecule.

[0047] As used herein, the term "aminocarbonyl C1-C n "Alkyl" refers to an alkyl group in which one of the hydrogen atoms in the group is replaced by a CONH2 group.

[0048] As used herein, the term "hydroxycarbonyl C1-C n "Alkyl" refers to an alkyl group in which one of the hydrogen atoms in the group is replaced by a COOH group.

[0049] As used herein, the term "C1-C n "Alkylsulfanyl" refers to a C1-C n Similarly, as used herein, the term "C1-C n "Haloalkylthio" or "C1-C n "Haloalkylsulfanyl" refers to a C1-C n Similarly, the term "C3-C n "Cycloalkylsulfanyl" refers to a 3-membered to n-membered cycloalkyl moiety attached through a sulfur atom.

[0050] As used herein, the term "C1-C n "Alkylsulfinyl" refers to a C1-C2-alkyl group attached through the sulfur atom of an S(=O) group. n Similarly, as used herein, the term "C1-C n "Haloalkylsulfinyl" refers to a C1-C2- n Similarly, the term "C3-C n "Cycloalkylsulfinyl" refers to a 3-membered to n-membered cycloalkyl moiety attached through the sulfur atom of an S(=O) group.

[0051] As used herein, the term "C1-Cn "Alkylsulfonyl" refers to a C1-C2 group attached through the sulfur atom of a S(=O)2 group. n Similarly, as used herein, the term "C1-C n "Haloalkylsulfonyl" refers to a C1-C2 group attached through the sulfur atom of a S(=O)2 group. n Similarly, the term "C3-C n "Cycloalkylsulfonyl" refers to a 3-membered to n-membered cycloalkyl moiety attached via the sulfur atom of a S(=O)2 group.

[0052] As used herein, the term "trimethylsilane C1-C n "Alkyl" refers to an alkyl group in which one of the hydrogen atoms in the group is replaced by a -Si(CH3)3 group.

[0053] As used herein, the term "C2-C n "Alkenyl" refers to a straight or branched alkenyl chain having from two to n carbon atoms and one or two double bonds, for example vinyl, prop-1-enyl, but-2-enyl.

[0054] As used herein, the term "C2-C n "Haloalkenyl" refers to a C2-C4 group substituted by one or more halogen atoms which may be the same or different. n Alkenyl moiety.

[0055] As used herein, the term "C2-C n "Alkynyl" refers to a straight or branched alkynyl chain having from two to n carbon atoms and one triple bond, for example ethynyl, prop-2-ynyl, but-3-ynyl.

[0056] As used herein, the term "C2-C n "Haloalkynyl" refers to a C2-C6 substituted by one or more halogen atoms which may be the same or different. n Alkynyl moiety.

[0057] Halogen or "halo" is typically fluorine, chlorine, bromine or iodine. This also applies correspondingly to halogen in combination with other meanings, such as haloalkyl.

[0058] The term "heteroaryl" as used herein refers to a 5- or 6-membered aromatic monocyclic ring having 1 to 3 heteroatoms independently selected from N, O and S. Examples are heteroaryl groups J-1 to J-39 shown below in Scheme J. Preferred heteroaryl groups are pyridinyl, pyrimidinyl, and pyrazolyl.

[0059] Table J: Heteroaryl groups J-1 to J-39:

[0060] The arrows in heteroaryl groups J-1 to J-39 indicate the point of attachment to the rest of the compound.

[0061]

[0062]

[0063] As used herein, the term "optionally substituted" means that the referenced group is unsubstituted or substituted with the specified substituent, for example, "C3-C4 cycloalkyl optionally substituted with 1 or 2 halogen atoms" means C3-C4 cycloalkyl, C3-C4 cycloalkyl substituted with 1 halogen atom, and C3-C4 cycloalkyl substituted with 2 halogen atoms.

[0064] As in this article, for example, in Q a , Q b 、R 4a 、R 4b The staggered lines used in , and T represent the point of connection / attachment to the rest of the compound.

[0065] As used herein, the term "control" refers to reducing the number of pests, eliminating pests, and / or preventing further pest damage so that damage to plants or to plant-derived products is reduced.

[0066] As used herein, the term "pest" refers to insects and molluscs present in agriculture, horticulture, forestry, storage of products of plant origin (such as fruit, grain and wood); and those pests associated with damage to man-made structures. The term pest covers all stages of the pest life cycle.

[0067] As used herein, the term "effective amount" refers to an amount of a compound or a salt thereof that provides the desired effect upon single or multiple administrations.

[0068] The effective amount is readily determined by one skilled in the art by using known techniques and by observing the results obtained under similar circumstances. In determining the effective amount, many factors are considered, including, but not limited to: the type of plant or derived product being applied; the pest to be controlled and its life cycle; the specific compound being applied; the type of application; and other relevant circumstances.

[0069] As will be understood by one of ordinary skill in the art, compounds of formula (I) contain stereocenters, which are indicated by an asterisk in the following formula (I*):

[0070]

[0071] Among them A 1 、A 2 、A 3 、A 4 、A 5 ,Q,R 1、R 2a 、R 2b and R 3 is as defined in the first aspect.

[0072] The present invention contemplates both racemates and individual enantiomers. Compounds with preferred stereochemistry are listed below. Particularly preferred compounds of the present invention are compounds of formula (I'):

[0073]

[0074] Among them A 1 、A 2 、A 3 、A 4 、A 5 ,Q,R 1 、R 2a 、R 2b and R 3 is as defined in the first aspect, as well as the stereoisomers, enantiomers and tautomers of the compound of formula (I') and N-oxides and agrochemically acceptable salts thereof.

[0075] Examples according to the present invention are provided as listed below.

[0076] In an embodiment of each aspect of the invention, A 1 、A 2 and A 3 The definition is as follows:

[0077] AA 1 、A 2 and A 3 N or CR independently of each other Y ; or A 1 =A 2 -A 3 Together is NR-C (=X 0 )-N; where X 0 is O or S;

[0078] BA 1 、A 2 and A 3 N or CR independently of each other Y , provided that no more than two of the three are N; or A 1 =A 2 -A 3 Together is NR-C (=X 0 )-N; or

[0079] CA 1 and A 3 It is N and A 2It's CR Y ; or A 1 =A 2 -A 3 together are NR-C(=O)-N; or

[0080] DA 1 、A 2 and A 3 are independently N or CH; or A 1 =A 2 -A 3 together are NR-C(=O)-N; or

[0081] EA 1 、A 2 and A 3 are independently N or CH, provided that no more than two of the three are N; or A 1 =A 2 -A 3 together is NH—C(═O)—N; or

[0082] FA 1 is N, and A 2 and A 3 is CH; or A 1 =A 2 -A 3 together is NH—C(═O)—N; or

[0083] GA 1 and A 2 is CH, and A 3 N; or A 1 =A 2 -A 3 together are NR-C(=O)-N; or

[0084] HA 1 and A 3 is N, and A 2 is CH; or A 1 =A 2 -A 3 together is NH—C(═O)—N; or

[0085] IA 1 、A 2 and A 3 N or CR independently of each other Y , provided that no more than two of the three are N; or

[0086] JA 1 and A 3 It is N and A 2 It's CRY ;or

[0087] KA 1 、A 2 and A 3 are independently N or CH; or

[0088] LA 1 、A 2 and A 3 are independently N or CH, provided that no more than two of the three are N; or

[0089] MA 1 is N, and A 2 and A 3 is CH; or

[0090] NA 1 and A 2 is CH, and A 3 is N; or

[0091] OA 1 and A 3 is N, and A 2 is CH; or

[0092] PA 1 =A 2 -A 3 Together is NR-C (=X 0 )-N; or

[0093] QA 1 =A 2 -A 3 Together is N(CH3)-C(=X 0 )-N; or

[0094] RA 1 =A 2 -A 3 Together is NH-C(=X 0 )-N; or

[0095] SA 1 =A 2 -A 3 together are NR-C(=O)-N; or

[0096] TA 1 =A 2 -A 3 Together they are N(CH3)-C(=O)-N; or

[0097] UA 1 =A 2 -A 3together is NH—C(═O)—N; or

[0098] VA 1 =A 2 -A 3 together are NR-C(=S)-N; or

[0099] WA 1 =A 2 -A 3 together is NH-C(=S)-N; or

[0100] XA 1 =A 2 -A 3 Together they are N(CH3)-C(=S)-N.

[0101] In an embodiment of each aspect of the present invention,

[0102] AX 0 is O or S; or

[0103] BX 0 is O; or

[0104] CX 0 It’s S.

[0105] In an embodiment of each aspect of the present invention,

[0106] AA 4 It's CR Y , and A 5 is N; or

[0107] BA 4 It's CR Y , and A 5 is CH; or

[0108] CA 4 is CH, and A 5 is N; or

[0109] DA 4 is N, and A 5 is CH; or

[0110] EA 4 and A 5 All are CH.

[0111] In an embodiment of each aspect of the present invention,

[0112] AA 1 It's N, A 2 and A 3 is CH, and A 4 and A5 All CH; or

[0113] BA 1 and A 2 It is CH, A 3 is N, and A 4 and A 5 All CH; or

[0114] CA 1 and A 3 It's N, A 2 is CH, and A 4 It's CR Y And A 5 is CH; or

[0115] DA 1 and A 3 It's N, A 2 is CH, and A 4 is CH and A 5 is N; or

[0116] EA 1 and A 3 It's N, A 2 is CH, and A 4 It is N and A 5 is CH; or

[0117] FA 1 and A 3 It's N, A 2 is CH, and A 4 is N or CH and A 5 is CH; or

[0118] GA 1 and A 3 It's N, A 2 is CH, and A 4 is CH and A 5 is N or CH; or

[0119] HA 1 and A 3 It's N, A 2 is CH, and A 4 and A 5 All N; or

[0120] IA 1 and A 3 It's N, A 2 is CH, and A 4 and A 5 All CH; or

[0121] JA1 =A 2 -A 3 Together they are NR-C(=O)-N and A 4 and A 5 All CH; or

[0122] KA 1 =A 2 -A 3 Together they are N(CH3)-C(=O)-N and A 4 and A 5 All CH; or

[0123] LA 1 =A 2 -A 3 Together they are NH-C(=O)-N and A 4 and A 5 All are CH.

[0124] In an embodiment of each aspect of the invention, R is

[0125] A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; or

[0126] B. hydrogen, methyl, ethyl, difluoroethyl or trifluoroethyl; or

[0127] C. hydrogen; methyl, ethyl, 2,2-difluoroethyl or 2,2,2-trifluoroethyl, or

[0128] D. Hydrogen; or

[0129] E. methyl or 2,2,2-trifluoroethyl; or

[0130] F. methyl; or

[0131] G. Methyl or hydrogen.

[0132] In an embodiment of each aspect of the invention, R 1 yes

[0133] A. Hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, aminocarbonyl C1-C6 alkyl, hydroxycarbonyl C1-C6 alkyl, C1-C6 nitroalkyl, trimethylsilyl C1-C6 alkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl C1-C6 -C2 alkyl-, or C3-C4 cycloalkyl C1-C2 alkyl-, wherein the C3-C4 cycloalkyl is substituted by 1 or 2 halogen atoms, oxetan-3-yl-CH2-, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl, benzyl or benzyl substituted by 1 to 3 substituents independently selected from halogen, C1-C6 alkoxy and C1-C6 haloalkyl; or

[0134] B. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, aminocarbonylC1-C6 alkyl, hydroxycarbonylC1-C6 alkyl, C1-C6 nitroalkyl, trimethylsilylC1-C6 alkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkylC1-C2 alkyl-, C3-C4 cycloalkylC1-C2 alkyl- wherein the C3-C4 cycloalkyl is substituted by 1 or 2 halogen atoms, oxetan-3-yl-CH2-, phenyloxycarbonyl, benzyloxycarbonyl, or benzyl; or

[0135] C. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, aminocarbonyl C1-C6 alkyl, hydroxycarbonyl C1-C6 alkyl, C1-C6 nitroalkyl, trimethylsilyl C1-C6 alkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl C1-C2 alkyl-, benzyloxycarbonyl, or benzyl; or

[0136] D. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, aminocarbonylC1-C6 alkyl, hydroxycarbonylC1-C6 alkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkylC1-C2 alkyl-, benzyloxycarbonyl, or benzyl; or

[0137] E. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkylC1-C2 alkyl-, benzyloxycarbonyl, or benzyl; or

[0138] F. hydrogen, C1-C3 alkyl, C1-C3 cyanoalkyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C3-C4 cycloalkylC1-C2 alkyl-, benzyloxycarbonyl, or benzyl; or

[0139] G. hydrogen, C1-C3 alkyl, C1-C3 cyanoalkyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C3-C4 cycloalkylC1-C2 alkyl-, benzyloxycarbonyl, or benzyl; or

[0140] H. hydrogen, methyl, ethyl, cyanomethyl, methoxymethyl, cyclopropyl-methyl, allyl, propargyl, benzyloxycarbonyl, or benzyl; or

[0141] I. hydrogen, methyl, or cyclopropyl-methyl; or

[0142] J. hydrogen, or methyl; or

[0143] K. Hydrogen.

[0144] In an embodiment of each aspect of the invention, R 2a yes

[0145] A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, substituted by one to three independently selected R x C3-C6 cycloalkyl, C3-C6 cycloalkylcarbonyl, phenyl, substituted by one to three independently selected R x substituted phenyl, heteroaryl, substituted by one to three independently selected R x Substituents substituted heteroaryl, OR 6 , piperidin-2-one-1-yl, one to two independently selected from R x Substituents substituted piperidin-2-one-1-yl, pyridin-2-one-1-yl, substituted by one to two independently selected from R xsubstituted pyridin-2-one-1-yl, azetidin-1-yl, substituted by one to two independently selected from R x substituted azetidin-1-yl, pyrrolidin-1-yl, substituted by one to two independently selected from R x substituted pyrrolidin-1-yl, C3-C6 cycloalkyl C1-C4 alkyl, substituted by one to two independently selected R z C3-C6 cycloalkyl C1-C4 alkyl, C3-C6 cycloalkyl C1-C3 alkoxy, substituted by one to two independently selected R x C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, substituted by one to three independently selected R x C1-C4 alkylsulfanyl, C1-C4 alkylsulfonyl, substituted by one to three independently selected R x C1-C4 alkylsulfonyl, C1-C4 alkylsulfinyl, and one to three independently selected R x a C1-C4 alkylsulfinyl group substituted with a substituent of

[0146] B. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl, heteroaryl selected from J-1 to J-39 (each of C3-C4 cycloalkyl, phenyl or heteroaryl is independently substituted by one to three substituents R X Replace), OR 6 , piperidin-2-one-1-yl, pyridin-2-one-1-yl, optionally R X Substituted azetidin-1-yl, pyrrolidin-1-yl, optionally substituted by R X Substituted C3-C6 cycloalkyl C1-C4 alkyl, optionally R X Substituted C3-C6 cycloalkyl C1-C3 alkoxy, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, optionally substituted by R X substituted C1-C4 alkylsulfonyl, or optionally substituted by R X substituted C1-C4 alkylsulfinyl; or

[0147] C. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl, heteroaryl selected from J-1 and J-25 (each of C3-C4 cycloalkyl, phenyl or heteroaryl is independently substituted by one to three substituents R X Replace), OR 6 , piperidin-2-one-1-yl, pyridin-2-one-1-yl, optionally R XSubstituted azetidin-1-yl, pyrrolidin-1-yl, optionally substituted by R X Substituted C3-C6 cycloalkyl C1-C4 alkyl, optionally R X Substituted C3-C6 cycloalkyl C1-C3 alkoxy, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, optionally substituted by R X substituted C1-C4 alkylsulfonyl, or optionally substituted by R X substituted C1-C4 alkylsulfinyl; or

[0148] D. Halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl, pyrazolyl (each of C3-C4 cycloalkyl, phenyl, pyrazolyl is independently substituted by one to three substituents R X Replace), OR 6 , piperidin-2-one-1-yl, pyridin-2-one-1-yl, optionally R X Substituted azetidin-1-yl, pyrrolidin-1-yl, optionally substituted by R X Substituted C3-C6 cycloalkyl C1-C4 alkyl, optionally R X Substituted C3-C6 cycloalkyl C1-C3 alkoxy, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, optionally substituted by R X substituted C1-C4 alkylsulfonyl, or optionally substituted by R X substituted C1-C4 alkylsulfinyl; or

[0149] E. Halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl or pyrazolyl (each of C3-C4 cycloalkyl, phenyl, pyrazolyl is independently substituted by one to two substituents R X Replace), OR 6 , optionally by R X substituted azetidin-1-yl, optionally substituted by R X Substituted C3-C6 cycloalkyl C1-C4 alkyl, optionally R X Substituted C3-C6 cycloalkyl C1-C3 alkoxy, optionally R X substituted C1-C4 alkylsulfonyl, or optionally substituted by R X substituted C1-C4 alkylsulfinyl; or

[0150] F. Halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, substituted by one or two R X Substituted C3-C4 cycloalkyl, OR 6 , C3-C6 cycloalkyl C1-C4 alkyl, R XSubstituted C3-C6 cycloalkyl C1-C4 alkyl, C1-C4 alkylsulfonyl, R X Substituted C1-C4 alkylsulfonyl, C1-C4 alkylsulfinyl, or R X substituted C1-C4 alkylsulfinyl; or

[0151] G. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C3-C4 cycloalkyl substituted by one to two halogen, C1-C3 alkyl, or C1-C3 haloalkyl, C3-C4 cycloalkylmethyl, C3-C4 cycloalkylmethyl substituted by one to two halogen, C1-C3 alkyl, or C1-C3 haloalkyl, or C1-C2 alkylsulfonyl substituted by one to three halogen; or

[0152] H. halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyclopropyl, cyclopropyl substituted by one to two halogen, methyl, or trifluoromethyl groups, cyclopropylmethyl substituted by one to two halogen or trifluoromethyl groups, or C1-C2 alkylsulfonyl substituted by one to three halogen groups; or

[0153] I. halogen, C1-C3 haloalkyl, cyclopropyl substituted by one to two fluorine groups, methyl groups, or trifluoromethyl groups, cyano groups, cyclopropylmethyl groups substituted by one to two fluorine groups, or trifluoromethylsulfonyl groups; or

[0154] J. Halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 alkoxy, C1-C3 haloalkoxy, CN, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted by one to three substituents independently selected from C1-C3 alkyl, C1-C3 haloalkyl, cyano and halogen, C3-C6 cycloalkyl C1-C4 alkyl, substituted by one to five substituents independently selected from C1 - C3-C6 cycloalkyl substituted with C3-C3 alkyl, C1-C3 haloalkyl, cyano and halogen substituents, C1-C4 alkyl, C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkylsulfinyl or C3-C6 cycloalkylsulfonyl; or

[0155] K. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 alkoxy, C1-C3 haloalkoxy, CN, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted by one or two substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C3-C6 cycloalkylC1-C4 alkyl, C3-C6 cycloalkylC1-C4 alkyl substituted by one to three substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkylsulfinyl or C3-C6 cycloalkylsulfonyl; or

[0156] L. halogen, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 haloalkoxy, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted by one or two substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C3-C6 cycloalkylC1-C4 alkyl, C3-C6 cycloalkylC1-C4 alkyl substituted by one to three substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkylsulfinyl or C3-C6 cycloalkylsulfonyl; or

[0157] M. halogen or C1-C3 haloalkyl; or

[0158] N. chlorine, fluorine, bromine, difluoromethyl or trifluoromethyl; or

[0159] O. fluorine, chlorine, bromine, or trifluoromethyl; or

[0160] P. trifluoromethyl; or

[0161] Q. chlorine or trifluoromethyl;

[0162] R. Chloro, bromo, iodo, or trifluoromethyl.

[0163] In an embodiment of each aspect of the invention, R 2b yes

[0164] A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, substituted by one to three independently selected R xC3-C6 cycloalkyl, C3-C6 cycloalkylcarbonyl, phenyl, substituted by one to three independently selected R x substituted phenyl, heteroaryl, substituted by one to three independently selected R x Substituents substituted heteroaryl, OR 6 , piperidin-2-one-1-yl, one to two independently selected from R x Substituents substituted piperidin-2-one-1-yl, pyridin-2-one-1-yl, substituted by one to two independently selected from R x substituted pyridin-2-one-1-yl, azetidin-1-yl, substituted by one to two independently selected from R x substituted azetidin-1-yl, pyrrolidin-1-yl, substituted by one to two independently selected from R x substituted pyrrolidin-1-yl, C3-C6 cycloalkyl C1-C4 alkyl, substituted by one to two independently selected R z C3-C6 cycloalkyl C1-C4 alkyl, C3-C6 cycloalkyl C1-C3 alkoxy, substituted by one to two independently selected R x C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, substituted by one to three independently selected R x C1-C4 alkylsulfanyl, C1-C4 alkylsulfonyl, substituted by one to three independently selected R x C1-C4 alkylsulfonyl, C1-C4 alkylsulfinyl, and one to three independently selected R x a C1-C4 alkylsulfinyl group substituted with a substituent of

[0165] B. halogen, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 alkoxy, C1-C3 haloalkoxy, or CN; or

[0166] C. halogen, C1-C3 haloalkyl, or C1-C3 haloalkoxy; or

[0167] D. halogen or C1-C3 haloalkyl; or

[0168] E. chlorine, fluorine, bromine, difluoromethyl or trifluoromethyl; or

[0169] F. fluorine, chlorine, bromine, or trifluoromethyl; or

[0170] G. trifluoromethyl; or

[0171] H. chloro or trifluoromethyl; or

[0172] I. Chloro, bromo, iodo, or trifluoromethyl.

[0173] In an embodiment of each aspect of the invention, R 3 yes

[0174] A. C1-C3 alkyl or C1-C3 haloalkyl; or

[0175] B. methyl or trifluoromethyl; or

[0176] C. Methyl.

[0177] In an embodiment of each aspect of the invention, Q is

[0178] A. or

[0179] BQ a , where R 4 It is R 4a or R 4b ;or

[0180] CQ a , where R 4 It is R 4a ;or

[0181] DQ a , where R 4 It is R 4b ;or

[0182] EQ b , where R 4 It is R 4a or R 4b ;or

[0183] FQ b , where R 4 It is R 4a ;or

[0184] GQ b , where R 4 It is R 4b .

[0185] In an embodiment of each aspect of the invention, Q a yes

[0186] A.Selected from Q A -1 to Q A -16; or

[0187] B.Selected from Q A -1, Q a -6, Q a -7, Q A -10 and Q A-15; or

[0188] CQ A -1 or Q A -15; or

[0189] D.Selected from Q A -1 to Q A -16, where R 4 It is R 4a ;or

[0190] E. Selected from Q A -1 to Q A -16, where R 4 It is R 4b ;or

[0191] F. Selected from Q A -1, Q a -6, Q a -7, Q A -10 and Q A -15; where R 4 It is R 4a ;or

[0192] G. Selected from Q A -1, Q a -6, Q a -7, Q A -10 and Q A -15; where R 4 It is R 4b ;or

[0193] HQ A -1 or Q A -15, where R 4 It is R 4a ;or

[0194] IQ A -1 or Q A -15, of which R 4 It is R 4b ;or

[0195] JQ A -1 and R 4 It is R 4a or R 4b ,

[0196]

[0197] In an embodiment of each aspect of the invention, Q b yes

[0198] A.Selected from Q B -1 to QB -13; or

[0199] BQ B -1; or

[0200] C.Selected from Q B -1 to Q B -13, of which R 4 It is R 4a ;or

[0201] D.Selected from Q B -1 to Q B -13, of which R 4 It is R 4b ;or

[0202] EQ B -1, and R 4 It is R 4a ;or

[0203] FQ B -1, and R 4 It is R 4a .

[0204]

[0205] In an embodiment of each aspect of the invention, R 4 yes

[0206] A. The interlaced lines represent R 4 With Q a or Q b connection; and wherein A 14 、A 24 and A 34 are independently N or CH; or

[0207] B. The interlaced lines represent R 4 With Q a or Q b connection; and wherein A 14 、A 24 and A 34 are independently N or CH; or

[0208] C. The interlaced lines represent R 4 With Q a or Q b connection; and wherein A 14 It is N or CH.

[0209] In an embodiment of each aspect of the invention, wherein R4 It is R 4a and

[0210] AA 14 、A 24 and A 34 are independently N or CH, provided that at least one is N; or

[0211] BA 14 、A 24 and A 34 are independently N or CH, provided that one is N and the other two are CH; or

[0212] CA 14 、A 24 and A 34 are independently N or CH, provided that at least one is CH; or

[0213] DA 14 、A 24 and A 34 are independently N or CH, provided that one is CH and the other two are N;

[0214] EA 14 It's N, A 24 is N or CH, and A 34 is N or CH; or

[0215] FA 14 N or CH, A 24 is N, and A 34 is N or CH; or

[0216] GA 14 N or CH, A 24 is N or CH, and A 34 is N; or

[0217] HA 14 It is CH, A 24 is N or CH, and A 34 is N or CH; or

[0218] IA 14 N or CH, A 24 is CH, and A 34 is N or CH; or

[0219] JA 14 N or CH, A 24 is N or CH, and A 34 is CH; or

[0220] KA 14It's N, A 24 is N, and A 34 is N or CH; or

[0221] LA 14 It's N, A 24 is CH, and A 34 is N or CH; or

[0222] MA 14 It is CH, A 24 is N, and A 34 is N or CH; or

[0223] NA 14 It is CH, A 24 is CH, and A 34 is N or CH; or

[0224] OA 14 It's N, A 24 is N or CH, and A 34 is N; or

[0225] PA 14 It's N, A 24 is N or CH, and A 34 is CH; or

[0226] QA 14 It is CH, A 24 is N or CH, and A 34 is N; or

[0227] RA 14 It is CH, A 24 is N or CH, and A 34 is CH; or

[0228] SA 14 N or CH, A 24 is N, and A 34 is N; or

[0229] TA 14 N or CH, A 24 is N, and A 34 is CH; or

[0230] UA 14 N or CH, A 24 is CH, and A 34 is N; or

[0231] VA 14 N or CH, A 24 is CH, and A 34is CH; or

[0232] WA 14 It's N, A 24 is N, and A 34 is N; or

[0233] XA 14 It's N, A 24 is N, and A 34 is CH; or

[0234] YA 14 It's N, A 24 is CH, and A 34 is N; or

[0235] ZA 14 It is CH, A 24 is N, and A 34 is N; or

[0236] AA.A 14 It's N, A 24 is CH, and A 34 is CH; or

[0237] BB.A 14 It is CH, A 24 is N, and A 34 is CH; or

[0238] CC.A 14 It is CH, A 24 is CH, and A 34 is N; or

[0239] DD.A 14 It is CH, A 24 is CH, and A 34 It is CH.

[0240] In an embodiment of each aspect of the invention, wherein R 4 It is R 4b

[0241] AA 14 is CH; or

[0242] BA 14 It's N.

[0243] In an embodiment of each aspect of the invention, R 4a is an oxo-triazinyl moiety, or an oxo-diazinyl moiety or an oxo-pyridinyl moiety. 4a is an oxo-diazinyl moiety. In an embodiment of each aspect of the invention, R 4ais an oxopyridinyl, oxopyrimidinyl, oxopyrazinyl or oxopyridazinyl moiety. In embodiments of each aspect of the invention, R 4b is an oxo-dihydro-pyridinyl or oxo-dihydro-pyridazinyl moiety. 4a and R 4b Each is linked to the remainder of the compound via a carbon atom on the corresponding ring (the "linking carbon atom"). The linking carbon atom and the carbonyl group C=O are in the para position relative to each other on the oxopyridinyl, oxopyrimidinyl, oxopyrazinyl or oxopyridazinyl moiety. 4a and R 4b The nitrogen atom having a substitution in the ortho position relative to the carbonyl C=O. The substituted nitrogen atom is R 4c In embodiments of each aspect of the present invention, R 4a is the oxopyridyl moiety (A 14 、A 24 and A 34 is CH, that is, R 4a is embodiment DD). In embodiments of each aspect of the invention, R 4a has an unsubstituted nitrogen atom in the second ortho position relative to the carbonyl C═O. In this case, R 4a is the oxopyrimidinyl moiety (A 14 and A 24 is CH, and A 34 is N, that is, R 4a is embodiment CC), wherein the carbonyl C=O is between the two nitrogen atoms of the ring. In embodiments of each aspect of the invention, R 4a has an unsubstituted nitrogen atom in the meta position relative to the carbonyl C=O. In this case, R 4a is the oxopyrazinyl moiety (A 14 and A 34 It is CH, A 24 is N, that is, R 4a is embodiment BB) or an oxopyridazinyl moiety (A 14 It's N, A 24 and A 34 is CH, that is, R 4a is embodiment AA). In embodiments of each aspect of the invention, R 4a is an oxopyridazinyl moiety (A 14 It's N, A 24 and A 34 is CH, that is, R 4a is embodiment AA). In embodiments of each aspect of the invention, R 4b is an oxo-dihydro-pyridazinyl moiety (A 14 is N, that is, R 4bis embodiment A). In embodiments of each aspect of the invention, R 4b is an oxo-dihydro-pyridinyl moiety (A 14 is CH, that is, R 4b This is embodiment A).

[0244] In an embodiment of each aspect of the invention, R 4c yes

[0245] A. C1-C3 alkyl, C1-C3 haloalkyl, allyl, propargyl, or C3-C6 cycloalkyl C1-C4 alkyl; or

[0246] B. C1-C2 alkyl, C1-C2 haloalkyl, allyl, propargyl, or C3-C4 cycloalkyl C1-C2 alkyl; or

[0247] C. methyl, ethyl, difluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoromethyl, allyl, propargyl, or cyclopropylmethyl; or

[0248] D. methyl, ethyl, difluoromethyl, 2,2-difluoroethyl, allyl, propargyl, or cyclopropylmethyl; or

[0249] E. methyl, ethyl, allyl, propargyl, or cyclopropylmethyl; or

[0250] F. methyl or ethyl; or

[0251] G. methyl or allyl; or

[0252] H. methyl or propargyl; or

[0253] I. methyl or cyclopropylmethyl; or

[0254] J. Meth.

[0255] In an embodiment of each aspect of the invention, wherein Q is Q a , R 5 yes

[0256] A. Hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, C3-C4 alkoxy C(O)-, (C1-C3 alkoxy)2CH-, halogen, CN, NH2C(O), amino (i.e., NH2), (C1-C3 alkyl)amino, di(C1-C3 alkyl)amino, hydroxy, C3-C4 halocycloalkyl, C3-C4 cyanocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C3 alkyl)C(O), (C1-C3 alkyl)2NC(O), (C1-C3 cycloalkyl)NHC(O), (C1-C3 cycloalkyl)(C1-C3 alkyl)NC(O), (C1-C3 alkyl)C(O)(C1-C3 alkyl)N, (C1-C3 alkyl)C(O)NH, (C1-C3 alkyl)C(O), (C1-C3 alkoxy)C(O), HC(O), diphenylcarbamate, C1-C3 haloalkoxy, phenyl, or a 5-membered heteroaromatic ring; or R 5 is phenyl substituted with one to three substituents selected from the group consisting of C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN, and hydroxy; or R 5 is a 5-membered heteroaromatic ring substituted with one to three substituents selected from the group consisting of C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN, and hydroxy; or

[0257] B. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, halogen, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)C(O), (C1-C3 alkoxy)C(O), HC(O), C1-C3 haloalkoxy, or a 5-membered heteroaromatic ring which may be optionally substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN, or hydroxy; or

[0258] C. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, halogen, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)C(O), (C1-C3 alkoxy)C(O), HC(O) or C1-C3 haloalkoxy; or

[0259] D. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, halogen, Cl, Br, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)C(O), (C1-C3 alkoxy)C(O), or C1-C2 haloalkoxy; or

[0260] E. hydrogen, C1-C3 alkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, C1-C3 haloalkoxy, halogen, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)C(O), HC(O), or (C1-C3 alkoxy)C(O); or

[0261] F. hydrogen, C1-C2 alkyl, C1-C2 alkoxy, C3-C4 cycloalkyl, C1-C2 haloalkoxy, halogen, C1-C2 alkoxy-C1-C2 alkyl, C1-C2 alkoxy-C1-C2 alkoxy-C1-C2 alkyl, (C1-C2 alkyl)C(O), HC(O), or (C1-C2 alkoxy)C(O); or

[0262] G. hydrogen, methyl, trifluoromethoxy, methoxy, cyclopropyl, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, difluoromethoxy, 2,2,2-trifluoroethyl, chlorine, bromine, methoxyethoxy, methylcarbonyl, or methoxycarbonyl; or

[0263] H. hydrogen, methyl, trifluoromethoxy, methoxy, cyclopropyl, difluoromethoxy, chlorine, bromine, methoxyethoxy, methylcarbonyl, or methoxycarbonyl; or

[0264] I. hydrogen, methyl, methoxy, cyclopropyl, chlorine, or methoxyethoxy; or

[0265] J. hydrogen, or methyl; or

[0266] K. Hydrogen.

[0267] In an embodiment of each aspect of the invention, wherein Q is Q b , R 5a yes

[0268] A. hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; or

[0269] B. hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl or C1-C3 alkoxy; or

[0270] C. hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl or C1-C3 alkoxy; or

[0271] D. hydrogen, halogen, CN, C1-C3 alkyl or C1-C3 alkoxy; or

[0272] E. hydrogen or halogen; or

[0273] F. Hydrogen.

[0274] In an embodiment of each aspect of the invention, wherein Q is Q b , R 5b yes

[0275] A. hydrogen, halogen, CN, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy; or

[0276] B. hydrogen, halogen or C1-C3 alkoxy; or

[0277] C. Hydrogen.

[0278] In an embodiment of each aspect of the invention, R 6 yes

[0279] A. phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl, each of which is independently optionally substituted with a X or

[0280] B. phenyl, benzyl, cyclopropyl or a group selected from R X The substituent is a cyclopropyl group substituted with.

[0281] In an embodiment of each aspect of the invention, R X Independently selected from:

[0282] A. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, NO2, SF5, CN, C(O)NH2, C(S)NH2, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl and C1-C4 alkylsulfonyl; or

[0283] B. halogen, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy or CN; or

[0284] CF, Cl, Br, OCF2H, OCH3 or CN.

[0285] In an embodiment of each aspect of the invention, R Y Independently selected from

[0286] A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, hydroxy, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, CN and cyclopropyl; or

[0287] B. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, CN and cyclopropyl; or

[0288] C. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, and cyclopropyl; or

[0289] D. hydrogen, C1-C3 alkyl, chlorine, C1-C3 haloalkyl and C1-C3 alkoxy; or

[0290] E. hydrogen, chlorine, methyl, trifluoromethyl and methoxy; or

[0291] F. hydrogen, chlorine, methyl; or

[0292] G. Chlorine, hydrogen.

[0293] In an embodiment of each aspect of the invention, R Z Independently selected from:

[0294] A. oxo, halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, and CN; or

[0295] B. oxo, halogen, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy or CN; or

[0296] C. Oxo, F, Cl, Br, OCF2H, OCH3 or CN.

[0297] The present invention thus makes available a compound of formula (I) having the substituents A as defined above in all combinations / permutations 1 、A 2 、A 3 、A 4 、A 5 、X 0 , Q a , Q b , R, R 1 、R 2a 、R 2b 、R 3 、R 4c 、R 5 、R 5a 、R 5b 、R 6 、R X 、R Y and R Z .

[0298] Thus, it is possible to obtain compounds of formula (I), for example, wherein A 1 、A 2 and A 3 is embodiment S (ie, A 1 =A 2 -A 3 Together is NR-C(=O)-N), A 4 and A 5 This is Example E (ie, A 4 and A 5 are all CH), R is Example B (i.e., R is hydrogen, methyl, ethyl, difluoroethyl or trifluoroethyl), R 1 is Example 1 (ie, R 1 is hydrogen, methyl, or cyclopropyl-methyl), R 2a is embodiment M (ie, R 2a is halogen or C1-C3 haloalkyl), such as R 2a is Example O (ie, R 2a is fluoro, chloro, bromo, or trifluoromethyl), R 2b is Example E (ie, R 2b is chloro, fluoro, bromo, difluoromethyl, or trifluoromethyl), R 3 is Example B (ie, R 3 is methyl or trifluoromethyl), Q is Example C (ie, Q is Q a , where R 4 It is R 4a ), where Q a is Example H (ie, Q a It's Q A-1 or Q A -15), R 4a This is Example 1 (i.e., A 14 N or CH, A 24 is CH, and A 34 is N or CH), R 4c is Example G (ie, R 4c is methyl or allyl).

[0299] It also makes it possible to obtain compounds of formula (I), for example, wherein A 1 、A 2 and A 3 This is Example J (ie, A 1 and A 3 is N, and A 2 It's CR Y ), where R Y is Example F (ie, R Y is hydrogen, chlorine, methyl), A 4 and A 5 This is Example E (ie, A 4 and A 5 Both CH), R 1 is Example F (ie, R 1 is hydrogen, C1-C3 alkyl, C1-C3 cyanoalkyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C3-C4 cycloalkyl, C1-C2 alkyl-, benzyloxycarbonyl, or benzyl), such as R 2a is embodiment M (ie, R 2a is halogen or C1-C3 haloalkyl), R 2b is Example C (ie, R 2b is halogen, C1-C3 haloalkyl, or C1-C3 haloalkoxy), R 3 is Example C (ie, R 3 is methyl), Q is Example C (ie, Q is Q a , where R 4 It is R 4a ), where Q a It's Q A -1, R 4a This is Example AA (ie, A 14 It's N, A 24 is CH, and A 34 is CH), R 4c is Example 1 (ie, R 4c is methyl or cyclopropylmethyl).

[0300] It also makes it possible to obtain compounds of formula (I), for example, wherein A 1 、A 2 and A 3 Example C (ie, A 1 and A 3 is N, and A 2 It's CR Y ; or A 1 =A 2 -A 3 Together is NR-C(=O)-N), where R Y is Example G (ie, R Y is hydrogen or chlorine), and R is embodiment G (i.e., R is methyl or hydrogen), A 4 and A 5 This is Example E (ie, A 4 and A 5 Both CH), R 1 is Example J (ie, R 1 is hydrogen or methyl); R 2a is embodiment R (ie, R 2a is chloro, bromo, iodo, or trifluoromethyl), R 2b is Example 1 (ie, R 2b is chloro, bromo, iodo, or trifluoromethyl), R 3 is Example C (ie, R 3 is methyl), Q is Example B (ie, Q is Q a , where R 4 It is R 4a or R 4b ), where Q a It's Q A -1, R 4a This is Example AA (ie, A 14 It's N, A 24 is CH, and A 34 is CH), R 4b Example B (ie, A 14 is N), and R 4c is Example F (ie, R 4c is methyl or ethyl).

[0301] In an embodiment, the compound of formula (I) is a compound of formula (I* a )、(I* b )、(I* c )、(I* d )、(I* e ) or (I* f )(where the asterisk indicates the stereocenter), where A 1 、A 2 、A 3、A 4 、A 5 , R, R 1 、R 2a 、R 2b 、R 3 、R 4c 、R 5 、R 5a 、R 5b and R Y are as defined in the first aspect, each having corresponding embodiments as described above.

[0302]

[0303]

[0304] In an embodiment, the preferred stereochemistry of the compound depicted by formula (I') is greater than that of the compound depicted by formula (I*). a ), (I*b), (I*c), (I*d), (I*e) or (I*f) are also preferred. In a preferred embodiment, a compound of formula (I') having the following stereochemistry a )、(I' b )、(I' c )、(I' d )、(I' e ) or (I' f ) are preferred:

[0305]

[0306]

[0307] Among them A 1 、A 2 、A 3 、A 4 、A 5 , R, R 1 、R 2a 、R 2b 、R 3 、R 4c 、R 5 、R 5a 、R 5b and R Y is as defined in the first aspect, and has the formula (I' a )、(I' b )、(I' c )、(I' d )、(I' e ) or (I' f) stereoisomers, enantiomers, tautomers and N-oxides of compounds of the invention, and agrochemically acceptable salts thereof.

[0308] Compounds of formula (I) can be prepared by those skilled in the art according to known methods. More specifically, compounds of formula (I), compounds of formula (I') and intermediates thereof can be prepared as described below in the schemes and examples. For the sake of clarity, certain stereocenters are not specified and are not intended to limit the teachings of these schemes in any way.

[0309] The process according to the invention for preparing the compounds of formula (I) is carried out by methods known to those skilled in the art.

[0310] Compounds having formula (I)

[0311]

[0312] Among them A 1 、A 2 、A 3 、A 4 、A 5 、R 1 、R 3 ,Q,R 2a and R 2b have the same meanings as given above for the compounds of formula (I) and can be prepared as follows: Amines of formula (III)

[0313]

[0314] or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or hydrobromide salt, or a trifluoroacetate salt, or any other equivalent salt), wherein R 1 、R 3 and Q have the same meanings as given above for the compound of formula (I), the reaction with the compound of formula (II)

[0315]

[0316] Among them A 1 、A 2 、A 3 、A 4 、A 5 、R 2a and R 2b has the same meanings as given above for the compound of formula (I), and wherein X 1 is a leaving group such as a halogen, a hydroxyl group, or a sulfonate.

[0317] Throughout the specification, for example in the following Schemes 1 to 11, or in Tables A-1 to A-78, Tables B-1 to B-78, Tables C-1 to C-21, and Tables D-1 to D-21, T represents Among them A 1 、A 2 、A 3 、A 4 、A 5 、R 2a and R 2b have the same meanings as given above for the compound of formula (I), and wherein the staggered lines indicate the connection to the rest of the compound, such as the compounds of formula (I), (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (II), (IV), (IVa), (X), (XI), (XVII) in Schemes 1 to 11.

[0318] Option 1:

[0319]

[0320] The compound of formula (I) can be prepared, for example, by the following method: a compound of formula (II) (wherein X 1 is a leaving group such as halogen, hydroxy or sulfonate, for example chlorine, and wherein T has the meaning given above) and a compound of formula (III) or a salt thereof (wherein R 1 、R 3 and Q have the same meanings as given above for the compound of formula (I). 1 In the case of hydroxyl groups, it may be advantageous to react the hydroxyl group with a dehydrating agent (e.g. a peptide coupling agent such as a carbodiimide or propanephosphonic acid cyclic anhydride). ) in the presence of . Such a reaction can be carried out at -100 ° C to + 300 ° C, preferably in a temperature range between ambient temperature and 200 ° C, in the presence or absence of a catalyst (for example, a metal catalyst such as a palladium complex), and with or without the addition of a base (such as an inorganic base (such as sodium carbonate, potassium carbonate or cesium carbonate) or an organic base (such as triethylamine, diisopropylethylamine or pyridine)), neat or in a solvent, preferably in a solvent such as an organic solvent such as acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, ethyl acetate, N, N-dimethylacetamide or N, N-dimethylformamide. Compounds with formula (II) are known or can be prepared similarly to the descriptions found, for example, in WO 2021 / 083936 and WO 2021 / 177160, or they can be prepared by methods known to those skilled in the art.

[0321] Option 2:

[0322]

[0323] The compound of formula (III) or a salt thereof can be prepared, for example, as shown in Scheme 2. A compound of formula (V) (wherein R 3 and Q have the same meanings as given above for the compound of formula (I) and wherein X 2 is a leaving group such as a halogen or sulfonate, for example bromine) with an amine of formula (XIX) or a salt thereof (wherein R 1 have the same meanings as given above for compounds of formula I) are processed to give compounds of formula (III) wherein Q, R 1 and R 3 has the same meanings as given above for the compounds of formula I. The reaction can be carried out neat or in a solvent, preferably in a solvent such as an organic solvent, for example acetonitrile, at a temperature range of -100°C to +300°C, preferably between ambient temperature and 200°C, with or without addition of a base, such as an inorganic base, for example potassium carbonate, or an organic base, such as, for example, triethylamine.

[0324] Alternatively, a compound of formula (VII) wherein R 3 and Q have the same meanings as given above for the compound of formula (I)) with an amine of formula (XIX) or a salt thereof (wherein R 1 have the same meanings as given above for compounds of formula I) are processed to give compounds of formula (III) wherein Q, R 1 and R 3 has the same meaning as given above for the compound of formula I. This reaction is carried out in the presence of a reducing agent (such as, for example, hydrogen or a hydride such as sodium borohydride), with or without a catalyst (such as a hydrogenation catalyst, for example palladium on carbon), with or without an acid (such as acetic acid or a Lewis acid such as zinc bromide or titanium (IV) isopropoxide), in a solvent such as, for example, methanol or in the absence of a solvent. The reaction can be carried out at a temperature ranging from -100°C to +300°C, preferably between ambient temperature and 200°C. Such methods for the alkylation of amines and the reductive alkylation of amines and the range of conditions under which they are carried out (for example, in the presence of NaBH(OAc)3 or NaBH3CN, in a suitable solvent, preferably in acetic acid, at room temperature, similar to WO2002 / 088073; or alternatively, by using a combination of Ti(i-OiPr)4 and NaBH4, as described in Synthesis 2003(14), 2206) are well known to those skilled in the art. An amine having formula (XIX) or a salt thereof (wherein R 1have the same meanings as given above for the compounds of formula (I)) are known or they can be prepared by methods known to a person skilled in the art.

[0325] Option 3:

[0326]

[0327] Alternatively, compounds of formula (I) can be prepared, for example, by the following: Compounds of formula (IV) (wherein T has the same meaning as given above in Scheme 1, and R 1 have the same meanings as given above for the compound of formula (I)) and the compound of formula (V) (wherein R 3 and Q have the same meanings as given above for the compound of formula (I), and X 2 The reaction is carried out in the temperature range of -100°C to +300°C, preferably between ambient temperature and 200°C, with or without the addition of a base, such as an inorganic base (e.g. potassium carbonate) or an organic base (e.g. triethylamine), neat or in a solvent, preferably an organic solvent (e.g. acetonitrile). Such methods for the alkylation of amines and the range of conditions under which they are carried out are well known to those skilled in the art.

[0328] Alternatively, compounds of formula (I) can be prepared by reacting a compound of formula (IVa) (wherein T has the same meaning as given above in Scheme 1) with a compound of formula (VII) (wherein R 3 and Q have the same meanings as given above for compounds of formula (I)). The reaction is carried out in the presence of a reducing agent (such as, for example, hydrogen or a hydride such as sodium borohydride), with or without a catalyst (such as a hydrogenation catalyst, for example, palladium on carbon), with or without an acid (such as acetic acid or a Lewis acid such as zinc bromide), in a solvent (such as, for example, methanol) or without a solvent. The reaction can be carried out at a temperature ranging from -100°C to +300°C, preferably between ambient temperature and 200°C. Such methods for the reductive alkylation of amines and the range of conditions under which they are carried out are well known to those skilled in the art.

[0329] Option 4:

[0330]

[0331] Compounds of formula (V) can be prepared, for example, as shown in Scheme 4. Treatment of compounds of formula (VIII) with a halogenating agent such as chlorine or bromine or N-bromosuccinimide gives, for example, compounds of formula (V) wherein the leaving group X 2 is a halogen, such as chlorine or bromine. The reaction is carried out with or without a solvent, preferably in a solvent, with or without an additive such as a free radical initiator, such as, for example, benzoyl peroxide or azoisobutyronitrile. The reaction can be carried out with or without exposure to visible light or ultraviolet light, and can be carried out at a temperature ranging from -100°C to +300°C, preferably between ambient temperature and 200°C.

[0332] Alternatively, a compound of formula (VII) may be treated with a reducing agent and then reacted with a sulfonyl chloride, such as methanesulfonyl chloride, to give a compound of formula (V) wherein the leaving group X 2 It is a sulfonic acid ester, such as methanesulfonic acid ester. The reaction can be carried out in a solvent or in the absence of a solvent, in the presence of a base (such as an inorganic base such as potassium carbonate, or an organic base such as an amine base such as trimethylamine) or in the absence of a base, and it can be carried out at -100 ° C to +300 ° C, preferably in the temperature range between ambient temperature and 200 ° C. Suitable reducing agents can be, for example, hydrogen or hydride (such as sodium borohydride), with or without a catalyst (such as a hydrogenation catalyst such as palladium carbon), with or without an acid (such as acetic acid or Lewis acid such as zinc bromide), in a solvent (such as methanol) or in the absence of a solvent. The reaction can be carried out at -100 ° C to +300 ° C, preferably in the temperature range between ambient temperature and 200 ° C. The method for the reduction of such halogenation, carbonyl compounds and the sulfonylation of alcohol and the condition range for implementing them are well known to those skilled in the art. Compounds with formula (VII) and compounds with formula (VIII) are known, or they can be prepared by methods known to those skilled in the art.

[0333] Option 5:

[0334]

[0335] Alternatively, compounds of formula (Ib) wherein T has the same meaning as given above in Scheme 1, and R 1 、R 3 and Q have the same meanings as given above for the compound of formula (I), except that R 1 is not hydrogen) can be prepared, for example, as shown in Scheme 5. Compounds of formula (Ia) wherein T has the same meaning as given above in Scheme 1 and R 3and Q have the same meanings as given above for compounds of formula (I)) can be combined with compounds of formula (VI) (wherein R 1 have the same meanings as given above for the compounds of formula (I), except that R 1 is not hydrogen, and where X 3 is a leaving group such as a halogen or sulfonate, for example chlorine, bromine, iodine or methanesulfonate) to give a compound of formula (Ib). The reaction can be carried out neat or in a solvent, preferably in a solvent such as an organic solvent, for example acetonitrile, N,N-dimethylformamide (DMF) or N,N-dimethylacetamide (DMA) or a mixture thereof, at a temperature range of -100°C to +300°C, preferably between ambient temperature and 200°C, with or without the addition of a base, such as an inorganic base (e.g. sodium carbonate, potassium carbonate or cesium carbonate) or an organic base (e.g. triethylamine, diisopropylethylamine or pyridine). Such methods for the alkylation of amines and the range of conditions under which they are carried out are well known to those skilled in the art.

[0336] The compound of formula (VI) (wherein R 1 have the same meanings as given above for the compounds of formula (I), except that R 1 is not hydrogen, and where X 3 The leaving groups, such as halogen or sulfonate, for example chloro, bromo, iodo or methanesulfonate) are known or they can be prepared by methods known to those skilled in the art.

[0337] Option 6:

[0338]

[0339] Compounds of formula (Ic) wherein T has the same meaning as given above in Scheme 1, and R 3 and R 4 Compounds of formula (II) wherein T has the same meaning as given above in Scheme 1 and wherein X 1 is a leaving group such as a halogen or sulfonate, for example chlorine) and a compound of formula (IX) or a salt thereof (wherein R 3 has the same meanings as given above for compounds of formula (I)) gives compounds of formula (X) (wherein T has the same meanings as given above in Scheme 1, and wherein R 3has the same meanings as given above for the compound of formula (I). The reaction can be carried out neat or in a solvent, preferably in a solvent such as an organic solvent, for example acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, ethyl acetate, N,N-dimethylacetamide or N,N-dimethylformamide, in the presence or absence of a catalyst, for example a metal catalyst such as a palladium complex, and with or without addition of a base, such as an inorganic base, for example sodium carbonate, potassium carbonate or cesium carbonate, or an organic base, such as, for example, triethylamine, diisopropylethylamine or pyridine.

[0340] Compounds of formula (X) wherein T has the same meaning as given above in Scheme 1, and wherein R 3 Subsequent treatment of the compound (XIII) (N,N-dimethylformamide dimethyl acetal, DMF-DMA) with the known compound (XIII) (N,N-dimethylformamide dimethyl acetal, DMF-DMA) gives the compound (XI) (wherein T has the same meaning as given above in Scheme 1, and wherein R 3 has the same meanings as given above for the compound of formula (I). This reaction can be carried out neat or in a solvent, preferably in a solvent, such as an organic solvent, for example dichloromethane, tetrahydrofuran, 2-methyltetrahydrofuran or dioxane, in the temperature range from -100°C to +300°C, preferably between ambient temperature and 100°C, or between ambient temperature and 50°C, in the absence of a base or in the presence of a base, such as an inorganic base, for example sodium carbonate, potassium carbonate or cesium carbonate, or an organic base, such as, for example, triethylamine, diisopropylethylamine or pyridine.

[0341] Compounds of formula (XI) wherein T has the same meaning as given above in Scheme 1, and wherein R 3 has the same meaning as given above for the compound of formula (I)) and a hydrazine compound of formula (XII) or a tautomer thereof or a salt thereof (wherein R 4 has the same meanings as given above for the compound of formula (I), preferably R 4 It is R 4a Further reaction (as defined above for compounds of formula (I)) gives compounds of formula (Ic) (wherein T has the same meaning as given above in Scheme 1, and wherein R 3 and R 4 has the same meanings as given above for the compound of formula (I), preferably R 4 It is R 4a(As defined above for compounds of formula (I)). The reaction can be carried out neat or in a solvent, preferably in a solvent such as an organic solvent, for example 1,4-dioxane or acetic acid or a mixture of 1,4-dioxane and acetic acid, in a temperature range of -100°C to +300°C, preferably between ambient temperature and 200°C or between ambient temperature and 80°C. Within this transformation sequence, the intermediate compounds of formula (X) and formula (XI) can be used as crude products in the subsequent step, or they can be purified, for example by chromatography, and used in the next transformation in purified form.

[0342] A compound of formula (IX) or a salt thereof (wherein R 3 have the same meanings as given above for the compounds of formula (I)) are known or they can be prepared by methods known to a person skilled in the art.

[0343] Compounds having formula (Ii)

[0344]

[0345] (where A 1 、A 2 、A 3 、A 4 、A 5 、R 1 、R 3 、R 4 、R 5 、R 2a and R 2b have the same meanings as given above for the compound of formula (I)) can be prepared by: an amine of formula (IIIa) or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or hydrobromide salt, or a trifluoroacetate salt or any other equivalent salt)

[0346]

[0347] (where R 1 、R 3 、R 4 and R 5 is as described in formula (I)) with a compound of formula (II)

[0348]

[0349] (where A 1 、A 2 、A 3 、A 4 、A 5 、R 2a and R 2b is as defined in formula (I) and X1 is a leaving group such as a halogen or sulfonate, for example chloro) under the conditions already described in Scheme 1.

[0350] Option 7:

[0351]

[0352] Compounds of formula (Ie) (wherein T has the same meaning as given above in Scheme 1, and R 1 、R 3 、R 4c and R 5 have the same meanings as given above for compounds of formula (I)) can (Scheme 7) be prepared from compounds of formula (Id) wherein T has the same meanings as given above in Scheme 1 and R 1 、R 3 、R 4c and R 5 The reaction may be carried out in the presence of hydrogen or by transfer hydrogenation, such as in the presence of formic acid or a formate salt. The reaction may be carried out in the presence of a catalyst (e.g., a homogeneous or heterogeneous catalyst). For example, the reaction is carried out in the presence of a palladium catalyst (e.g., palladium on carbon). It may be advantageous to carry out the reaction in a solvent or neat, preferably in a solvent such as methanol or ethanol as a solvent. The reaction may be carried out at a temperature between -100°C and +300°C, preferably between ambient temperature and 200°C, or between ambient temperature and 80°C, optionally in a pressure vessel.

[0353] Option 7a:

[0354]

[0355] Similarly, compounds of formula (Ih) wherein T has the same meaning as given above in Scheme 1, and R 1 、R 3 、R 4c 、R 5a and R 5b have the same meanings as given above for compounds of formula (I)) can (Scheme 7a) be prepared from compounds of formula (Ig) wherein T has the same meanings as given above in Scheme 1 and R 1 、R 3 、R 4c 、R 5a and R 5bhas the same meanings as given above for the compound of formula (I)) is prepared by hydrogenation under similar conditions as described in Scheme 7.

[0356] Option 8:

[0357]

[0358] Compounds of formula (XII-1) (a subset of compounds of formula (XII) wherein R 4 Specifically, R 4a or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or hydrobromide salt, or a trifluoroacetate salt or any other equivalent salt), wherein A 14 、A 24 、A 34 and R 4c having the same meanings as defined above for compounds of formula (I), can be (Scheme 8) treated with hydrazine or hydrazine hydrate or a salt thereof to obtain a compound of formula (XV) (wherein A 14 、A 24 、A 34 and R 4c has the same meaning as defined above for the compound of formula (I), and X 4 is a leaving group, such as a halogen, a sulfonate, a C1-C4-sulfanyl, a C1-C4-sulfinyl or a C1-C4-sulfonyl). The reaction can be carried out neat or in a solvent such as water, an alcohol such as methanol or ethanol, or methoxycyclopentane at a temperature between -100°C and 200°C, more usually between 0°C and 150°C, such as at 100°C. Such reactions are known from the literature, for example from Bioorganic & Medicinal Chemistry Letters (2012), 22(2), 1226-1229. Many compounds of formula (XV) are known or even commercially available or they can be prepared by known methods. In particular, compounds of formula (XV) wherein A 14 、A 24 、A 34 and R 4c has the same meaning as defined above for the compound of formula (I), and X 4 is a leaving group, such as a halogen, a sulfonate, a C1-C4-sulfanyl, a C1-C4-sulfinyl or a C1-C4-sulfonyl group) can be removed by using a group having the formula R 4c -X 6 Reagents (where R 4c has the same meaning as defined above for the compound of formula (I), and X 6is a leaving group such as a halogen or sulfonate, for example chlorine, bromine, iodine or methanesulfonate) to treat a compound of formula (XVa) or a tautomer thereof (wherein A 14 、A 24 and A 34 has the same meaning as defined above for the compound of formula (I), and X 4 is a leaving group such as a halogen, a sulfonate, a C1-C4-sulfanyl, a C1-C4-sulfinyl or a C1-C4-sulfonyl group. The reaction can be carried out neat or in a solvent, preferably in an organic solvent such as acetonitrile, N,N-dimethylformamide (DMF) or N,N-dimethylacetamide (DMA) or a mixture thereof, at a temperature ranging from -100°C to +300°C, preferably between ambient temperature and 200°C, with or without the addition of a base such as an inorganic base such as sodium carbonate, potassium carbonate or cesium carbonate or an organic base such as triethylamine, diisopropylethylamine or pyridine. Such alkylation methods and the range of conditions under which they are carried out are well known to those skilled in the art and are described, for example, in Bioorganic & Medicinal Chemistry Letters (2012), 22(2), 1226-1229. 4c -X 6 The reagents and the compounds of formula (XVa) or their tautomers are known or even commercially available or they can be prepared by known methods.

[0359] Compounds of formula (XIIa) (a subset of compounds of formula (XII-1) wherein A 14 is N) or a salt thereof (wherein A 24 、A 34 and R 4c has the same meaning as defined above for the compound of formula (I)) may exist in different tautomeric forms, such as (XIIb) and / or (XIIc), or salts thereof, wherein A 24 、A 34 and R 4c has the same meaning as defined above for the compound of formula (I):

[0360]

[0361] The present invention encompasses all such tautomers and mixtures thereof in all proportions.

[0362] Option 9:

[0363]

[0364] A compound of formula (XVI) (wherein A 14 、A 24 、A 34 and R 4c has the same meaning as defined above for the compound of formula (I), and M 1 is a metal-containing substituent, such as a boron substituent or a tin substituent, such as tributylstannyl (M 1 is -SnBu3), dihydroxyboryl (M 1 is -B(OH)2) or a boronate ester such as 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) can be (Scheme 9) by treating a compound of formula (XV) (wherein A is -B(OH)2) or a boronate ester such as 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) with tributyl(tributylstannyl)stannane or diboronic acid or 4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolan (also known as bis(pinacolato)diboron) 14 、A 24 、A 34 and R 4c has the same meaning as defined above for the compound of formula (I), and X 4 The reaction can be carried out in the presence of a catalyst (such as a metal catalyst, such as a palladium catalyst, for example palladium acetate) and in the presence of a ligand (such as a phosphine ligand, for example 2-dicyclohexylphosphino-2', 4', 6'-triisopropylbiphenyl (XPhos)). The reaction can be carried out in the presence of a base (such as an alkoxide or carboxylate base, for example potassium acetate). The reaction can be carried out neat or in a solvent (such as dioxane or toluene as a solvent) at a temperature between -100°C and 200°C, more typically between 0°C and 150°C, such as at 100°C. Some compounds with formula (XVI) are known or even commercially available or they can be prepared by known methods.

[0365] Option 10:

[0366]

[0367] Compounds of formula (If) (wherein T has the same meaning as given above in Scheme 1, and wherein A 14 、A 24 、A 34 、R 1 、R 3 、R 4c 、R 5a and R 5bhave the same meanings as given above for compounds of formula (I)) can (Scheme 10) be prepared from compounds of formula (XVII) (wherein T has the same meanings as given above in Scheme 1, and wherein R 1 、R 3 、R 5a and R 5b has the same meanings as given above for the compound of formula (I), and wherein X 5 is a leaving group, such as chlorine, bromine or iodine) by reacting with a compound of formula (XVI) (wherein A 14 、A 24 、A 34 and R 4c has the same meaning as defined above for the compound of formula (I), and M 1 is a metal-containing substituent (which has the same meaning as given above in Scheme 9)). The reaction can be carried out in the presence of a catalyst (such as a palladium catalyst, for example, 1,1'-bis(diphenylphosphino)-ferrocene]dichloropalladium(II) (PdCl2dppf)) and a base (such as a carbonate base, for example, Cs2CO3, or a carboxylate base, for example, potassium acetate). The reaction can be carried out neat or in a solvent (such as dioxane as a solvent) at a temperature between -100°C and 200°C, more typically between 0°C and 150°C, such as at 85°C. Such reactions (known as Suzuki-Miyaura or Stiller cross-coupling reactions) are familiar to those skilled in the art.

[0368] Compounds of formula (XVII) (wherein T has the same meaning as given above in Scheme 1, and wherein R 1 、R 3 、R 5a and R 5b has the same meanings as given above for the compound of formula (I), and wherein X 5 is a leaving group, such as chlorine, bromine or iodine) by allowing a compound of formula (XVIIa) or a salt thereof (wherein R 1 、R 3 、R 5a and R 5b has the same meanings as given above for the compound of formula (I), and wherein X 5 is a leaving group such as chlorine, bromine or iodine) and a compound of formula (II) wherein T has the same meaning as given above in Scheme 1, and wherein X 1 is a leaving group such as a halogen or sulfonate, for example chloro) under similar conditions to those already described in Scheme 1 above.

[0369] A compound of formula (XVIIa) or a salt thereof (wherein T has the same meaning as given above in Scheme 1, and wherein R 1 、R 3 、R 5a and R 5b has the same meanings as given above for the compound of formula (I), and wherein X 5 is a leaving group, such as, for example, chlorine, bromine or iodine) are known from the literature, for example from WO 2021 / 170881, WO 2021 / 037614, WO 2020 / 208036, WO 2020 / 201398 or WO 2020 / 070049, or they can be prepared analogously to the descriptions found therein.

[0370] Option 11:

[0371]

[0372] The compound of formula (XXII) (wherein R 3 and R 4a is as defined for compounds of formula (I)) can be (Scheme 11) prepared from compounds of formula (XX) wherein R 3 and R 4a is as defined for the compound of formula (I) and X - is an anion) by treatment with a base (such as a hydroxide base or a carbonate base, for example sodium hydroxide or potassium carbonate) or an ion exchange resin. Such procedures are well known to those skilled in the art and are known from the literature and textbooks.

[0373] Anion X - It is the conjugate base of an acid such as an inorganic acid, for example hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid, etc., or an organic acid, for example a carboxylic acid or a sulfonic acid, for example trifluoroacetic acid, methanesulfonic acid or p-toluenesulfonic acid. Many such acids are known to those skilled in the art.

[0374] A compound having the formula (XX) (wherein R 3 and R 4a is as defined for the compound of formula (I), and X - is an anion) can be formed from a compound having formula (XXI) (wherein R 3 and R 4ais as defined for compounds of formula (I)) by treatment with an acid such as those listed above. The reaction can be carried out neat or in a solvent such as an organic solvent, such as methanol, CPME, tetrahydrofuran, 2-methyltetrahydrofuran, dichloromethane or dioxane, or an inorganic solvent such as water, or a mixture of such solvents. The reaction can be carried out at a temperature between -100°C and 200°C, more typically between 0°C and 150°C, such as at ambient temperature.

[0375] A compound of formula (XXI) wherein R 3 and R 4a is as defined for the compound of formula (I)) can be prepared, for example, from a compound of formula (XII-1) or a tautomer thereof or a salt thereof (wherein R 4a is as defined for the compound of formula (I) by reacting with a compound of formula (XVIII) wherein R 3 The reaction can be carried out neat or in a solvent such as an organic solvent or in a mixture of solvents (dioxane and acetic acid as solvents). The reaction can be carried out in the presence or absence of a drying agent, such as in the presence of molecular sieves, at a temperature between -100°C and 200°C, more usually between 0°C and 150°C, such as at 80°C. The compound of formula (XVIII) wherein R 3 are as defined for the compounds of formula (I)) are known, for example, from WO 2021 / 083936 or WO 2021 / 165195, or they can be prepared analogously to the descriptions found therein.

[0376] Option 12:

[0377]

[0378] Compounds of formula (XX-1) (a subset of compounds of formula (XX) wherein R 3 and R 4c has the same meaning as defined above for the compound of formula (I) and X - is an anion having the same meaning as given above in Scheme 11) can be (Scheme 12) formed from a compound of formula (XXI-1) (a subset of compounds of formula (XXI) wherein R 3 and R 4c has the same meaning as defined above for the compound of formula (I)) by treatment with an acid under the conditions already described above in Scheme 11 (XXI converted to XX).

[0379] Compounds of formula (XXI-1) (a subset of compounds of formula (XXI) wherein R 3 and R 4c has the same meaning as defined above for the compound of formula (I) can be obtained by using a compound of formula R 4c -X 6 Reagents (where R 4c has the same meaning as defined above for the compound of formula (I), and X 6 is a leaving group such as a halogen or sulfonate, for example chloro, bromo, iodo or methanesulfonate) is treated with a compound of formula (XXIII) or a tautomer thereof (wherein R 3 having the same meaning as defined above for the compound of formula (I)).

[0380] A compound of formula (XXIII) or a tautomer thereof (wherein R 3 has the same meaning as defined above for the compound of formula (I)) can be prepared by treating a compound based on formula (XXIV) (wherein R is present) with, for example, benzaldehyde oxime PhC=NOH, preferably (E)-benzaldehyde oxime in the presence of a base (such as potassium carbonate or cesium carbonate), optionally in the presence of a palladium catalyst (such as RockPhos-G3-cyclopalladium complex ([(2-di-tert-butylphosphino-3-methoxy-6-methyl-2′,4′,6′-triisopropyl-1,1′-biphenyl)-2-(2-aminobiphenyl)]methanesulfonate palladium(II)) in an aprotic solvent (such as acetonitrile or N,N-dimethylformamide DMF) at a temperature between 0°C and 100°C, preferably between room temperature and 80°C. 3 has the same meaning as defined above for the compound of formula (I) and wherein X 7 is a leaving group such as a halogen, for example chlorine, bromine or iodine), as described, for example, in Angew. Chem. Int. Ed. [Applied Chemistry International Edition] 56(16), 4478-4482, 2017.

[0381] A compound of formula (XXIV) wherein R 3 has the same meaning as defined above for the compound of formula (I) and wherein X 7 is a leaving group such as a halogen, for example chlorine, bromine or iodine) can be obtained by using a compound of formula (XVIII) wherein R 3 is as defined for the compound of formula (I)) is treated under similar conditions to those described in Scheme 11 above with a compound of formula (XXV) or a tautomer or salt thereof (wherein X 7is a leaving group, such as a halogen, for example, chlorine, bromine or iodine) to obtain (XII-1 + XVIII is converted to XXI). A compound having formula (XXV) or a tautomer thereof or a salt thereof (wherein X 7 The leaving groups, such as halogens, for example chlorine, bromine or iodine, are known or even commercially available, or they can be prepared by known methods.

[0382] Compounds of formula (XXIII) (all substituents are as defined above in Scheme 12) may exist in different tautomeric forms

[0383] wherein the staggered lines represent the connection to the remainder of the compound of formula (XXIII). The present invention encompasses all such tautomers and mixtures thereof in all proportions.

[0384] Option 13:

[0385]

[0386] The compound of formula (XXVII) (wherein R 3 and R 4c has the same meaning as defined above for the compound of formula (I) and X- is an anion having the same meaning as given above in Scheme 11) can (Scheme 13) be prepared from a compound of formula (XXVI) wherein R 3 and R 4c has the same meaning as defined above for the compound of formula (I)) by treatment with an acid under the conditions already described above in Scheme 11 (XXI converted to XX).

[0387] A compound of formula (XXVI) wherein R 3 and R 4c have the same meanings as defined above for the compound of formula (I)) can be prepared from the compound of formula (XXI-I) described above (wherein R 3 and R 4c has the same meaning as defined above for the compound of formula (I)) is prepared by hydrogenation under similar conditions to those already described in Scheme 7 above.

[0388] Option 14:

[0389]

[0390] A compound of formula (XXVIII) or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or hydrobromide salt, or a trifluoroacetate salt or any other equivalent salt), wherein R3 、R 4c 、R 5a and R 5b have the same meanings as defined above for compounds of formula (I)) can be (Scheme 14) prepared from compounds of formula (VII-1) (a subset of compounds of formula (VII) wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I)) is prepared by reductive amination under similar conditions to those already described in Scheme 2 above (conversion of VII to III).

[0391] Compounds of formula (VII-1) (a subset of compounds of formula (VII) wherein R 3 、R 4c 、R 5a and R 5b have the same meanings as defined above for compounds of formula (I)) can be prepared by using compounds of formula (XVI-1) (a subset of compounds of formula (XVI) wherein R 4c has the same meaning as defined above for the compound of formula (I) and M 1 is a metal-containing substituent having the same meaning as given above in Scheme 9) is treated under similar conditions to those already described above in Scheme 10 to obtain a compound of formula (XXIX) wherein R 3 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I), and wherein X 8 is a leaving group such as a halogen, for example chlorine, bromine or iodine) to obtain (XVII + XVI is converted to If). Compounds of formula (XXIX) (wherein R 3 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I), and wherein X 8 The leaving groups, such as halogens, for example chlorine, bromine or iodine, are known or even commercially available, or they can be prepared by known methods.

[0392] Alternatively, compounds of formula (VII-1) (a subset of compounds of formula (VII) wherein R 3 、R 4c 、R 5a and R 5bhave the same meanings as defined above for compounds of formula (I)) can be obtained by, for example, oxidation of the following (Scheme 15) compounds of formula (XXXI) (wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for compounds of formula (I), the oxidation being generally carried out in a chlorinated solvent such as dichloromethane or chloroform at a temperature between 0°C and 50°C, preferably at about room temperature.

[0393] Option 15:

[0394]

[0395] Alternatively, a compound of formula (XXVIII) or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or hydrobromide salt, or a trifluoroacetate salt or any other equivalent salt), wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I), can be (Scheme 15) formed from a compound of formula (XXX) (wherein R 3 、R 4c 、R 5a and R 5bhaving the same meaning as defined above for compounds of formula (I) and Z3 is -NPhth (N-phthalimide group) or -NBoc2 (N-bis(tert-butyloxycarbonyl) group) are typically prepared by treatment with hydrazine (preferably hydrazine hydrate or hydrazine monohydrate) in an alcoholic solvent such as ethanol or isopropanol (Z3 is -NPhth) or with an acid such as trifluoroacetic acid or hydrochloric acid in the presence of a suitable solvent such as dichloromethane, tetrahydrofuran, 2-methyltetrahydrofuran or dioxane (Z3 is -NBoc2) under deprotection conditions known to those skilled in the art and in the literature, such as described in Protective Groups in Organic Synthesis, 3rd edition, Theodora W. Green (The Rowland Institute for Science) and Peter G.M. Wuts (Pharmacia and Upjohn Company), John Wiley & Sons, Inc., New York, NY 1999, ISBN 0-471-16019-9.

[0396] A compound having the formula (XXX) (wherein R 3 、R 4c 、R 5a and R 5b having the same meaning as defined above for the compound of formula (I) and Z3 is -NPhth (N-phthalimide group) or -NBoc2 (N-bis(tert-butyloxycarbonyl) group) can be obtained by the compound of formula (XXXI) (wherein R 3 、R 4c 、R 5a and R 5b (having the same meaning as defined above for compounds of formula (I)) are prepared by the Mitsunobu reaction. Such a reaction involves treating a compound of formula (XXXI) with an azodicarboxylic acid (such as diethyl azodicarboxylate or diisopropyl azodicarboxylate) in the presence of a phosphine (such as triphenylphosphine or tributylphosphine) and an amine (such as phthalimide (HNPhth) or bis(tert-butoxycarbonyl)amine (HNBoc2)). Mitsunobu reactions (and conditions for carrying out them) are known to those skilled in the art and are described, for example, in Chem. Rev. 2009, 109, 2551-2651.

[0397] A compound of formula (XXXI) (wherein R 3 、R 4c 、R 5a and R 5bhave the same meanings as defined above for the compound of formula (I)) can be prepared from a silyl ether compound of formula (XXXII) (wherein R 3 、R 4c 、R 5a and R 5b The alkyl radicals R and R are preferably C-C-alkyl radicals (i.e., C-C-alkyl radicals) are preferably C-C-alkyl radicals (i.e., C-C-alkyl radicals) and ...

[0398] Alternatively, a compound of formula (XXXI) wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I)) can be obtained by, for example, reducing the compound of formula (VII-1) described above (Scheme 14) (a subset of the compounds of formula (VII) in which R 3 、R 4c 、R 5a and R 5b having the same meaning as defined above for the compound of formula (I)).

[0399] The compound of formula (XXXII) (wherein R 3 、R 4c 、R 5a and R 5bhaving the same meaning as defined above for the compound of formula (I), and wherein the groups Ra are each independently C1-C4 alkyl) can be formed from a silyl ether compound of formula (XXXIII) wherein R 3 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I), X 9 is a leaving group such as a halogen, for example bromine or iodine, and wherein each group R is independently C1-C4 alkyl) by metalation, for example by treatment with a Turbo Grignard reagent (iPrMgCl·LiCl) or butyllithium. Such metalations are known to those skilled in the art and are described in the literature, for example in: Carey, Francis A. (2007). "Organometallic compounds of Group I and II metals". Advanced Organic Chemistry: Reaction and Synthesis Pt. B (Kindle ed.). Springer. ISBN 978-0-387-44899-2. The lithium or magnesium species thus produced can be transmetalated, for example, with a zinc halide, for example zinc chloride, and subsequently reacted with a compound of formula (XV-1) (a subset of compounds of formula (XV) wherein R 4c has the same meaning as defined above for the compound of formula (I), and X 4 is a leaving group such as a halogen, for example bromine or iodine) in the presence of a catalyst such as a palladium catalyst, for example tris(dibenzylideneacetone)dipalladium(0) and a ligand such as a phosphine ligand such as tri(2-furyl)phosphine in an inert solvent such as tetrahydrofuran or 2-methyltetrahydrofuran. The reaction can be carried out at a temperature ranging from -100°C to 100°C, for example between -78°C and 80°C. This transformation is known to those skilled in the art, for example as a Negishi cross-coupling reaction, and is described in the literature, for example in: Jie Jack Li, Name Reactions, A Collection of Detailed Mechanisms and Synthetic Applications, Springer, ISBN: 978-3-030-50865-4.

[0400] The compound of formula (XXXIII) (wherein R 3 、R5a and R 5b has the same meaning as defined above for the compound of formula (I), X 9 is a leaving group such as a halogen, for example bromine or iodine, and wherein the groups Ra are each independently C1-C4 alkyl) can be prepared from a compound of formula (XXXIV) wherein R 3 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I), and X 9 is a leaving group such as a halogen, for example bromine or iodine) by treatment with a silylating agent of formula Ra3Si-Xa, wherein Xa is a leaving group such as, for example, chlorine, bromine, iodine or trifluoromethanesulfonate, and wherein the groups Ra are each independently C1-C4-alkyl (Ra3Si is a trialkylsilyl group such as, for example, dimethyl-tert-butylsilyl; in the compound Ra3Si-Xa, Ra is a linear or branched C1-C4-alkyl group such as methyl or tert-butyl), in the presence of a base such as an amine base such as imidazole, in an inert solvent such as, for example, tetrahydrofuran or 2-methyltetrahydrofuran. The reaction can be carried out at a temperature ranging from 0°C to 100°C, for example between 10°C and 80°C. Such silylation reactions are known to those skilled in the art and are described in the literature, for example, as described in: Protective Groups in Organic Synthesis, 3rd edition, Theodora W. Green (The Rowland Institute for Science [Rowland Institute of Science] and Peter G.M. Wuts (Pharmacia and Upjohn Company), John Wiley & Sons, Inc., New York, NY 1999, ISBN 0-471-16019-9.

[0401] The compound of formula (XXXIV) (wherein R 3 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I), and X 9 is a leaving group such as a halogen, for example bromine or iodine) can be prepared by a compound having formula (XXXV) wherein R 5a and R 5b has the same meaning as defined above for the compound of formula (I) and X 9is a leaving group such as a halogen, for example bromine or iodine) by treatment with a base such as a lithium amide base, for example lithium 2,2,6,6-tetramethylpiperidinium, and then reacting the lithiated species with an aldehyde compound of formula (XXXVI) wherein R 3 The reaction can be carried out neat or in a solvent, for example in an organic solvent, such as tetrahydrofuran or 2-methyltetrahydrofuran as a solvent. The reaction can be carried out at a temperature of -100°C to 100°C, for example in a temperature range between -80°C and 0°C, for example at 0°C or -78°C. A compound of formula (XXXV) wherein R 5a and R 5b has the same meaning as defined above for the compound of formula (I), and X 9 is a leaving group such as a halogen, for example bromine or iodine), and a compound of formula (XXXVI) wherein R 3 have the same meanings as given above in formula (I)) are known or even commercially available, or they can be prepared by known methods.

[0402] Option 16:

[0403]

[0404] A compound of formula (XXVIIIb) or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or hydrobromide salt, or a trifluoroacetate salt or any other equivalent salt), wherein R 1 、R 3 、R 4c 、R 5a and R 5b has the same meanings as defined above for the compound of formula (I), can be (Scheme 16) by using a compound of formula (XXXVII) (wherein R 1 is as defined in Formula I) by treating a compound of formula (XXVIIIa) or a salt thereof (wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I)) to obtain (VII is converted to III).

[0405] A compound of formula (XXVIIIa) or a salt thereof (wherein R 3 、R 4c 、R 5a and R 5bhas the same meaning as defined above for the compound of formula (I)) can be biocatalytically deracemized to a compound of formula (XXVIII) or a salt thereof (wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for compounds of formula (I). This can be obtained, for example, using a final immobilized form (e.g. 435), for example, Candida Antarctica lipase B or Pseudomonas fluorescens lipase, in the presence of an acyl donor, for example, ethyl methoxyacetate or vinyl acetate, in a suitable solvent, such as acetonitrile or methyl tert-butyl ether, at a temperature between 20° C. and 100° C. Such methods are described, for example, in J. Org. Chem. 2007, 72, 6918-6923 or Adv. Synth. Catal. 2007, 349, 1481-1488. The expected stereochemical outcome of such enzymatic deracemization is known to the person skilled in the art and is documented in the literature, for example in J. Org. Chem. 1991, 56, 2656-2665 or J. Am. Chem. Soc. 2015, 137, 3996-4009.

[0406] Option 17:

[0407]

[0408] In an alternative process (Scheme 17), a compound of formula (XXVIIIa) or a salt thereof (wherein R 3 、R 4c 、R 5a and R 5b have the same meanings as defined above for the compound of formula (I)) can be prepared from a compound of formula (XXX-1) (wherein R 3 、R 4c 、R 5a and R 5b having the same meaning as defined above for the compound of formula (I) and Z3 is -NPhth (N-phthalimide group) or -NBoc2 (N-bis(tert-butyloxycarbonyl) group) is obtained under the deprotection conditions already described in Scheme 15 above (XXX is converted to XXVIII).

[0409] A compound having the formula (XXX-1) (wherein R 3 、R4c 、R 5a and R 5b having the same meaning as defined above for the compound of formula (I) and Z3 is -NPhth (N-phthalimide group) or -NBoc2 (N-bis(tert-butyloxycarbonyl) group) can be obtained by a compound of formula (XXXI-1) wherein R 3 、R 4c 、R 5a and R 5b (having the same meanings as defined above for compounds of formula (I)) are obtained by Mitsunobu reaction with phthalimide (HNPhth) or bis(tert-butoxycarbonyl)amine (HNBoc2) under the conditions already described in Scheme 15 above (XXXI is converted to XXX). Such a process is known to those skilled in the art for inversion of stereocenters.

[0410] A compound having the formula (XXXI-1) (wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I)) can be obtained by enantioselective reduction of a ketone of formula (VII-1) (wherein R 3 、R 4c 、R 5a and R 5b (having the same meaning as defined above for compounds of formula (I)). Such reduction can be carried out in the presence of a hydrogen donor system (such as, for example, HCOOH / Et3N or HCO2NH4) using a catalyst (for example, a ruthenium or rhodium catalyst with a chiral ligand such as RuCl[(R,R)-TsDPEN] (mesitylene) or RuBF4[(R,R)-TsDPEN] (p-cymene). Such methods are described in the literature, for example, in J.Org.Chem. 2017, 82, 5607.

[0411] Alternatively, a compound of formula (XXVIIIa) or a salt thereof (wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I)) can be obtained by reducing the azide compound of formula (XXXVIII) (wherein R 3 、R 4c 、R 5a and R 5bThe procedures and conditions for such azide reduction are well known to those skilled in the art and are known from the literature and textbooks.

[0412] A compound of formula (XXXVIII) wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for the compound of formula (I)) can be prepared by treating an alcohol compound of formula (XXXI-1) (wherein R 3 、R 4c 、R 5a and R 5b has the same meaning as defined above for compounds of formula (I)). Such methods are known to those skilled in the art for inversion of stereocenters and are described in the literature, for example, in Adv. Synth. Catal. [Advanced Synthesis and Catalysis] 2018, 360, 2157-2165.

[0413] Any of the compounds of formula (XX), (XXII) (substituents as defined in Scheme 11), formula (XX-1) (substituents as defined in Scheme 12), formula (XXVII) (substituents as defined in Scheme 13), formula (XXVIII) (substituents as defined in Scheme 14 / 15), formula (XXVIIIa) (substituents as defined in Scheme 16 / 17) and formula (XXVIIIb) (substituents as defined in Scheme 16) or (where applicable) their salts or (where applicable) their free bases represent a specific subset of the compounds of formula (III) defined above in Scheme 1 and can therefore be used to prepare compounds of formula (I) according to the instructions outlined in Scheme 1.

[0414] Compounds having formula (XXVIII), (XXVIIIa) or (XXVIIIb) (substituents are defined as in Schemes 14, 15, 16 and 17) (wherein the fragment where R 4c is as defined above under formula (I) and wherein the staggered lines represent the connection to the remainder of the compound of formula (XXVIII), (XXVIIIa) or (XXVIIIb), separated by the fragment Substitution) can be obtained analogously to the chemical descriptions found in Schemes 14, 15, 16 and 17, but by replacing the starting materials of formula XVI-1 and XV-1 with compounds of formula XVI-2 and XV-2, respectively, wherein R 4c 、X 4 and M 1 Keep its definition:

[0415]

[0416] Such compounds of the formula XVI-2 and XV-2 are known or even commercially available or they can be prepared by known methods.

[0417] Depending on the procedure or reaction conditions, the reactants can be reacted in the presence of a base. Examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxide and carbocyclic amines. Examples that may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU).

[0418] These reactants can react with each other as is, i.e. without adding solvents or diluents. However, in most cases, it is advantageous to add inert solvents or diluents or mixtures thereof. If the reaction is carried out in the presence of a base, the base used in excess (e.g., triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline) can also serve as a solvent or diluent.

[0419] These reactions are advantageously carried out in a temperature range of from about -80°C to about +140°C, preferably from about -30°C to about +100°C, in many cases in a range between ambient temperature and about +80°C.

[0420] Depending on the reaction conditions and starting materials chosen as appropriate in the respective case, it is possible, for example, to replace only one substituent with another substituent according to the invention in one reaction step or to replace several substituents with other substituents according to the invention in one and the same reaction step.

[0421] Salts of compounds of formula (I) can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds of formula (I) are obtained by treatment with a suitable acid or a suitable ion exchange reagent, and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchange reagent.

[0422] Salts of compounds of formula (I) can be converted in a customary manner into the free compounds of formula (I), into acid addition salts (for example by treatment with suitable basic compounds or with suitable ion exchange reagents) and into salts with bases (for example by treatment with suitable acids or with suitable ion exchange reagents).

[0423] Salts of compounds of formula (I) can be converted into other salts, acid addition salts of compounds of formula (I) in a manner known per se, for example into other acid addition salts, for example by treating salts of inorganic acids (such as hydrochlorides) with suitable metal salts of the acid (such as sodium salts, barium salts or silver salts, for example with silver acetate) in a suitable solvent in which the inorganic salt formed (such as silver chloride) is insoluble and therefore precipitates from the reaction mixture.

[0424] Depending on the procedure or reaction conditions, compounds of formula (I) having salt-forming properties can be obtained in free form or in the form of salts.

[0425] Depending on the number of asymmetric carbon atoms present in the molecule, the absolute and relative configuration and / or the configuration of non-aromatic double bonds present in the molecule, the compounds of the formula (I) and, where appropriate, their tautomers, in each case in free form or in salt form, may be present in the form of one of the possible isomers or as a mixture thereof, for example in the form of pure isomers, such as enantiomers and / or diastereomers, or as isomer mixtures, such as enantiomeric mixtures, for example racemates, diastereomeric mixtures or racemic mixtures; the present invention relates both to the pure isomers and also to all possible isomer mixtures, and the above and below are to be understood as such in each case, even if stereochemical details are not explicitly mentioned in each case.

[0426] Diastereomeric mixtures or racemic mixtures of compounds of formula (I) in free form or in salt form, the acquisition of which may depend on the starting materials and procedures chosen, can be separated in a known manner into the pure diastereomers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and / or chromatography.

[0427] Enantiomeric mixtures obtainable in an analogous manner (e.g., racemates) can be resolved into the optical antipodes by known methods, for example, by recrystallization from optically active solvents; by chromatography on chiral adsorbents, for example, high performance liquid chromatography (HPLC) on acetylcellulose; by cleavage with specific immobilized enzymes with the aid of suitable microorganisms; by forming inclusion compounds, for example, using chiral crown ethers, in which only one enantiomer is complexed; or by conversion into diastereomeric salts, for example, by reacting the basic end product racemate with an optically active acid (e.g., a carboxylic acid, for example, camphoric acid, tartaric acid or malic acid, or a sulfonic acid, for example, camphorsulfonic acid) and separating the diastereomeric mixtures obtainable in this way, for example, by fractional crystallization on the basis of their different solubilities, thereby obtaining the diastereomers from which the desired enantiomer can be freed by the action of suitable reagents, for example, basic reagents.

[0428] Pure diastereomers or enantiomers can be obtained according to the invention not only by separation of the appropriate isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the method according to the invention with starting materials having the appropriate stereochemistry.

[0429] N-oxides can be prepared by reacting a compound of formula (I) with a suitable oxidizing agent (e.g. H O / urea adduct) in the presence of an anhydride (e.g. trifluoroacetic anhydride). Such oxidations are known from the literature, for example from J. Med. Chem., 32 (12), 2561-73, 1989 or WO 2000 / 15615.

[0430] If the individual components have different biological activities, it is advantageous to isolate or synthesize the biologically more effective isomers, such as enantiomers or diastereomers or isomer mixtures, such as enantiomeric mixtures or diastereomeric mixtures, in each case.

[0431] The compounds of formula (I) and, where appropriate, their tautomers (in each case in free form or in salt form) can, if appropriate, also be obtained in the form of hydrates and / or include other solvents, such as those which can be used for crystallization of compounds present in solid form.

[0432] The compounds of formula (I) according to the following Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21 can be prepared according to the methods described above. The following examples are intended to illustrate the present invention and show preferred compounds of formula (I) (in the form of compounds of formula (IA), (IB), (IC) and (ID)).

[0433]

[0434] Tables A-1 to A-78 (Formula IA)

[0435] Table A-1 32 compounds A-1.001 to A-1.032 of formula IA are provided, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z. For example, A-1.002 is

[0436]

[0437] Table A-2 Provided are 32 compounds A-2.001 to A-2.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0438] Table A-3 Provided are 32 compounds A-3.001 to A-3.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0439] Table A-4 Provided are 32 compounds A-4.001 to A-4.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0440] Table A-5 Provided are 32 compounds A-5.001 to A-5.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0441] Table A-6 Provided are 32 compounds A-6.001 to A-6.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0442] Table A-7 Provided are 32 compounds A-7.001 to A-7.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0443] Table A-8 Provided are 32 compounds A-8.001 to A-8.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0444] Table A-9 Provided are 32 compounds A-9.001 to A-9.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R4c is CH2-cyclopropyl and T is as defined in Table Z.

[0445] Table A-10 Provided are 32 compounds A-10.001 to A-10.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0446] Table A-11 Provided are 32 compounds A-11.001 to A-11.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0447] Table A-12 Provided are 32 compounds A-12.001 to A-12.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0448] Table A-13 Provided are 32 compounds A-13.001 to A-13.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0449] Table A-14 Provided are 32 compounds A-14.001 to A-14.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4cis CH2-CF2H and T is as defined in Table Z.

[0450] Table A-15 Provided are 32 compounds A-15.001 to A-15.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0451] Table A-16 Provided are 32 compounds A-16.001 to A-16.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0452] Table A-17 Provided are 32 compounds A-17.001 to A-17.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0453] Table A-18 Provided are 32 compounds A-18.001 to A-18.032 of formula IA, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0454] Table A-19 Provided are 32 compounds A-19.001 to A-19.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R4c is CH3 and T is as defined in Table Z.

[0455] Table A-20 Provided are 32 compounds A-20.001 to A-20.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0456] Table A-21 Provided are 32 compounds A-21.001 to A-21.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0457] Table A-22 Provided are 32 compounds A-22.001 to A-22.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0458] Table A-23 Provided are 32 compounds A-23.001 to A-23.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0459] Table A-24 Provided are 32 compounds A-24.001 to A-24.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4cis CH2-cyclopropyl and T is as defined in Table Z.

[0460] Table A-25 Provided are 32 compounds A-25.001 to A-25.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0461] Table A-26 Provided are 32 compounds A-26.001 to A-26.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0462] Table A-27 Provided are 32 compounds A-27.001 to A-27.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0463] Table A-28 Provided are 32 compounds A-28.001 to A-28.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0464] Table A-29 Provided are 32 compounds A-29.001 to A-29.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4cis CH2-CF2H and T is as defined in Table Z.

[0465] Table A-30 Provided are 32 compounds A-30.001 to A-30.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0466] Table A-31 Provided are 32 compounds A-31.001 to A-31.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0467] Table A-32 Provided are 32 compounds A-32.001 to A-32.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0468] Table A-33 Provided are 32 compounds A-33.001 to A-33.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0469] Table A-34 Provided are 32 compounds A-34.001 to A-34.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R4c is CH3 and T is as defined in Table Z.

[0470] Table A-35 Provided are 32 compounds A-35.001 to A-35.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0471] Table A-36 Provided are 32 compounds A-36.001 to A-36.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0472] Table A-37 Provided are 32 compounds A-37.001 to A-37.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0473] Table A-38 Provided are 32 compounds A-38.001 to A-38.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0474] Table A-39 Provided are 32 compounds A-39.001 to A-39.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R4c is CH2-cyclopropyl and T is as defined in Table Z.

[0475] Table A-40 Provided are 32 compounds A-40.001 to A-40.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0476] Table A-41 Provided are 32 compounds A-41.001 to A-41.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0477] Table A-42 Provided are 32 compounds A-42.001 to A-42.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0478] Table A-43 Provided are 32 compounds A-43.001 to A-43.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0479] Table A-44 Provided are 32 compounds A-44.001 to A-44.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R4c is CH2-CF2H and T is as defined in Table Z.

[0480] Table A-45 Provided are 32 compounds A-45.001 to A-45.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0481] Table A-46 Provided are 32 compounds A-46.001 to A-46.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0482] Table A-47 Provided are 32 compounds A-47.001 to A-47.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0483] Table A-48 Provided are 32 compounds A-48.001 to A-48.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0484] Table A-49 Provided are 32 compounds A-49.001 to A-49.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R4c is CH3 and T is as defined in Table Z.

[0485] Table A-50 Provided are 32 compounds A-50.001 to A-50.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0486] Table A-51 Provided are 32 compounds A-51.001 to A-51.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0487] Table A-52 Provided are 32 compounds A-52.001 to A-52.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0488] Table A-53 Provided are 32 compounds A-53.001 to A-53.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0489] Table A-54 Provided are 32 compounds A-54.001 to A-54.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0490] Table A-55 Provided are 32 compounds A-55.001 to A-55.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0491] Table A-56 Provided are 32 compounds A-56.001 to A-56.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0492] Table A-57 Provided are 32 compounds A-57.001 to A-57.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0493] Table A-58 Provided are 32 compounds A-58.001 to A-58.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0494] Table A-59 Provided are 32 compounds A-59.001 to A-59.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R4c is CH2-CF2H and T is as defined in Table Z.

[0495] Table A-60 Provided are 32 compounds A-60.001 to A-60.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0496] Table A-61 Provided are 32 compounds A-61.001 to A-61.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0497] Table A-62 Provided are 32 compounds A-62.001 to A-62.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0498] Table A-63 Provided are 32 compounds A-63.001 to A-63.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0499] Table A-64 Provided are 32 compounds A-64.001 to A-64.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It's H, R3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0500] Table A-65 Provided are 32 compounds A-65.001 to A-65.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0501] Table A-66 Provided are 32 compounds A-66.001 to A-66.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0502] Table A-67 Provided are 32 compounds A-67.001 to A-67.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0503] Table A-68 Provided are 32 compounds A-68.001 to A-68.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0504] Table A-69 Provided are 32 compounds A-69.001 to A-69.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0505] Table A-70 32 compounds A-70.001 to A-70.032 of formula IA are provided, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0506] Table A-71 Provided are 32 compounds A-71.001 to A-71.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0507] Table A-72 Provided are 32 compounds A-72.001 to A-72.032 of formula IA, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0508] Table A-73 Provided are 32 compounds A-73.001 to A-73.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0509] Table A-74 Provided are 32 compounds A-74.001 to A-74.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R1 It is CH3, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0510] Table A-75 Provided are 32 compounds A-75.001 to A-75.032 of formula IA, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0511] Table A-76 Provided are 32 compounds A-76.001 to A-76.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0512] Table A-77 Provided are 32 compounds A-77.001 to A-77.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0513] Table A-78 Provided are 32 compounds A-78.001 to A-78.032 of formula IA, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0514] Tables B-1 to B-78 (Formula IB)

[0515] Table B-1 Provided are 32 compounds B-1.001 to B-1.032 of formula IB, wherein A14 It's N, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0516] Table B-2 Provided are 32 compounds B-2.001 to B-2.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0517] Table B-3 Provided are 32 compounds B-3.001 to B-3.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0518] Table B-4 Provided are 32 compounds B-4.001 to B-4.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0519] Table B-5 Provided are 32 compounds B-5.001 to B-5.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0520] Table B-6 Provided are 32 compounds B-6.001 to B-6.032 of formula IB, wherein A 14 It's N, A 24It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0521] Table B-7 Provided are 32 compounds B-7.001 to B-7.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0522] Table B-8 Provided are 32 compounds B-8.001 to B-8.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0523] Table B-9 Provided are 32 compounds B-9.001 to B-9.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0524] Table B-10 Provided are 32 compounds B-10.001 to B-10.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0525] Table B-11 Provided are 32 compounds B-11.001 to B-11.032 of formula IB, wherein A 14 It's N, A 24 It's N, A34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0526] Table B-12 Provided are 32 compounds B-12.001 to B-12.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0527] Table B-13 Provided are 32 compounds B-13.001 to B-13.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0528] Table B-14 Provided are 32 compounds B-14.001 to B-14.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0529] Table B-15 Provided are 32 compounds B-15.001 to B-15.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0530] Table B-16 Provided are 32 compounds B-16.001 to B-16.032 of formula IB, wherein A 14 It's N, A 24 It's N, A34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0531] Table B-17 Provided are 32 compounds B-17.001 to B-17.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0532] Table B-18 Provided are 32 compounds B-18.001 to B-18.032 of formula IB, wherein A 14 It's N, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0533] Table B-19 Provided are 32 compounds B-19.001 to B-19.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0534] Table B-20 Provided are 32 compounds B-20.001 to B-20.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0535] Table B-21 Provided are 32 compounds B-21.001 to B-21.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0536] Table B-22 Provided are 32 compounds B-22.001 to B-22.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0537] Table B-23 Provided are 32 compounds B-23.001 to B-23.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0538] Table B-24 Provided are 32 compounds B-24.001 to B-24.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0539] Table B-25 Provided are 32 compounds B-25.001 to B-25.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0540] Table B-26 Provided are 32 compounds B-26.001 to B-26.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0541] Table B-27 Provided are 32 compounds B-27.001 to B-27.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0542] Table B-28 Provided are 32 compounds B-28.001 to B-28.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0543] Table B-29 Provided are 32 compounds B-29.001 to B-29.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0544] Table B-30 Provided are 32 compounds B-30.001 to B-30.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0545] Table B-31 Provided are 32 compounds B-31.001 to B-31.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0546] Table B-32 Provided are 32 compounds B-32.001 to B-32.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0547] Table B-33 Provided are 32 compounds B-33.001 to B-33.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0548] Table B-34 Provided are 32 compounds B-34.001 to B-34.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0549] Table B-35 Provided are 32 compounds B-35.001 to B-35.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0550] Table B-36 Provided are 32 compounds B-36.001 to B-36.032 of formula IB, wherein A 14 It's N, A 24It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0551] Table B-37 Provided are 32 compounds B-37.001 to B-37.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0552] Table B-38 Provided are 32 compounds B-38.001 to B-38.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0553] Table B-39 Provided are 32 compounds B-39.001 to B-39.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0554] Table B-40 Provided are 32 compounds B-40.001 to B-40.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0555] Table B-41 Provided are 32 compounds B-41.001 to B-41.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0556] Table B-42 Provided are 32 compounds B-42.001 to B-42.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0557] Table B-43 Provided are 32 compounds B-43.001 to B-43.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0558] Table B-44 Provided are 32 compounds B-44.001 to B-44.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0559] Table B-45 Provided are 32 compounds B-45.001 to B-45.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0560] Table B-46 Provided are 32 compounds B-46.001 to B-46.032 of formula IB, wherein A 14 It is CH, A24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0561] Table B-47 Provided are 32 compounds B-47.001 to B-47.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0562] Table B-48 Provided are 32 compounds B-48.001 to B-48.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0563] Table B-49 Provided are 32 compounds B-49.001 to B-49.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0564] Table B-50 Provided are 32 compounds B-50.001 to B-50.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0565] Table B-51 Provided are 32 compounds B-51.001 to B-51.032 of formula IB, wherein A 14 It is CH, A24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0566] Table B-52 Provided are 32 compounds B-52.001 to B-52.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0567] Table B-53 Provided are 32 compounds B-53.001 to B-53.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0568] Table B-54 Provided are 32 compounds B-54.001 to B-54.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0569] Table B-55 Provided are 32 compounds B-55.001 to B-55.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0570] Table B-56 Provided are 32 compounds B-56.001 to B-56.032 of formula IB, wherein A 14It is CH, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0571] Table B-57 Provided are 32 compounds B-57.001 to B-57.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0572] Table B-58 Provided are 32 compounds B-58.001 to B-58.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0573] Table B-59 Provided are 32 compounds B-59.001 to B-59.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0574] Table B-60 Provided are 32 compounds B-60.001 to B-60.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0575] Table B-61 Provided are 32 compounds B-61.001 to B-61.032 of formula IB, wherein A 14It is CH, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0576] Table B-62 Provided are 32 compounds B-62.001 to B-62.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0577] Table B-63 Provided are 32 compounds B-63.001 to B-63.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0578] Table B-64 Provided are 32 compounds B-64.001 to B-64.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0579] Table B-65 Provided are 32 compounds B-65.001 to B-65.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0580] Table B-66 Provided are 32 compounds B-66.001 to B-66.032 of formula IB, wherein A14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0581] Table B-67 Provided are 32 compounds B-67.001 to B-67.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0582] Table B-68 Provided are 32 compounds B-68.001 to B-68.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0583] Table B-69 Provided are 32 compounds B-69.001 to B-69.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0584] Table B-70 Provided are 32 compounds B-70.001 to B-70.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0585] Table B-71Provided are 32 compounds B-71.001 to B-71.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0586] Table B-72 Provided are 32 compounds B-72.001 to B-72.032 of formula IB, wherein A 14 It is CH, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0587] Table B-73 Provided are 32 compounds B-73.001 to B-73.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0588] Table B-74 Provided are 32 compounds B-74.001 to B-74.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0589] Table B-75 Provided are 32 compounds B-75.001 to B-75.032 of formula IB, wherein A 14 It's N, A 24 It is CH, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0590] Table B-76 Provided are 32 compounds B-76.001 to B-76.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0591] Table B-77 Provided are 32 compounds B-77.001 to B-77.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0592] Table B-78 Provided are 32 compounds B-78.001 to B-78.032 of formula IB, wherein A 14 It is CH, A 24 It's N, A 34 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0593] Tables C-1 to C-21 (IC)

[0594] Table C-1 Provided are 32 compounds C-1.001 to C-1.032 of formula IC, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0595] Table C-2 Provided are 32 compounds C-2.001 to C-2.032 of formula IC, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0596] Table C-3Provided are 32 compounds C-3.001 to C-3.032 of formula IC, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0597] Table C-4 Provided are 32 compounds C-4.001 to C-4.032 of formula IC, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0598] Table C-5 Provided are 32 compounds C-5.001 to C-5.032 of formula IC, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0599] Table C-6 Provided are 32 compounds C-6.001 to C-6.032 of formula IC, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0600] Table C-7 Provided are 32 compounds C-7.001 to C-7.032 of formula IC, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0601] Table C-8 Provided are 32 compounds C-8.001 to C-8.032 of formula IC, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0602] Table C-9Provided are 32 compounds C-9.001 to C-9.032 of formula IC, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0603] Table C-10 Provided are 32 compounds C-10.001 to C-10.032 of formula IC, wherein A 14 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0604] Table C-11 Provided are 32 compounds C-11.001 to C-11.032 of formula IC, wherein A 14 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0605] Table C-12 Provided are 32 compounds C-12.001 to C-12.032 of formula IC, wherein A 14 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0606] Table C-13 Provided are 32 compounds C-13.001 to C-13.032 of formula IC, wherein A 14 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0607] Table C-14 Provided are 32 compounds C-14.001 to C-14.032 of formula IC, wherein A 14 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0608] Table C-15Provided are 32 compounds C-15.001 to C-15.032 of formula IC, wherein A 14 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0609] Table C-16 Provided are 32 compounds C-16.001 to C-16.032 of formula IC, wherein A 14 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0610] Table C-17 Provided are 32 compounds C-17.001 to C-17.032 of formula IC, wherein A 14 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0611] Table C-18 Provided are 32 compounds C-18.001 to C-18.032 of formula IC, wherein A 14 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0612] Table C-19 Provided are 32 compounds C-19.001 to C-19.032 of formula IC, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0613] Table C-20 Provided are 32 compounds C-20.001 to C-20.032 of formula IC, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0614] Table C-21Provided are 32 compounds C-21.001 to C-21.032 of formula IC, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0615] Tables D-1 to D-21 (Formula ID)

[0616] Table D-1 32 compounds of formula ID D-1.001 to D-1.032 are provided, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0617] Table D-2 Provided are 32 compounds D-2.001 to D-2.032 of formula ID, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0618] Table D-3 Provided are 32 compounds D-3.001 to D-3.032 of formula ID, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0619] Table D-4 Provided are 32 compounds D-4.001 to D-4.032 of formula ID, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0620] Table D-5 Provided are 32 compounds D-5.001 to D-5.032 of formula ID, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0621] Table D-6 Provided are 32 compounds D-6.001 to D-6.032 of formula ID, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0622] Table D-7 Provided are 32 compounds D-7.001 to D-7.032 of formula ID, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0623] Table D-8 Provided are 32 compounds D-8.001 to D-8.032 of formula ID, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0624] Table D-9 Provided are 32 compounds D-9.001 to D-9.032 of formula ID, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0625] Table D-10 Provided are 32 compounds D-10.001 to D-10.032 having formula ID, wherein A 14 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0626] Table D-11 Provided are 32 compounds D-11.001 to D-11.032 having formula ID, wherein A 14 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0627] Table D-12Provided are 32 compounds D-12.001 to D-12.032 having formula ID, wherein A 14 It is CH, R 1 It's H, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0628] Table D-13 Provided are 32 compounds D-13.001 to D-13.032 having formula ID, wherein A 14 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0629] Table D-14 Provided are 32 compounds D-14.001 to D-14.032 having formula ID, wherein A 14 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0630] Table D-15 Provided are 32 compounds D-15.001 to D-15.032 having formula ID, wherein A 14 It is CH, R 1 It is CH3, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0631] Table D-16 Provided are 32 compounds D-16.001 to D-16.032 having formula ID, wherein A 14 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH3 and T is as defined in Table Z.

[0632] Table D-17 Provided are 32 compounds D-17.001 to D-17.032 having formula ID, wherein A 14 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-CF2H and T is as defined in Table Z.

[0633] Table D-18Provided are 32 compounds D-18.001 to D-18.032 having formula ID, wherein A 14 It is CH, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2-cyclopropyl and T is as defined in Table Z.

[0634] Table D-19 Provided are 32 compounds D-19.001 to D-19.032 having formula ID, wherein A 14 It's N, R 1 It's H, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0635] Table D-20 Provided are 32 compounds D-20.001 to D-20.032 having formula ID, wherein A 14 It's N, R 1 It is CH3, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0636] Table D-21 Provided are 32 compounds D-21.001 to D-21.032 having formula ID, wherein A 14 It's N, R 1 is CH2-cyclopropyl, R 3 It is CH3, R 4c is CH2CH3 and T is as defined in Table Z.

[0637] Table Z :Definition of substituents of T

[0638]

[0639]

[0640]

[0641]

[0642] It also provides access to certain intermediate compounds of formula II(i), III(i), IV(i), IVa(i), V(i), VI(i), VII(i), VIII(i), IX(i), X(i), XI(i), XII(i), XIV(i), XV(i), XVI(i), XX(i), XXI(i), and XXII(i), some of which are novel. For example:

[0643] - a compound having formula XII(i) or a tautomer thereof, or a salt thereof:

[0644]

[0645] Among them A 14 、A 24 、A 34 and R 4c is as defined in any one of Tables A-1 to A-78 and Tables B-1 to B-78, with the proviso that the compound is not

[0646] 6-Hydrazino-2-methyl-3(2H)-pyridazinone, nor its tautomers; nor

[0647] 6-Hydrazino-2-ethyl-3(2H)-pyridazinone, nor its tautomers.

[0648] - a compound having formula XVI(i):

[0649]

[0650] Among them A 14 and A 24 One is N, the other is CH, R 4c is as defined in any one of Tables A-1 to A-78 and Tables B-1 to B-78, and M 1 is a metal-containing substituent, for example a boron substituent or a tin substituent, such as tributylstannyl, dihydroxyboronyl or 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl, with the proviso that the compound of formula XVI(i) is not:

[0651] -2-Methyl-6-trimethylstannyl-pyridazin-3-one (CAS 2254337-53-4),

[0652] -[5-Oxo-4-(2,2,2-trifluoroethyl)pyrazin-2-yl]boronic acid (CAS 2509138-33-2),

[0653] -5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)pyrazin-2-one (CAS 2509138-04-7),

[0654] -(2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazin-3-one (CAS1610374-18-9),

[0655] -2-Isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazin-3-one (CAS 2768712-84-9),

[0656] -(1-methyl-6-oxo-pyridazin-3-yl)boronic acid (CAS 1872185-45-9), nor

[0657] -(1-Isopropyl-6-oxo-pyridazin-3-yl)boronic acid (CAS 2334476-21-8).

[0658] - compounds of formula XX(i), XXI(i) and XXII(i),

[0659]

[0660] where R 4a (Including A 14 、A 24 、A 34 and R 4c ) is as defined in any one of Tables A-1 to A-78 and Tables B-1 to B-78, and wherein X - is an anion, i.e., anion X - is the conjugate base of an acid such as an inorganic acid, for example, hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid, etc., or an organic acid, for example, a carboxylic acid or a sulfonic acid, for example, trifluoroacetic acid, methanesulfonic acid or p-toluenesulfonic acid. Preferably A 14 It's N, A 24 It is CH, A 34 is CH and R 4c selected from methyl or ethyl,

[0661] - compounds of formula XXVI(i), XXVII(i) and XXVII-a(i),

[0662]

[0663] where R 4b (Including A 14 and R 4c) is as defined in any one of Tables C-1 to C-21 and Tables D-1 to D-21, and wherein X - is an anion, i.e., anion X - is the conjugate base of an acid such as an inorganic acid, for example, hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid, etc., or an organic acid, for example, a carboxylic acid or a sulfonic acid, for example, trifluoroacetic acid, methanesulfonic acid or p-toluenesulfonic acid. Preferably A 14 is N, and R 4c Selected from methyl or ethyl.

[0664] In another aspect, the present invention thus makes available compounds of formula II(i), III(i), IV(i), IVa(i), V(i), VI(i), VII(i), VIII(i), IX(i), X(i), XI(i), XII(i), XIV(i), XV(i), XVI(i), XX(i), XXI(i), and XXII(i), wherein in each case, where applicable, A 1 、A 2 、A 3 、A 4 、A 5 、X 0 、R 1 、R 2a 、R 2b 、R 3 , Q a (including R 5 、R 4c and R 4 As R 4a or R 4b ), Q b (including R 5a 、R 5b 、R 4c and R 4 As R 4a or R 4b ), R 4 、R 4a (Including A 14 、A 24 、A 34 and R 4c ), R 4b (Including A 14 and R 4c ), R X 、R Y and R Z is as defined for formula (I) in the first aspect, and

[0665] -T is wherein the staggered lines represent the connection to the remainder of the compound of formula (II), (IV), (IVa), (X), (XI), (XVII)

[0666] - With respect to compounds having formula Ii(i), X 1 is a leaving group, such as a halogen, a hydroxyl, or a sulfonate, e.g., chlorine;

[0667] - With respect to compounds of formula V(i), X 2 is a leaving group, such as a halogen (e.g., chlorine or bromine), or a sulfonate (e.g., mesylate);

[0668] - With respect to compounds of formula VI(i), X 3 is a leaving group, such as a halogen (e.g., chlorine, bromine, iodine), or a sulfonate (e.g., methanesulfonate);

[0669] - With respect to compounds of formula XV(i), X 4 is a leaving group, such as, for example, halogen (e.g., chlorine), sulfonate, C1-C4-sulfanyl, C1-C4-sulfinyl or C1-C4-sulfonyl;

[0670] - With respect to compounds having formula XVI(i), M 1 is a metal-containing substituent, for example a boron substituent or a tin substituent, such as tributylstannyl, dihydroxyboronyl or 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl;

[0671] - With respect to compounds of formula XX(i), X - is an anion, ie, the conjugate base of an acid such as an inorganic acid, for example, hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid, etc., or an organic acid, for example, a carboxylic acid or a sulfonic acid, for example, trifluoroacetic acid, methanesulfonic acid or p-toluenesulfonic acid.

[0672] In addition, the corresponding embodiments shown for formula (I) also apply to compounds having formula II(i), III(i), IV(i), IVa(i), V(i), VI(i), VII(i), VIII(i), IX(i), X(i), XI(i), XII(i), XIV(i), XV(i), XVI(i), XX(i), XXI(i), and XXII(i), as applicable.

[0673] The compounds of formula (I) according to the invention are active ingredients of preventive and / or therapeutic value in the field of pest control. Even at low application rates, they have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish, and plants. These active ingredients according to the invention act on all or individual developmental stages of normally sensitive as well as resistant animal pests (such as insects or representatives of the order Acarina). The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i.e., by destroying the pests immediately or only after a certain period of time (e.g., during molting), or indirectly, for example, by reducing egg laying and / or hatching rates.

[0674] Examples of the animal pests mentioned above are:

[0675] From the order Acarina, e.g.

[0676] Acalitus spp., Aculus spp., Acaricalus spp., Aceria spp., Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp., Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp., Eotetranychus spp., Eriophyes spp.), Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Olygonychus spp., Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp., Polyphagotarsonemus spp., Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp.), Steneotarsonemus spp., Tarsonemus spp., and Tetranychus spp.;

[0677] From the order Phthirus, e.g.

[0678] Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp., and Phylloxera spp.;

[0679] From the order Coleoptera, e.g.

[0680] Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp., Astylus atromaculatus, Ataenius spp., Atomaria linearis, Chaetocnema tibialis, Cerotomas spp., Conoderus spp., Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp., Dermestes spp., Diabrotica spp.), Argentine beetle (Diloboderus abderus), Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa ​​decemlineata, Lissorhoptrus spp., Liogenys spp., Maecolaspis spp., Maladera castanea, Megascelis spp., Melighetes aeneus, Melolontha spp., Myochrous armatus), Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp., Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp.), Scarabeidae, Sitophilus spp., Sitotroga spp., Somaticus spp., Sternechus subsignatus, Tenebrio spp., Tribolium spp., and Trogoderma spp.;

[0681] From the order Diptera, e.g.

[0682] Aedes spp., Anopheles spp., Antherigona soccata, Bactrocea oleae, Bibio hortulanus, Bradysia spp., Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp., Drosophila melanogaster, Fannia spp., Gastrophilus spp., Geomyza tripunctata), Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp., Rivelia quadrifasciata, Scatella spp., Sciara spp.), Stomoxys spp., Tabanus spp., Tannia spp., and Tipula spp.;

[0683] From the order Hemiptera, e.g.

[0684] Acanthocoris scabrator, Acrosternum spp., Adelphocoris lineolatus, Aleurodes spp., Amblypeltanitida, Bathycoelia thalassina, Bathycoelia spp., Clavigralla tomentosicollis, Creontiades spp., Dichelops furcatus, Edessa spp., Euchistus spp., Eurydema pulchrum, Horcias spp., Brown-winged stink bug, Horcias spp. nobilellus), rice stink bug species, grass stink bug species, tropical scale bug species, cabbage stink bug (Murgantia histrionic), new long-margin stink bug species, tobacco blind bug (Nesidiocoris tenuis), green stink bug species, Nysius simulans, island stink bug, skin stink bug species, wall stink bug species, red assassin bug species, cocoa stink bug, chestnut stink bug (Scaptocoris castanea), black stink bug species (Scotinophara spp.), Thyanta spp., trypanosoma species, cassava web stink bug (Vatiga illudens);

[0685] From the order Homoptera, e.g.

[0686] Acyrthosium pisum, Adalges species, Agalliano ensigera, Targuiron vein psyllid, Aleurodicus species, Aleurocanthus species, sugarcane hole whitefly, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, lemon leafhopper, Nephrodisiac species, Aphididae, Aphid species, Aspidiotus species, eggplant groove aphid, Bactericera cockerelli, Aleurodicus species, Brachycaudus species, cabbage aphid, Cavariella species, Cavariella aegopodii Scop.), wax scale species, black-brown round shield scale, orange-brown round shield scale, leafhopper species, large white leafhopper (Cofana spectra), Cryptophyllum species, leafhopper species, brown soft scale, corn yellow-winged leafhopper, naked whitefly species, citrus psyllid, wheat aphid, western round tail aphid species, small green leafhopper species, apple aphid, grape leafhopper species, Gascardia species, red eucalyptus psyllid (Glycaspis brimblecombei), cabbage constrictor aphid (Hyadaphis pseudobrassicae), large tail aphid species (Hyalopterus spp.), Hyperomyzus pallidus, lemon green leafhopper (Idioscopus clypealis), African leafhopper, Laodelphax striatellus species, water-hard scale, oyster shield scale species, radish aphid (Lopaphis erysimi), Lyogenys maidis, Aphids spp., Cicadas spp., Metcalfa pruinosa, Wheat Aphid, Wheat Waxhopper, Aphids spp., Neotoxoptera sp., Black Leafhopper spp., Nilaparvata spp., Pear Green Aphid, Odonaspis ruthae, Sugarcane Cotton Aphid, Bayberry Whitefly, Caulis Psyllid, Shield Scale spp., Gall Aphid spp., Corn Waxhopper, Planthopper spp., Hoppian Aphid, Phylloxera spp.), Mosella species, Morus alba species, Mealybug species, Pseudatomoscelis seriatus, Psyllid species, Pulvinaria aethiopica, Toothed Shield Scale species, Quesada gigas, Recilia dorsalis, Aphid species, Black-helmeted Scale species, Leafhopper species, Schizophrenia species, Sitobion spp., White-backed Planthopper, Spissistilus festinus, Tarophagus proserpina, Aphid species, Whitefly species, Tridiscus sporoboli, Trionymus spp., African Psyllid, Scale, Flame Leafhopper, Zyginidia scutellaris);.

[0687] From the order Hymenoptera, e.g.

[0688] Acromyrmex, Arge spp., Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplocampa spp., Lasius spp., Monomorium pharaonis, Neodiprions spp., Pogonomyrmex spp., Slenopsis invicta, Solenopsis spp., and Vespa spp.

[0689] From the order Isoptera, e.g.

[0690] Coptotermes spp., Corniternes cumulans, Incisitermes spp., Macrotermes spp., Mastotermes spp., Microtermes spp., Reticulitermes spp.; Tropical fire ants (Solenopsis geminate)

[0691] From the order Lepidoptera, for example,

[0692] Species of the genus Long-winged Roller Moth, species of the genus Brown-banded Roller Moth, species of the genus Clearwing Moth, species of the genus Noctua, cotton leafworm, species of the genus Amylois, species of the genus Mucuna, species of the genus Yellow Roller Moth, species of the genus Argyresthia, species of the genus Banded Roller Moth, species of the genus Spodoptera, species of cotton miner, corn armyworm, powdery moth, peach fruit moth, species of the genus Graminus, species of the genus Color Roller Moth, Chrysoteuchia topiaria, grape fruit moth, species of the genus Leaf Roller, species of the genus Cloud Roller, species of the genus Striped Roller Moth, species of the genus Sheath Moth, Colias lesbia, Cosmophila flava), grass borer species, cabbage borer, apple fritter moth, boxwood moth, fritter moth species, boxwood silk borer, stem borer species, Sudan cotton bollworm, Spodoptera species, South American corn seedling borer (Elasmopalpus lignosellus), sweet potato stem borer, mealybug species, leaf fritter moth species (Epinotia spp.), salt marsh moth (Etiella acrea), bean pod borer (Etiella zinckinella), flower fritter moth species, ring needle fritter moth, yellow tussock moth species, root cutter species, Feltia jaculiferia, small borer species (Grapholita spp.), clouded broad-winged fritter moth, Heliothis species, cabbage borer, leaf cutter species (Herpetogramma spp.), American white moth, tomato codling moth, Lasmopalpus lignosellus, spiral leafminer, leafminer species, grape flower moth, Loxostege bifidalis, tussock moth species, miner species, Malacosoma spp., cabbage armyworm, tobacco hornworm, Mythimna spp., noctuid species, fall moth species, Orniodes indica, European corn borer, super-small tortoise species, brown tortoise species, small-eyed moth, stem borer, red bell moth, coffee leafminer, one-star armyworm, potato moth, cabbage butterfly, Pieris species, diamondback moth, white nest moth species, leaf moth species, mint ash moth (Rachiplusia nu), western bean groundworm (Richia albicosta), Scirpophaga spp., Spodoptera spp., Cyprinodon spp., Spodoptera spp., Cotton Leaffolder, Cnaphalocrocis spp., Heteroptera spp., Cyprinodon spp., Trichoplusia spp., Tomato Leafminer, and Lycosa spp.;

[0693] From the order Mallophaga, for example,

[0694] Damalina spp. and Trichodectes spp.;

[0695] From the order Orthoptera, for example,

[0696] Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp., Scapteriscus spp., and Schistocerca spp.;

[0697] From the order Psocoptera, for example,

[0698] Liposcelis spp.;

[0699] From the order Siphonaptera, for example,

[0700] Ceratophyllus spp., Ctenocephalides spp., and Xenopsylla cheopis;

[0701] From the order Thysanoptera, for example,

[0702] Calliothrips phaseoli, Frankliniella spp., Heliothrips spp., Hercinothrips spp., Parthenothrips spp., Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp.

[0703] From the order of the Thysanura, for example, Lepisma saccharina.

[0704] In another aspect, the present invention may also relate to a method for controlling damage to plants and parts thereof by plant-parasitic nematodes (endoparasitic nematodes, semi-endoparasitic nematodes and ectoparasitic nematodes), in particular the following plant-parasitic nematodes, such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other species of Meloidogyne; cyst-forming nematodes, Globodera rostochiensis and other species of Globodera; Heterodera avenae, Heteroderaglycines, Heterodera schachtii and Heterodera schachtii. schachtii), Heterodera trifolii, and other Heterodera species; Seed gall nematodes, Anguina species; Stem and foliar nematodes, Aphelenchoides species; Sting nematodes, Belonolaimus longicaudatus, and other Belonolaimus species; Pine nematodes, Bursaphelenchus xylophilus, and other Bursaphelenchus species; Ring nematodes, nematodes), Criconema species, Criconemella species, Criconemoides species, Mesocriconema species; Stemand bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci, and other Ditylenchus species; Awl nematodes, Dolichodorus species;Spiral nematodes, Heliocotylenchus multicinctus, and other species of the genus Helicotylenchus; Sheath and sheathoid nematodes, species of the genera Hemicycliophora, and species of the genera Hemicriconemoides; Hirshmanniella species; Lancenematodes, species of the genus Hoploaimus; False rootknot nematodes, species of the genus Nacobbus; Needle nematodes, Longidoruse longatus, and other species of the genus Longidorus; Pin nematodes, species of the genus Pratylenchus; Lesion nematodes. nematodes), Pratylenchus negletus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi, and other Pratylenchus species; Burrowing nematodes, Radopholus similis, and other Radopholus species; Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis, and other Rotylenchus species; Scutellonema species; Stubby root nematodes, Trichodorus primitivus) and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius, and other Tylenchorhynchus species;Citrus nematodes, Tylenchulus species; Dagger nematodes, Xiphinema species; and other plant-parasitic nematode species, such as Subanguina spp., Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp., and Quinisulcius spp.

[0705] The compounds of the present invention may also have activity against molluscs. Examples include, for example, the Pomacea family; the Arion family (A. ater, A. circumscriptus, A. hortensis, A. rufus); the Bradybaenidae family (Bradybaenidae, A. rufus); fruticum); Cepaea (Cepaea hortensis, C. nemoralis); Ochlodina; Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum); Discus (D. rotundatus); Euomphalia; Galba (Galba trunculata); Helicelia (H. itala, H. obvia); Helicigona (Helicidae). arbustorum); Helicodiscus; Helix (H. aperta); Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus); Lymnaea; Milax (M. gagates, M. marginatus, M. sowerbyi); Opeas; Pomacea (P. canaticulata); Vallonia and Zanitoides.

[0706] The active ingredients according to the invention can be used for controlling (i.e. suppressing or destroying) pests of the above-mentioned type, which occur in particular on plants, especially on useful and ornamental plants in agriculture, in horticulture and in forestry, or on organs of these plants, such as fruits, flowers, leaves, stems, tubers or roots, and in some cases even plant organs formed at a later point in time still remain protected against these pests.

[0707] In particular, suitable target crops are cereals, such as wheat, barley, rye, oats, rice, corn or sorghum; beets, such as sugar beets or fodder beets; fruits, such as pome, stone or soft fruit, such as apples, pears, plums, peaches, apricots, cherries or berries, such as strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soybeans; oilseed crops, such as rapeseed, mustard, poppy, olives, sunflower, coconut, castor, cocoa beans, or peanuts; cucurbits such as pumpkin, cucumber, or melon; fiber plants such as cotton, flax, hemp, or jute; citrus fruits such as oranges, lemons, grapefruits, or tangerines; vegetables such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, or bell peppers; lauraceae such as avocado, cinnamon, or camphor; and also tobacco, nuts, coffee, eggplant, sugarcane, tea, pepper, grapevines, hops, plantago, and latex plants.

[0708] The compositions and / or methods of the present invention may also be used on any ornamental and / or vegetable crop, including flowers, shrubs, broadleaf trees, and evergreen plants.

[0709] For example, the present invention can be used with any of the following ornamental plant species: Ageratum species, Alonsoa species, Anemone species, Anisodontea capsenisis, Anthemis species, Antirrhinum species, Aster species, Begonia species (e.g., Rieger Begonia, Begonia sempervirens, Begonia tubéreux), Bougainvillea species, Brachycome species, Brassica species (ornamentals), Calceolaria species, Capsicum, Catharanthus roseus, Canna species, Centaurea species, Chrysanthemum species, Cineraria species (C. maritime), Coreopsis species, Crassula coccinea, Cupheaignea, Dahlia species, Delphinium species, Dicentra species, Dorotheantus species. spp.), Lisianthus, Forsythia species, Fuchsia species, Geranium gnaphalium, Gerbera species, Globe amaranth, Heliotrope species, Sunflower species, Hibiscus species, Hydrangea species, Hydrangea species, Rhododendron, Impatiens species (African balsam), Amaranth species (Iresines spp.), Kalanchoe species, Lantana, March flower, Lion's ear, Lilium species, Mesembryanthemum species, Physalis species, Monarda species, Dracaena species, Marigold species, Dianthus species (carnation), Canna species, Oxalis species, Daisy species, Pelargonium species (Shieldleaf Pelargonium, Horseshoe Pelargonium), Viola species (Viola tricolor), Petunia species, Phlox species, Plecthranthus species spp.), poinsettia species, creeper species (five-leaf creeper, Parthenocissus quinquefolia), primula species, ranunculus species, azalea species, Rosa species (roses), rudbeckia species, African violet species, salvia species, Scaevola aemola, Schizanthus wisetonensis, sedum species, Solanum species, Surfinia petunia species (Surfinia spp.), marigold species, Nicotiana species, verbena species, zinnia species, and other bedding plants.

[0710] For example, the present invention can be used with any of the following vegetable species: Allium species (garlic, onion, shallot (A.oschaninii), leek, shallot, scallion), fennel, celery (Apium graveolus), asparagus, beet (Betavulgarus), Brassica species (cabbage, Chinese cabbage, turnip), peppers, chickpeas, endive, chicory species (chicory, endive), watermelon, Cucumber species (cucumber, melon), Cucurbita species (zucchini, Indian pumpkin), Cynara species (artichoke, cardoon), wild carrot, fennel, Hypericum species, lettuce, Lycopersicon species (tomato, cherry tomato), mint species, basil, parsley, Phaseolus species (bean, pea), pea, radish, edible rhubarb, Rosemary species, sage species, black salsify (Scorzonera hispanica), eggplant, spinach, new Valerian species (V. eriocarpa), and broad beans.

[0711] Preferred ornamental plant species include African violet, begonia, dahlia, gerbera, hydrangea, verbena, rose, kalanchoe, poinsettia, aster, cornflower, coreopsis, delphinium, monarda, phlox, rudbeckia, sedum, petunia, violet, impatiens, geranium, chrysanthemum, ranunculus, fuchsia, salvia, hydrangea, rosemary, sage, St. John's wort, mint, sweet pepper, tomato, and cucumber.

[0712] The active ingredients according to the invention are particularly suitable for controlling the bean aphid, cucumber leaf beetle, tobacco budworm, peach aphid, diamondback moth and sea moth on cotton, vegetables, corn, rice and soybean crops. The active ingredients according to the invention are also particularly suitable for controlling the cabbage looper (preferably on vegetables), the codling moth (preferably on apples), the green leafhopper (preferably on vegetables, in vineyards), the potato beetle (preferably on potatoes) and the striped stem borer (preferably on rice).

[0713] Compounds of formula (I) are particularly suitable for controlling:

[0714] pests of the order Hemiptera, for example one or more of the following species: Bemisia tabaci, Bean aphid, Green peach aphid, Rhopalosiphum padi, Brown rice hopper (Nilaparvata lugens), and Euschistus heros (preferably on vegetables, soybeans, and sugarcane);

[0715] Pests of the order Lepidoptera, for example one or more of the following species: Spodoptera littoralis, Spodoptera frugiperda, Plutella xylostella, Cnaphalocrocis medinalis, Codling moth, Chrysodeixis includes, Chilo suppressalis, Elasmopalpus lignosellus, Pseudoplusia includesns, and Tomato leafminer (preferably on vegetables and corn);

[0716] pests of the order Thysanoptera, such as the family Thripidae, for example one or more of Thrips tabaci and Thrips occidentalis (preferably on vegetables); and

[0717] • Soil pests (e.g. of the order Coleoptera), for example species of Diabrotica spp., species of the genus Leptinotarsa ​​and potato beetles (preferably on vegetables and maize).

[0718] The term "crops" is to be understood as also including crop plants which have been transformed by the use of recombinant DNA techniques so as to enable them to synthesize one or more selectively acting toxins, such as are known, for example, from toxigenic bacteria, in particular those of the genus Bacillus.

[0719] Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, such as those from Bacillus cereus or Bacillus japonicus; or insecticidal proteins from Bacillus thuringiensis, such as delta-endotoxins, for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, or Cry9C, or vegetative insecticidal proteins (Vips), such as Vip1, Vip2, Vip3, or Vip3A; or insecticidal proteins of bacterial colonizing nematodes, for example, Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophila, or Xenorhabdus spp. nematophilus); toxins produced by animals, such as scorpion toxins, spider toxins, bee toxins and other insect-specific neurotoxins; toxins produced by fungi, such as streptomycin, plant lectins, such as pea lectin, barley lectin or snowdrop lectin; agglutinin; protease inhibitors, such as trypsin inhibitor, silk proteinase inhibitor, potato glycoprotein, cystatin, papain inhibitor; ribosome inactivating protein (RIP), such as ricin, maize-RIP, abrin, luffain, saporin or bryophyllin; steroid metabolizing enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidase, ecdysteroid inhibitors, HMG-COA-reductase, ion channel blockers, such as sodium channel or calcium channel blockers, juvenile hormone esterase, diuretic hormone receptor, stilbene synthase, bibenzyl synthase, chitinase and glucanase.

[0720] In the context of the present invention, δ-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vips), such as Vip1, Vip2, Vip3 or Vip3A, should be understood to include, but are not limited to, mixed toxins, truncated toxins and modified toxins. Mixed toxins are recombinantly produced by the new combination of different domains of those proteins (see, for example, WO 02 / 15701). Truncated toxins, such as truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of a naturally occurring toxin are replaced. In such amino acid replacements, it is preferred that a non-naturally occurring protease recognition sequence be inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G recognition sequence is inserted into the Cry3A toxin (see WO 03 / 018810).

[0721] Examples of such toxins or transgenic plants capable of synthesizing such toxins are disclosed in, for example, EP-A-0 374 753, WO 93 / 07278, WO 95 / 34656, EP-A-0 427 529, EP-A-451 878 and WO 03 / 052073.

[0722] Methods for preparing such transgenic plants are generally known to those skilled in the art and are described, for example, in the publications mentioned above. CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO 95 / 34656, EP-A-0 367474, EP-A-0 401 979 and WO 90 / 13651.

[0723] The toxins contained in the transgenic plants render the plants tolerant to harmful insects. Such insects can be found in any insect taxonomic group, but are particularly common among beetles (Coleoptera), two-winged insects (Diptera), and moths (Lepidoptera).

[0724] Transgenic plants comprising one or more genes encoding insecticide resistance and expressing one or more toxins are known and some of them are commercially available. Examples of such plants are: (corn variety expressing Cry1Ab toxin); YieldGard (corn variety expressing Cry3Bb1 toxin); YieldGard (corn varieties expressing Cry1Ab and Cry3Bb1 toxins); (corn variety expressing Cry9C toxin); Herculex (a corn variety expressing the Cry1Fa2 toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) that confers tolerance to the herbicide glufosinate ammonium); NuCOTN (cotton variety expressing Cry1Ac toxin); Bollgard (cotton variety expressing Cry1Ac toxin); Bollgard (cotton varieties expressing Cry1Ac and Cry2Ab toxins); (cotton variety expressing Vip3A and Cry1Ab toxins); (potato variety expressing Cry3A toxin); GT Advantage (GA21 glyphosate tolerance trait), CB Advantage (Bt11 corn borer (CB) trait) and

[0725] Further examples of such genetically modified crops are:

[0726] 1. Bt11 corn, from Syngenta Seeds SAS, Chemin de Hobit 27, F-31 790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. This genetically modified maize plant is resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia inermis) by transgenic expression of a truncated Cry1Ab toxin. Bt11 corn also transgenicly expresses the PAT enzyme to confer tolerance to the herbicide glufosinate ammonium.

[0727] 2. Bt176 maize, from Syngenta Seeds, 27 Rue de Hobbit, F-31 790 Saint-Sauveur, France, registration number C / FR / 96 / 05 / 10. This genetically modified maize strain is resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia inermis) by transgenic expression of the toxin Cry1Ab. Bt176 maize also transgenicly expresses the enzyme PAT to confer tolerance to the herbicide glufosinate-ammonium.

[0728] 3. MIR604 maize, from Syngenta Seeds, 27 Rue de Hobbit, F-31 790 Saint-Sauveur, France, registration number C / FR / 96 / 05 / 10. This maize plant is rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin G protease recognition sequence. The preparation of this transgenic maize plant is described in WO 03 / 018810.

[0729] 4. MON 863 maize, from Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / DE / 02 / 9. MON 863 expresses the Cry3Bb1 toxin and confers resistance to certain coleopteran insects.

[0730] 5. IPC 531 cotton, from Monsanto Europe AB, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / ES / 96 / 02.

[0731] 6.1507 maize, from Pioneer Overseas Corporation, Avenue Tedesco, 7B-1160 Brussels, Belgium, registration number C / NL / 00 / 10. Genetically modified maize expressing the protein Cry1F for resistance to certain lepidopteran insects and the protein PAT for tolerance to the herbicide glufosinate.

[0732] 7. NK603×MON 810 maize, from Monsanto Europe, 270-272 Boulevard Tervuren, B-1150 Brussels, Belgium, registration number C / GB / 02 / M3 / 03. This is a conventionally bred hybrid maize variety, constructed by crossing the genetically modified varieties NK603 and MON 810. NK603×MON 810 maize is transgenic for the expression of the protein CP4 EPSPS obtained from the Agrobacterium strain CP4, rendering it herbicide tolerant. (contains glyphosate), and also Cry1Ab toxin from Bacillus thuringiensis subsp. kurstakia, which confers resistance to certain lepidopteran insects, including the European corn borer.

[0733] Transgenic crops of insect-resistant plants are also described in the BATS (Zentrum für Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) report 2003 ( http: / / bats.ch )middle.

[0734] The term "crop" is to be understood as also including crop plants that have been transformed using recombinant DNA technology to enable them to synthesize selectively acting antipathogenic substances, such as, for example, so-called "pathogenesis-related proteins" (PRPs, see, for example, EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesizing such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95 / 33818, and EP-A-0 353 191. Methods for producing such transgenic plants are generally known to those skilled in the art and are described, for example, in the publications mentioned above.

[0735] Crops can also be modified to increase resistance to fungal (eg, Fusarium, Anthracnose, or Phytophthora), bacterial (eg, Pseudomonas), or viral (eg, Potato Leaf Roll Virus, Tomato Spotted Wilt Virus, Cucumber Mosaic Virus) pathogens.

[0736] Crops also include those with increased resistance to nematodes, such as Heterodera glycines.

[0737] Crops with tolerance to abiotic stress include those with increased tolerance to drought, high salinity, high temperature, cold, frost or light radiation, for example, through expression of NF-YB or other proteins known in the art.

[0738] Antipathogenic substances that can be expressed by such transgenic plants include, for example, ion channel blockers, such as sodium channel and calcium channel blockers, for example viral KP1, KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; so-called "pathogenesis-related proteins" (PRPs; see, for example, EP-A-0 392 225); antipathogenic substances produced by microorganisms, such as peptide antibiotics or heterocyclic antibiotics (see, for example, WO 95 / 33818) or proteins or polypeptide factors that are involved in plant pathogen defense (so-called "plant disease resistance genes", as described in WO 03 / 000906).

[0739] Other areas of use of the compositions according to the invention are the protection of stored goods and storage rooms and the protection of raw materials such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, in particular the protection of humans, domestic animals and productive livestock from pests of the types mentioned.

[0740] The present invention provides a compound of the first aspect for use in therapy. The present invention provides a compound of the first aspect for use in controlling parasites in or on an animal. The present invention further provides a compound of the first aspect for use in controlling parasites on the body of an animal. The present invention further provides a compound of the first aspect for use in preventing and / or treating a disease transmitted by parasites on the body.

[0741] The present invention provides the use of the compound of the first aspect for the manufacture of a medicament for controlling parasites in or on the body of an animal. The present invention further provides the use of the compound of the first aspect for the manufacture of a medicament for controlling parasites on the body of an animal. The present invention further provides the use of the compound of the first aspect for the manufacture of a medicament for preventing and / or treating diseases transmitted by parasites on the body.

[0742] The present invention provides a use of the compound of the first aspect in controlling parasites in or on the body of an animal. The present invention further provides a use of the compound of the first aspect in controlling parasites on the body of an animal.

[0743] When used in the context of parasites in or on animals, the term "control" means reducing the number of pests or parasites, eliminating pests or parasites and / or preventing further infestation by pests or parasites.

[0744] When used in the context of parasites in or on animals, the term "treat" means to inhibit, slow, halt or reverse the progression or severity of existing symptoms or disease.

[0745] The term "prevent" when used in the context of parasites in or on animals means avoiding the development of symptoms or disease in the animal.

[0746] When used in the context of parasites in or on animals, the term "animal" may refer to both mammals and non-mammals, such as birds or fish. In the case of a mammal, it can be a human or a non-human mammal. Non-human mammals include, but are not limited to, livestock animals and pets. Livestock animals include, but are not limited to, cattle, camels, pigs, sheep, goats, and horses. Pets include, but are not limited to, dogs, cats, and rabbits.

[0747] A "parasite" is a harmful organism that lives in or on a host animal and benefits by obtaining nutrients at the host animal's expense. An "endoparasite" is a parasite that lives inside the host animal. An "ectoparasite" is a parasite that lives on the host animal's surface. ectoparasites include, but are not limited to, ticks, insects, and crustaceans (e.g., sea lice). The subclass Ixodida (or Acarina) includes ticks and mites. Ticks include, but are not limited to, members of the genera Rhipicaphalus, such as Rhipicaphalus microplus (Boophilus microplus) and Rhipicephalus sanguineus; Amblyomrna; Dermacentor; Haemaphysalis; Hyalomma; Ixodes; Rhipicentor; Margaropus; Argas; Otobius; and Ornithodoros. Mites include, but are not limited to, members of the genera: Dermestes, such as P. calves; P. spp., such as P. goat; Cheyletus; Dermatophagida; such as Dermatophagida gallinae; Ortnithonyssus; Demodex, such as Demodex canis; Sarcoptes, such as Sarcoptes hominis; and Psoralea. Insects include, but are not limited to, members of the orders: Siphonaptera, Diptera, Trichoderma, Lepidoptera, Coleoptera, and Homoptera. Members of Siphonaptera include, but are not limited to, Ctenocephatides cati and Ctenocephatides canis. Members of Diptera include, but are not limited to, species of the genus Musca; skin flies, such as horse flies and sheep flies; biting flies; gadflies, such as species of the genus Tabunus and species of the genus Tabunus; black horn flies, such as blood flies; biting flies; green flies; midges; and mosquitoes. Members of the order Trichoderma include, but are not limited to, blood-sucking lice and chewing lice, such as the wool louse (Bovicola Ovis) and the bovine feather louse.

[0748] The term "effective amount," when used in the context of parasites in or on an animal, refers to an amount or dosage of a compound of the invention, or a salt thereof, which, when administered to an animal in a single dose or multiple doses, provides the desired effect in or on the animal. An effective amount can be readily determined by the attending diagnostician (being one skilled in the art) by using known techniques and by observing results obtained in similar situations. In determining an effective amount, the attending diagnostician considers a number of factors, including, but not limited to: the species of mammal; its size, age, and general health; the parasite to be controlled and the degree of infestation; the specific disease or condition involved; the extent or severity of the disease or condition; the individual's response; the specific compound to be administered; the mode of administration; the bioavailability characteristics of the administered formulation; the dosing regimen selected; the use of concomitant medications; and other relevant circumstances.

[0749] The compounds of the present invention can be administered to animals by any route with the desired effect, including but not limited to topical, oral, parenteral and subcutaneous administration. Topical administration is preferred. Preparations suitable for topical administration include, for example, solutions, emulsions and suspensions, and can be administered in the form of watering, spot coating, spraying, spray race or dipping. In an alternative, the compounds of the present invention can be administered by ear tags or collars.

[0750] The salt forms of the compounds of the present invention include both pharmaceutically acceptable salts and veterinarily acceptable salts, which may be different from agrochemically acceptable salts. Pharmaceutically and veterinarily acceptable salts and common methods for preparing them are well known in the art. See, for example, Gould, PL, "Salt selection for basic drugs", International Journal of Pharmaceutics, 33: 201-217 (1986); Bastin, RJ et al. "Salt Selection and Optimization Procedures for Pharmaceutical New Chemical Entities", Organic Process Research and Development, 4: 427-435 (2000); and Berge, SM et al., "Pharmaceutical Salts", Journal of Pharmaceutical Sciences, 66: 1-19, (1977). It will be appreciated by those skilled in the art that the compound of the present invention easily changes into salt using technology and conditions known to those of ordinary skill in the art, and can be used as salt (such as hydrochloride) to separate.In addition, it will be appreciated by those skilled in the art that the compound of the present invention easily changes into corresponding free alkali, and can be used as corresponding free alkali to separate from corresponding salt.

[0751] The present invention also provides methods for controlling pests (such as mosquitoes and other disease vectors; see also http: / / www.who.int / malaria / vector_control / irs / en / ). In one embodiment, the method for controlling pests comprises applying the composition of the present invention to the target pests, their locus, or a surface or substrate by painting, rolling, spraying, coating, or dipping. By way of example, IRS (indoor residual spraying) application to surfaces (such as walls, ceilings, or floor surfaces) is contemplated by the methods of the present invention. In another embodiment, application of such compositions to substrates such as nonwoven or fabric materials in the form of (or that can be used in the manufacture of) netting, coverings, bedding, curtains, and tents is contemplated.

[0752] In one embodiment, the method for controlling this type of harmful organism comprises applying the composition of the present invention of pest-killing effective dose to target harmful organism, their place or surface or substrate, so that on this surface or substrate, effective pest-killing activity of retention is provided.Such application can be carried out by brushing, rolling, spraying, coating or dipping pest-killing composition of the present invention.By way of example, the IRS application of surface (such as wall, ceiling or floor surface) is considered by method of the present invention, so that effective pest-killing activity of retention is provided on this surface.In another embodiment, it is considered to use this type of composition for the residual control of the harmful organism on substrate, this substrate is the fabric material as in the form (or can be used for the manufacture of these articles) of netting, covering, quilt, curtain and tent.

[0753] The substrate to be treated (including nonwovens, fabrics or nettings) can be made of natural fibers (such as cotton, raffia, jute, flax, sisal, burlap or wool) or synthetic fibers (such as polyamide, polyester, polypropylene, polyacrylonitrile, etc.). Polyester is particularly suitable. Methods for treating textiles are known, for example WO 2008 / 151984, WO 2003 / 034823, US 5631072, WO 2005 / 64072, WO 2006 / 128870, EP 1724392, WO 2005113886 or WO 2007 / 090739.

[0754] A further area of ​​use of the compositions according to the invention is in the field of tree injection / trunk treatment of all ornamental trees as well as all kinds of fruit and nut trees.

[0755] In the field of tree injection / trunk treatment, the compounds according to the invention are particularly suitable for combating wood-boring insects from the orders Lepidoptera and from the orders Coleoptera mentioned above, in particular against the wood-boring insects listed in the following Tables A and B:

[0756] Table A. Examples of economically important exotic wood-boring insects.

[0757]

[0758] Table B. Examples of economically important native wood-boring insects.

[0759]

[0760]

[0761]

[0762]

[0763] The present invention can also be used to control any insect pest that may be present in turfgrass, including, for example, beetles, caterpillars, fire ants, ground pearls, millipedes, woodlice, mites, mole crickets, scale insects, mealybugs, ticks, cicadas, southern wheat stink bugs, and white grubs. The present invention can be used to control insect pests at all stages of their life cycle, including eggs, larvae, nymphs, and adults.

[0764] In particular, the present invention can be used to control insect pests that feed on the roots of turfgrasses, including grubs (such as Cyclocephala spp. (e.g., marked beetles, C. lurida), Rhizotrogus spp. (e.g., European beetles, European root-cutting gill beetles (R. majalis)), Cotinus spp. (e.g., Green June beetles, Green June flower beetles (C. nitida)), Popillia spp. (e.g., Japanese beetles, Japanese arc beetles (P. japonica)), Phyllophaga spp. (e.g., May / June beetles), Ataenius spp. (e.g., Black turfgrass ataenius, Black velvet beetles (A. spretulus)), Maladera spp. spp.) (e.g., Asiatic garden beetle, M. castanea, and Tomarus spp.), ground pearls (Margarodes spp.), mole crickets (tawny, southern, and short-winged; Scapteriscus spp., Gryllotalpa africana), and leatherjackets (European crane fly, Tipula spp.).

[0765] The present invention can also be used to control insect pests of turfgrass in thatched homes, including armyworms (such as the fall armyworm Spodoptera frugiperda, and the common armyworm Pseudaletia unipuncta), cutworms, weevils (Sphenophorus spp., such as S. venatus vestitus and S. parvulus), and meadow moths (such as Crambus spp. and the tropical meadow moth, Herpetogramma phaeopteralis).

[0766] The present invention can also be used to control insect pests in turfgrasses that live above ground and feed on turfgrass leaves, including wheat stink bugs (such as the southern wheat stink bug, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), Grass mealybug (Antonina graminis), Prosapia bicincta, leafhoppers, cutworms (Noctuidae), and Schizaphis graminis.

[0767] The present invention can also be used to control other pests in turfgrass, such as introduced fire ants (Solenopsis invicta) that create nests in lawns.

[0768] In the hygiene sector, the compositions according to the invention are effective against epiparasites such as hard ticks, soft ticks, scabies, autumn mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.

[0769] Examples of such parasites are:

[0770] From the order of the Pediculus: Haemaphysalis spp., Linognathus spp., Pediculus hominis spp., and Phtirus spp., Phitirus spp.

[0771] From the order Trichophagus: Felicola species, Felicola species, Felicola species, Felicola species, Werneckiella spp., Lepikentron spp., Felicola species, Felicola species, and Felicola species.

[0772] Of the order Diptera and the suborders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp. spp.), Braula spp., Musca spp., Hydrotaea spp., Biting flies, Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp.) and Melophagus spp.,

[0773] From the order of the Siphonapterida, for example, Pulex spp., Ctenopsida spp., Xenopsylla spp., Ceratophyllum spp.,

[0774] From the order of the Heteropterida, for example, Cimex spp., Triatominae spp., Panstrongylus spp.,

[0775] From the order of the Blattarida, for example, Blatta orientalis, Periplaneta americana, Blattelagermanica and Supella spp.

[0776] Subclass Acaria (family Acarida) and orders Meta-stigmata and Meso-stigmata, for example, Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyommas spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp. spp.), Sternostoma spp., and Varroa spp.

[0777] From the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example, Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp. spp.), Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedress spp., Knemidocoptes spp., Cytodites spp., and L. aminosioptes spp.

[0778] The compositions according to the invention are also suitable for protecting materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and construction materials from infestation by insects.

[0779] The compositions according to the invention can be used, for example, to combat the following pests: beetles, such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale), Minthes rugicollis, Xyleborus spec., Tryptodendron spec., Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec., and Dinoderus minutus, as well as Hymenoptera, such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus, and Urocerus augu, and termites, such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes spp. indicola), Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis and Coptotermes formosanus, as well as borers such as Silverfish (Lepisma saccharina).

[0780] The compounds of formula (I) and (I') or their salts are particularly suitable for controlling one or more pests selected from the following families: Noctuidae, Diamondback Moths, Chrysomelidae, Thripidae, Pentatomidae, Tomentosaidae, Delphacidae, Aphididae, Noctuidae, Pyralidae, Meloidogyneidae and Heteroderae. In a preferred embodiment of each aspect, compound TX (wherein the abbreviation "TX" means "a compound selected from the compounds defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21") controls one or more pests selected from the following families: Noctuidae, Diamondback Moths, Chrysomelidae, Thripidae, Pentatomidae, Tomentosaidae, Delphacidae, Aphididae, Noctuidae, Pyralidae, Meloidogyneidae and Heteroderae.

[0781] The compounds of formula (I) and (I') or salts thereof are particularly suitable for controlling one or more pests selected from the following genera: Spodoptera species, Diamondback moth species, Thrips species, Thrips species, American stink bug species, Tomentosa species, Nilaparvata species, Myzus persicae species, Aphis species, Diabrotica species, Aphis species, Spodoptera species, Geometridae species and Graminophora species. In preferred embodiments of each aspect, compound TX (wherein the abbreviation "TX" means "a compound selected from the group consisting of the compounds defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21") controls one or more pests selected from the group consisting of Spodoptera species, Diamondback moth species, Thrips species, Thrips species, Stink bug species, Tomentosa species, Nilaparvata species, Myzus persicae species, Aphis species, Diabrotica species, Aphis species, Spodoptera species, Geometridae species, and Graminophora species.

[0782] The compounds of formula (I) and (I') or salts thereof are particularly useful for controlling one or more of the following: Spodoptera littoralis, Plutella xylostella, Western flower thrips, Thrips tabaci, American stink bug, codling moth, brown rice hopper, peach aphid, soybean looper, bean aphid, cucumber leaf beetle, cereal aphid, and striped stem borer.

[0783] In preferred embodiments of each aspect, compound TX (wherein the abbreviation "TX" means "a compound selected from the compounds defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21") controls one or more of: Spodoptera littoralis, Plutella xylostella, western flower thrips, Thrips tabaci, American stink bug, codling moth, brown rice hopper, green peach aphid, soybean looper, bean aphid, cucumber leaf beetle, cereal aphid, and striped stem borer, such as Spodoptera littoralis+TX, Plutella xylostella+TX; western flower thrips+TX, Thrips tabaci+TX, American stink bug+TX, codling moth+TX, brown rice hopper+TX, green peach aphid+TX, soybean looper+TX, bean aphid+TX, cucumber leaf beetle+TX, cereal aphid+TX, and striped stem borer+TX.

[0784] In embodiments of each aspect, a compound from Tables A-1 to A-78, B-1 to B-78, C-1 to C-21, and D-1 to D-21 is suitable for controlling Spodoptera littoralis, Plutella xylostella, Western flower thrips, Thrips tabaci, American stink bug, Codling moth, Brown rice hopper, Myzus persicae, Bean looper, Bean aphid, Cucumber leaf beetle, Grain aphid, and Chilo suppressalis in cotton, vegetables, corn, cereals, rice, and soybean crops.

[0785] In an embodiment, a compound from Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21 is suitable for controlling Spodoptera spp. (preferably on vegetables), Codling moth (preferably on apples), Empoasca spp. (preferably on vegetables, vineyards), Diabrotica spp. (preferably on potatoes) and Chilo suppressalis (preferably on rice).

[0786] The compounds according to the present invention may have any number of benefits, including, among others, favorable levels of biological activity for protecting plants against insects or superior properties for use as agrochemical active ingredients (e.g., higher biological activity, favorable activity spectrum, increased safety (to non-target organisms above and below ground, such as fish, birds, and bees), improved physico-chemical properties, or increased biodegradability). In particular, it has been unexpectedly discovered that certain compounds of formula (I) can exhibit favorable safety profiles relative to non-target arthropods, particularly pollinators such as honey bees, solitary bees, and bumble bees. Most particularly, relative to the Italian honey bee (Apis mellifera).

[0787] The compounds according to the invention can be used as pesticides in unmodified form, but they are usually formulated into compositions in various ways using formulation adjuvants such as carriers, solvents and surfactants. These formulations can be in different physical forms, for example, in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent compressed tablets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, mobile oils, aqueous dispersions, oily dispersions, suspoemulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water-miscible organic solvent as a carrier), impregnated polymer films or in other known forms, for example, from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, 1st edition, second revision (2010). Such formulations can be used directly or diluted before use. Dilution can be performed with, for example, water, liquid fertilizers, micronutrients, biological organisms, oils or solvents.

[0788] These formulations can be prepared, for example, by mixing the active ingredient with a formulation adjuvant in order to obtain a composition in the form of a finely divided solid, granules, solution, dispersion or emulsion. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surfactants or combinations thereof.

[0789] These active ingredients can also be contained in very fine microcapsules. Microcapsules contain active ingredients in porous carriers. This allows the active ingredient to be released (e.g., slowly released) into the environment in a controlled amount. Microcapsules typically have a diameter of from 0.1 to 500 microns. The amount of active ingredient they contain is approximately from 25% to 95% of the capsule weight by weight. These active ingredients can be in the form of a holistic solid, in the form of fine particles in a solid or liquid dispersion, or in the form of a suitable solution. The encapsulated membrane can include, for example, natural or synthetic rubber, cellulose, styrene / butadiene copolymer, polyacrylonitrile, polyacrylate, polyester, polyamide, polyurea, polyurethane, or chemically modified polymers and starch xanthate or other polymers known to those skilled in the art. Alternatively, very fine microcapsules can be formed, in which the active ingredient is contained in the form of finely dispersed particles in a solid matrix of a base material, but these microcapsules themselves are not wrapped.

[0790] Formulation adjuvants suitable for preparing the compositions according to the invention are known per se. As liquid carriers, water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol rosinate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl Formamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, dipropylene glycol, alkyl pyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, α-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, γ-butyrolactone, glycerol, acetic acid glyceryl, diacetic acid glyceryl, triacetic acid glyceryl, decaglycerol Hexadecane, Hexanediol, Isoamyl Acetate, Isobornyl Acetate, Isooctane, Isophorone, Cumene, Isopropyl Myristate, Lactic Acid, Lauramine, Mesityl Oxide, Methoxypropanol, Methyl Isoamyl Ketone, Methyl Isobutyl Ketone, Methyl Laurate, Methyl Caprylate, Methyl Oleate, Methylene Chloride, m-Xylene, n-Hexane, n-Octylamine, Octadecanoic Acid, Octylamine Acetate, Oleic Acid, Oleylamine, o-Xylene, Phenol, Polyethylene Glycol, Propionic Acid, Propyl Lactate , propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol and higher molecular weight alcohols such as amyl alcohol, tetrahydrofuranol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone, etc.

[0791] Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, diatomaceous earth, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed hulls, wheat flour, soy flour, pumice, wood flour, ground walnut shells, lignin, and similar substances.

[0792] Many surface-active substances can be used advantageously in both solid and liquid formulations, especially those which can be diluted with a carrier before use. Surface-active substances can be anionic, cationic, nonionic or polymeric and they can act as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium laurylsulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol / alkylene oxide addition products, such as ethoxylated nonylphenol; alcohol / alkylene oxide addition products, such as ethoxylated tridecanol; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; salts of dialkylsulfosuccinates, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary ammoniums, such as dodecyltrimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and dialkyl phosphates; and further substances, such as are described, for example, in McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Company. Corp., Ridgewood New Jersey (1981).

[0793] Additional adjuvants that can be used in pesticidal formulations include crystallization inhibitors, viscosity modifiers, suspending agents, dyes, antioxidants, foaming agents, light absorbers, mixing aids, defoamers, complexing agents, substances and buffers that neutralize or alter the pH, corrosion inhibitors, fragrances, wetting agents, absorption enhancers, micronutrients, plasticizers, glidants, lubricants, dispersants, thickeners, antifreeze agents, microbicides, and liquid and solid fertilizers.

[0794] The composition according to the invention may comprise an additive comprising an oil of plant or animal origin, a mineral oil, an alkyl ester of such an oil or a mixture of such an oil and an oil derivative. The amount of the oil additive in the composition according to the invention is generally from 0.01% to 10% based on the mixture to be applied. For example, the oil additive may be added to the spray tank in the desired concentration after the spray mixture has been prepared. Preferred oil additives include mineral oil or an oil of plant origin, such as rapeseed oil, olive oil or sunflower oil; emulsified vegetable oils; alkyl esters of oils of plant origin, such as methyl derivatives; or oils of animal origin, such as fish oil or tallow. Preferred oil additives include C8-C 22 Alkyl esters of fatty acids, especially C 12 -C 18Methyl derivatives of fatty acids, such as the methyl esters of lauric acid, palmitic acid, and oleic acid (methyl laurate, methyl palmitate, and methyl oleate, respectively). Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10th edition, Southern Illinois University, 2010.

[0795] These compositions according to the invention generally comprise from 0.1% to 99% by weight, in particular from 0.1% to 95% by weight, of a compound according to the invention and from 1% to 99.9% by weight of formulation adjuvants, which preferably include from 0 to 25% by weight of surface-active substances. Whereas commercial products may preferably be formulated as concentrates, the end user will generally use dilute formulations.

[0796] The application rate varies within wide limits and depends on the nature of the soil, the application method, the crop plants, the harmful organisms to be controlled, the prevailing climatic conditions, and other factors dictated by the application method, the time of application, and the target crop. In general, the compound can be applied at a rate of from 1 l / ha to 2000 l / ha, in particular from 10 l / ha to 1000 l / ha.

[0797] Formulation types include emulsion concentrates (EC), suspension concentrates (SC), suspoemulsions (SE), capsule suspensions (CS), water-dispersible granules (WG), emulsifiable granules (EG), water-in-oil emulsions (EO), oil-in-water emulsions (EW), microemulsions (ME), oil dispersions (OD), oil suspensions (OF), oil-soluble concentrates (OL), soluble concentrates (SL), ultra-low volume suspensions (SU), ultra-low volume concentrates (UL), finished products (TK), dispersible concentrates (DC), wettable powders (WP), soluble granules (SG), or any technically feasible formulation in combination with agriculturally acceptable adjuvants.

[0798] A preferred formulation may have the following composition (wt %):

[0799] Emulsifiable concentrates:

[0800] Active ingredient: 1% to 95%, preferably 60% to 90%

[0801] Surfactant: 1% to 30%, preferably 5% to 20%

[0802] Liquid carrier: 1% to 80%, preferably 1% to 35%

[0803] Dust powder:

[0804] Active ingredient: 0.1% to 10%, preferably 0.1% to 5%

[0805] Solid carrier: 99.9% to 90%, preferably 99.9% to 99%

[0806] Suspension concentrate:

[0807] Active ingredient: 5% to 75%, preferably 10% to 50%

[0808] Water: 94% to 24%, preferably 88% to 30%

[0809] Surfactant: 1% to 40%, preferably 2% to 30%

[0810] Wettable powder:

[0811] Active ingredient: 0.5% to 90%, preferably 1% to 80%

[0812] Surfactants: 0.5% to 20%, preferably 1% to 15%

[0813] Solid carrier: 5% to 95%, preferably 15% to 90%

[0814] Granules:

[0815] Active ingredient: 0.1% to 30%, preferably 0.1% to 15%

[0816] Solid carrier: 99.5% to 70%, preferably 97% to 85%

[0817] The following mixtures of a compound of formula (I) and an active ingredient are preferred (wherein the abbreviation "TX" means "a compound selected from the group consisting of the compounds defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21, and Table P"):

[0818] An auxiliary agent selected from the group consisting of: petroleum (alias) (628) + TX;

[0819] Abamectin + TX, acetamiprid + TX, acetamiprid + TX, acetofluanid + TX, flumethrin + TX, acynonapyr + TX, cyclohexanil + TX, afoxolaner + TX, cotton boll carbendazim + TX, allethrin + TX, α-cypermethrin + TX, alpha-cypermethrin + TX, sulfamethoxazole + TX, cypermethrin + TX, triazotin + TX, sulfamethoxazole + TX, benzyltrimethoxam + TX, benzpyrimoxan + TX, β-cyfluthrin + TX, β-cypermethrin + TX, bifenazate + TX, bifenthrin + TX, binapacryl + TX, bioallethrin + TX, S-bioallethrin +TX, bio-resmethrin+TX, bistrifluan+TX, broflanilide+TX, brofluthrin+TX, bromophos-ethyl+TX, buprofezin+TX, butacarb+TX, cadusafos+TX, carbaryl+TX, butacarb+TX, batan+TX, CAS No.: 1632218-00-8+TX, CAS No.: 1808115-49-2+TX, CAS No.: 2032403-97-5+TX, CAS No.: 2044701-44-0+TX, CAS No.: 2128706-05-6+TX, CAS No.: 2095470-94-1+TX, CAS No.: 237708 4-09-6+TX、CAS No.:1445683-71-5+TX、CAS No.:2408220-94-8+TX、CAS No.:2408220-91-5+TX、CAS No.:1365070-72-9+TX、CAS No.:2171099-09-3+TX、CAS No.:2396747-83-2+TX、CAS No.:2133042-31-4+TX、CAS No.:2133042-44-9+TX、CAS No.:1445684-82-1+TX、CAS No.:1445684-82-1+TX、CAS No.:1922957-45-6+TX、CAS No.: 1922957-46-7+TX、CAS No.:1922957-47-8+TX、CAS No.:1922957-48-9+TX、CAS No.:2415706-16-8+TX、CAS No.:1594624-87-9+TX、CAS No.:1594637-65-6+TX、CAS No.:1594626-19-3+TX、CAS No.:1990457-52-7+TX、CAS No.:1990457-55-0+TX、CAS No.:1990457-57-2+TX、CAS No.:1990457-77-6+TX、CAS No.:1990457-66-3+TX、CAS No.: 1990457-85-6+TX, CAS No.: 2220132-55-6+TX, CAS No.: 1255091-74-7+TX, CAS No.: RNA (potato beetle-specific recombinant double-stranded interference GS2)+TX, CAS No.: 2719848-60-7+TX, CAS No.: 1956329-03-5+TX, chlorantraniliprole+TX, chlordane+TX, chlorfenapyr+TX, chlorpromazine+TX, chlorpropamide+TX, chlorfenapyr+TX, chlorfenapyr+TX, chlorfenapyr+TX, chlorfenapyr+TX, cloethocarb+TX, clothianidin+TX, 2-chlorophenyl N-methylcarbamate (CPMC)+TX, benzonitrile+TX, cyantraniliprole+TX TX, cyclobromofenapyr + TX, cyclobutrifluram + TX, pyrethroid + TX, cycloxanil + TX, cytoxanil + TX, cyetpyrafen (or etpyrafen) + TX, cyflumetofen + TX, cyhalodiamide + TX, cyhalothrin + TX, cypermethrin + TX, cypermethrin + TX, cyproflanilide + TX, cyromazine + TX, deltamethrin + TX, cyprofenuron + TX, chlorpyrifos + TX, dibrom + TX, dichlorothiazolin (dichlorothiazolin) cloromezotiaz)+TX, fluazifop+TX, diflubenzuron+TX, dimpropyridaz+TX, dilprofen+TX, dinotefuran+TX, vegetable phosphorus+TX, emamectin (or emamectin benzoate)+TX, d-epsilon+TX, epsilon-momfluorothrin+TX, epsilon-metofluthrin+TX, esfenvalerate+TX, ethion+TX, ethiprole+TX, ethofenprox+TX, etoxazole+TX, valproate+TX, fenazaquin+TX, pentothrin+TX, fenmezoditiaz+TX, fenitrothion Phosphorus + TX, fenbucarb + TX, fenthiocarb + TX, fenoxycarb + TX, cypermethrin + TX, fenpyroximate + TX, fensulfuron + TX, fenthion + TX, cypermethrin + TX, fipronil + TX, flometoquin + TX, flonicamid + TX, pyrimidifen + TX, fluazaindolizine + TX, flupyralid + TX, flubendiamide + TX, fluchlordiniliprole + TX, flucitrinate + TX, flufenoxuron + TX, flucythrin + TX,Fluthiazolin + TX, flumethrin + TX, triflumethrin + TX, butenefipronil + TX, fluhexafon + TX, fluchlorfenapyr + TX, fluopyram + TX, flupentiofenox + TX, flupyronil + TX, flupyrimin + TX, fluralaner + TX, fluvalinate + TX, fluxametamide + TX, thiazolin + TX, gamma-cyhalothrin + TX, pyrimidine + TX, chlorfenapyr + TX, benzylfen + TX, heptafluthrin + TX, thiophanate Acyril + TX, hydrazone + TX, imicyafos + TX, imidacloprid + TX, imiprodinil + TX, indazapyroxamet + TX, indoxacarb + TX, iodomethane + TX, iprodione + TX, isocycloseram + TX, isosulfuron + TX, ivermectin + TX, kappa-bifenthrin + TX, kappa-tefluthrin + TX, lambda-cyhalothrin + TX, lepidomycin + TX, lotilaner + TX, chlorfenuron + TX, metaflumizone + TX, metaldehyde + TX, methomyl + TX, methomyl + TX, methoxyfenozide + TX, metofluthrin +TX, cypermethrin +TX, chlorpyrifos +TX, acarbamide +TX, momfluorothrin +TX, cypermethrin +TX, nicofluprole +TX; nitenpyram +TX, nithiazine +TX, omethoate +TX, oxamyl +TX, Oxazosulfyl +TX, parathion-ethyl +TX, permethrin +TX, phenothrin +TX, phosphamidon +TX, piperonyl butoxide +TX, pirimicarb +TX, pyrimidophos-ethyl +TX, pyrimidophos-methyl +TX, polyhedrosis virus +TX, prallethrin +TX, profenofos +TX, profluthrin +TX, propargyl +TX, propoxur +TX, propoxur +TX, Phosphate + TX, Protrifenbute + TX, Pyflubumide + TX, Pymetrozine + TX, Pyraclofos + TX, Pyrafluprole + TX, Pyridaben + TX, Pyridalyl + TX, Pyrifluquinazon + TX, Pyrimidine + TX, Pyrimidine + TX, Pyrifluquinazon + TX, Pyrimidine + TX, Pyriflufen + TX, Resmolin + TX, Sarolaner + TX, Selamectin + TX, Silafluthrin + TX, Spinetoram + TX, Spinosad + TX, spirobudifen + TX, Spirodiclofen + TX,Spiromesifen + TX, Spiropidion + TX, Spirotetramat + TX, spidoxamat + TX, Sulfonamidin + TX, Tebufenozide + TX, Tebufenpyrad + TX, Tebupirimiphos + TX, Tefluthrin + TX, Tetrafluthrin + TX, Tetracycline + TX, Tetradiphon + TX, Tetramethrin + TX, Tetracycline + TX, Cypermethrin + TX, Flucyrantel + TX, θ-Cypermethrin + TX, Thiacloprid + TX, Thiamethoxam + TX, Thiamethoxam + TX, Thiocycline + TX, Thiodicarb + TX, Longxiaowei + TX, Methylsulfonate + TX, Dimethoate + TX, Tiolaner + TX, Tiorantraniliprole + TX, Tioxazafen + TX, Tolfenpyrad + TX, Toxaphene + TX X, tralomethrin + TX, transfluthrin + TX, triazophos + TX, trichlorfon + TX, trifluenfuronate + TX, chlorpyrifos + TX, trichlorfon + TX, triflumezopyrim + TX, Tyclopyrazoflor + TX, ζ-cypermethrin + TX, seaweed extract and fermentation products derived from sugar acyl + TX, seaweed extract and fermentation products derived from sugar acyl (containing urea + TX, amino acids + TX, potassium and molybdenum and EDTA chelated manganese) + TX, seaweed extract and fermented plant products + TX, seaweed extract and fermented plant products (containing plant hormones + TX, vitamins + TX, EDTA chelated copper + TX, zinc + TX, and iron + TX), azadirachtin + TX, Bacillus ayuzawa (Bacillus aizawai) + TX, Bacillus chitinosporus AQ746 (NRRL registration number B-21 618) + TX, Bacillus firmus + TX, Bacillus kurstak (Bacillus Kurstaki) + TX, Bacillus mycoides AQ726 (NRRL Accession No. B-21664) + TX, Bacillus pumilus (NRRL Accession No. B-30087) + TX, Bacillus pumilus AQ717 (NRRL Accession No. B-21662) + TX, Bacillus species AQ178 (ATCC Accession No. 53522) + TX, Bacillus species AQ175 (ATCC Accession No. 55608) + TX, Bacillus species AQ177 (ATCC Accession No. 55609) + TX, unspecified Bacillus subtilis + TX, Bacillus subtilis AQ153 (ATCC Accession No. 55614) + TX, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421) + TX, Bacillus subtilis AQ30004 (NRRL Accession No. B-50455) + TX,Bacillus subtilis AQ713 (NRRL Accession No. B-21661) + TX, Bacillus subtilis AQ743 (NRRL Accession No. B-21665) + TX, Bacillus thuringiensis AQ52 (NRRL Accession No. B-21619) + TX, Bacillus thuringiensis BD#32 (NRRL Accession No. B-21530) + TX, Bacillus thuringiensis subspec. kurstaki BMP 123 + TX, Beauveria bassiana + TX, D-limonene + TX, granulovirus + TX, Harpin + TX, Helicoverpa armigera nuclear polyhedrosis virus + TX, Helicoverpa viridis nuclear polyhedrosis virus + TX, Helicoverpa viridis nuclear polyhedrosis virus + TX, Helicoverpa viridis nuclear polyhedrosis virus + TX, Helicoverpa armigera nuclear polyhedrosis virus + TX, Metarhizium species + TX, Muscodora albus 620 (NRRL Accession No. 30547) + TX, Muscodor roseus A3-5 (NRRL Accession No. 30548) + TX, neem-based products + TX, Paecilomyces fumosorum + TX, Paecilomyces lilacinus + TX, Pasteuria szabalensis + TX, Pasteuria penetranta + TX, Pasteuria mycoides + TX, Pasteuria thornei + TX, Pasteuria + TX, p-cymene + TX, Plutella xylostella granulosis virus + TX, Plutella xylostella nuclear polyhedrosis virus + TX, polyhedrosis virus + TX, pyrethrum + TX, QRD 420 (terpenoid blend) + TX, QRD 452 (terpenoid blend) + TX, QRD 460 (terpenoid blend) + TX, Quillaja sapodilla + TX, Rhodococcus sphaeroides AQ719 (NRRL Accession No. B-21663) + TX, Spodoptera frugiperda nuclear polyhedrosis virus + TX, Streptomyces flavus (NRRL Accession No. 30232) + TX, Streptomyces sp. (NRRL Accession No. B-30145) + TX, terpenoid blend + Tx, and Verticillium sp. + TX;

[0820] an algaecide selected from the group consisting of bethoxazin [CCN] + TX, copper dioctanoate (IUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endoxan (295) + TX, fentin (347) + TX, slaked lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347) + TX;

[0821] Anthelmintics selected from the group consisting of: avermectin (1) + TX, clofosinate (1011) + TX, cyclobutrifluram + TX, doramectin (alias) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alias) [CCN] + TX, ivermectin (alias) [CCN] + TX, milbemycinoxime (alias) [CCN] + TX, moxidectin (alias) [CCN] + TX, piperazine [CCN] + TX, selamectin (alias) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX;

[0822] Avicides selected from the group consisting of chloralose (127) + TX, endrin (1122) + TX, fenthion (346) + TX, pyridin-4-amine (IUPAC name) (23) and strychnine (745) + TX;

[0823] Bactericide selected from the group consisting of: 1-hydroxy-1H-pyridine-2-thione (IUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (IUPAC name) (170) + TX, copper hydroxide (IUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1105) + TX, doxine (1112) + TX, sodium fenaminosulf (1144) + TX, formaldehyde (404) + TX, mercaptophenone (also known as )[CCN]+TX, kasugamycin (483)+TX, kasugamycin hydrochloride hydrate (483)+TX, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308)+TX, nitrapyrin (580)+TX, octhilinone (590)+TX, oxolinic acid (606)+TX, oxytetracycline (611)+TX, potassium hydroxyquinoline sulfate (446)+TX, probenazole (658)+TX, streptomycin (744)+TX, streptomycin sesquisulfate (744)+TX, chlorpheniramine (766)+TX, and thimerosal (alias)[CCN]+TX;

[0824] A biological agent selected from the group consisting of: GV of cotton brown banded moth (alias) (12) + TX, Agrobacterium radiobacterium (alias) (13) + TX, Amblyseius spp. (alias) (19) + TX, NPV of celery budworm (alias) (28) + TX, Anagrus atomus (alias) (29) + TX, Aphelinus abdominalis (alias) (33) + TX, Aphidius colemani (alias) (34) + TX, Aphidoletes aphidimyza (alias) (35) + TX, NPV of lucerne budworm (alias) (38) + TX, Bacillus firmus (alias) (48) + TX, Bacillus sphaericus Neide)(scientific name)(49)+TX、Bacillus thuringiensis Berliner)(scientific name)(51)+TX、Bacillus thuringiensis subsp.aizawai)(scientific name)(51)+TX、Bacillus thuringiensis subsp.israelensis)(scientific name)(51)+TX、Bacillus thuringiensis subsp.japonensis)(scientific name)(51)+TX、Bacillus thuringiensis subsp.kurstaki)(scientific name)(51)+TX、Bacillus thuringiensis subsp.tenebrionis (scientific name) (51) + TX, Beauveria bassiana (alias) (53) + TX, Beauveria brongniartii (alias) (54) + TX, Chrysoperla carnea (alias) (151) + TX, Cryptolaemus montrouzieri (alias) (178) + TX, Codling moth GV (alias) (191) + TX, Dacnusa sibirica (alias) (212) + TX, Diglyphus isaea (alias) (254) + TX, Eretmocerus sibirica (scientific name) (293) + TX, Eretmocerus sibirica (alias) eremicus) (alias) (300) + TX, Spodoptera exigua NPV (alias) (431) + TX, Heterorhabditis bacteriophora and H. megidis (alias) (433) + TX, Hippodamia convergens (alias) (442) + TX, Leptomastix dactylopii (alias) (488) + TX, Macrolophus caliginosus (alias) (491) + TX, Spodoptera exigua NPV (alias) (494) + TX, Metaphycus helvolus (alias) (522) + TX, Metarhizium anisopliae var.acridum)(scientific name)(523)+TX, Metarhizium anisopliae var. anisopliae)(scientific name)(523)+TX, Neodiprion sertifer NPV and Neodiprion sertifer (Neodiprion sertifer) NPV.lecontei)NPV (alias) (575) + TX, Paecilomyces species (alias) (596) + TX, Paecilomyces fumosoroseus (alias) (613) + TX, Phytoseiulus persimlis (alias) (644) + TX, Spodoptera exigua multicapsidnuclear polyhedrosis virus (scientific name) (741) + TX, Steinernema bibionis (alias) (742) + TX, Steinernema carpocapsae (alias) (742) + TX, Steinernema glaseri (alias) (742) + TX, Steinernema riobrave) (alias) (742) + TX, Steinernema riobravis (alias) (742) + TX, Steinernema scapterisci (alias) (742) + TX, Steinernema spp. (alias) (742) + TX, Trichogramma spp. (alias) (826) + TX, Typhlodromus occidentalis (alias) (844) and Verticillium lecanii (alias) (848) + TX;

[0825] Soil disinfectant selected from the group consisting of methyl iodide (IUPAC name) (542) and methyl bromide (537) + TX;

[0826] A chemical sterilant selected from the group consisting of: apholanate [CCN] + TX, bis(aziridine) methylaminophosphine sulfide (bisazir) (alias) [CCN] + TX, busulfan (alias) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alias) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methylsulfonate Methotepa [CCN] + TX, methylapholate [CCN] + TX, morzid [CCN] + TX, penfluron (other name) [CCN] + TX, tepa [CCN] + TX, thiohempa (other name) [CCN] + TX, thiotepa (other name) [CCN] + TX, trotamide (other name) [CCN] and urethaneimide (other name) [CCN] + TX;

[0827] An insect pheromone selected from the group consisting of (E)-dec-5-en-1-yl acetate and (E)-dec-5-en-1-ol (IUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (IUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541) + TX, (E,Z)-tetradec-4,10-dien-1-yl acetate (IUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (IUPAC name) (285) + TX, (Z)-hexadecan-11-enal (IUPAC name) (436) + TX, (Z)-hexadecan-11-en-1-yl acetate (IUPAC name) (437) + TX X, (Z)-hexadec-13-en-11-yn-1-yl acetate (IUPAC name) (438) + TX, (Z)-eicos-13-en-10-one (IUPAC name) (448) + TX, (Z)-tetradec-7-en-1-al (IUPAC name) (782) + TX, (Z)-tetradec-9-en-1-ol (IUPAC name) (783) + TX, (Z)-tetradec-9-en-1-yl acetate (IUPAC name) (784) + TX, (7E,9Z)-dodec-7,9-dien-1-yl acetate (IUPAC name) (283) + TX, (9Z,11E)-tetradec-9,11-dien-1-yl acetate (IUPAC name) (780) + TX, (9Z,12E)-tetradec-9,12-Dien-1-yl acetate (IUPAC name) (781) + TX, 14-methyloctadec-1-ene (IUPAC name) (545) + TX, 4-methylnonan-5-ol and 4-methylnonan-5-one (IUPAC name) (544) + TX, α-multistriatin (alternative name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-1-yl acetate (IUPAC name) (286) + TX, dodec-9-en-1-yl acetate (IUPAC name) (287) + TX, dodec-8 + TX, 10-dien-1-yl acetate (IUPAC name) (284) + TX, dominicalure (alias) [CCN] + TX, ethyl 4-methyloctanoate (IUPAC name) (317) + TX, eugenol (alias) [CCN] + TX, southern pine beetle aggregation pheromone (frontalin) (alias) [CCN] + TX, (Alternative name; a 1:1 mixture of (Z,E) and (Z,Z) isomers of hexadecane-7,11-dien-1-yl acetate) (420) + TX, grandlure (421) + TX, grandlure I (alternative name) (421) + TX, grandlure II (alternative name) (421) + TX, grandlure III (alternative name) (421) + TX, grandlure IV (alternative name) (421) + TX, hexalure [CCN] + TX, Ipsdienol (alias) [CCN] + TX, ipsenol (alias) [CCN] + TX, japonilure (alias) (481) + TX, lineatin (alias) [CCN] + TX, litlure (alias) [CCN] + TX, looplure (alias) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alias) [CCN] + TX, methyl Eugenol)(alias)(540)+TX, muscalure(563)+TX, octadec-2,13-dien-1-yl acetate(IUPAC name)(588)+TX, octadec-3,13-dien-1-yl acetate(IUPAC name)(589)+TX, orfralure(alias)[CCN]+TX, oryctalure(alias)(317)+TX, ostramone(alias)[CCN]+TX, si glure) [CCN] + TX, sordidin (alias) (736) + TX, sulcatol (alias) [CCN] + TX, tetradec-11-en-1-yl acetate (IUPAC name) (785) + TX, terephthalone (839) + TX, terephthalone A (alias) (839) + TX, terephthalone B1 (alias) (839) + TX, terephthalone B2 (alias) (839) + TX, terephthalone C (alias) (839) and trunc-call (alias) [CCN] + TX;

[0828] Insect repellents selected from the group consisting of 2-(octylthio)ethanol (IUPAC name) (591) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (IUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (IUPAC name) (1048) + TX, DEET [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1137) + TX, hexylurea [CCN] + TX, methoquin-butyl (1276) + TX, methyl neodecylamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX;

[0829] Molluscicides selected from the group consisting of di(tributyltin) oxide (IUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, chloranil (999) + TX, copper acetyl arsenite [CCN] + TX, copper sulfate (172) + TX, triphenyltin (347) + TX, iron phosphate (IUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-ethanolamine (576) + TX, pentachlorophenol ( 623)+TX, sodium pentachlorophenoxide (623)+TX, tazimcarb (1412)+TX, thiodicarb (799)+TX, tributyltin oxide (913)+TX, trifenmorph (1454)+TX, trimethacarb (840)+TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+TX, pyriprole [394730-71-3]+TX;

[0830] A nematicide selected from the group consisting of: AKD-3088 (compound code) + TX, 1,2-dibromo-3-chloropropane (IUPAC / Chemical Abstracts name) (1045) + TX, 1,2-dichloropropane (IUPAC / Chemical Abstracts name) (1062) + TX, 1,2-dichloropropane and 1,3-dichloropropene (IUPAC name) (1063) + TX, 1,3-dichloropropene (233) + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide (IUPAC / Chemical Abstracts name) Abstract name) (1065) + TX, 3-(4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980) + TX, 5-methyl-6-thioxo-1,3,5-thiadiazin-3-yl acetic acid (IUPAC name) (1286) + TX, 6-isopentenylaminopurine (alias) (210) + TX, avermectin (1) + TX, acetofenamide [CCN] + TX, cotton bell carb (15) + TX, aldicarb (16) + TX, aldicarb (863) + TX, AZ 60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben (alias) + TX, carbofuran (109) + TX, carbofuran (118) + TX, carbon disulfide (945) + TX, carbofuran (119) + TX, chloropicrin (141) + TX, chlorpyrifos (145) + TX, cyclobutrifluram (999) + TX, Cyclobutrifluram + TX, cytokinin (alias) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, diclofos (1051) + TX, dicliphos (alias) + TX, dimethoate (262) + TX, Lactin (alias) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alias) [CCN] + TX, ethoprophos (312) + TX, dibromoethane (316) + TX, fenamiphos (326) + TX, fenpyrad (alias) + TX, fensulfonyl (1158) + TX, thiazophos (408) + TX, butasulfonyl (1196) + TX, Furfural (alias) [CCN] + TX, GY-81 (research code) (423) + TX, cypermethrin [CCN] + TX, iodomethane (IUPAC name) (542) + TX, isamidophos (1230) + TX, chlorfenapyr (1231) + TX, ivermectin (alias) [CCN] + TX, kinetin (alias) (210) + TX, methyl aphidoxime (1258) + TX,Metamex (519) + TX, Metamex potassium salt (alias) (519) + TX, Metamex sodium salt (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, Milbemycin oxime (alias) [CCN] + TX, Moxidectin (alias) [CCN] + TX, Myrothecium verrucaria composition (alias) (565) + TX, NC-184 (compound code) + TX, Oxamyl (602) + TX, Phorate (636) + TX, Phosphamidon (639) + TX, Phosphamidon [CCN] + TX, Claxant (alias) + TX, Selamectin ( Synonyms) [CCN] + TX, spinosad (737) + TX, terbufos (synonyms) + TX, terbufos (773) + TX, tetrachlorothiophene (IUPAC / Chemical Abstracts name) (1422) + TX, thiafenox (synonyms) + TX, fenamiphos (1434) + TX, triazophos (820) + TX, triazuron (synonyms) + TX, xylenol [CCN] + TX, YI-5302 (compound code) and zeatin (synonyms) (210) + TX, fluensulfone [318290-98-1] + TX, fluopyram + TX;

[0831] A nitrification inhibitor selected from the group consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX;

[0832] Plant activators selected from the group consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alias) (720) + TX;

[0833] Rodenticides consisting of the following substance groups: 2-isovalerylindan-1,3-dione (IUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, α-chlorohydrin [CCN] + TX, aluminum phosphide (640) + TX, antoconazole (880) + TX, arsenic trioxide (882) + TX, barium carbonate (891) + TX, bisulfamethoxazole (912) + TX, brodifacoum (89) + TX, bromadiolone (including Including α-Bromadiolone) + TX, Bromadiolamine (92) + TX, Calcium Cyanide (444) + TX, Chloralose (127) + TX, Chloralone (140) + TX, Cholecalciferol (alias) (850) + TX, Chlorodiclofenac (1004) + TX, Cytoxan (1005) + TX, Cytoxan (175) + TX, Cytoxan (1009) + TX, Cytoxan (246) + TX, Cytoxan (249) + TX, Cytoxan (273) + TX, Calcifedol (301) + TX, Fludioxaline (357) + TX, fluoroacetamide (379) + TX, fludioxaline (1183) + TX, fludioxaline hydrochloride (1183) + TX, γ-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (IUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (IUPAC name) (640) + TX, methyl bromide (537) + TX, fosfomycin (1318) + TX, fosfomycin (1 336) + TX, phosphine (IUPAC name) (640) + TX, phosphorus [CCN] + TX, warfarin (1341) + TX, potassium arsenite [CCN] + TX, warfarin (1371) + TX, scilla glycoside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851), and zinc phosphide (640) + TX;

[0834] Synergists selected from the group consisting of 2-(2-butoxyethoxy)ethyl piperate (IUPAC name) (934) + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903) + TX, farnesol with nerolidol (alias) (324) + TX, MB-599 (research code) (498) + TX, MGK 264 (research code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (research code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX;

[0835] Animal repellents, which are selected from the group consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper cyclohexane [CCN] + TX, copper oxychloride (171) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetate (422) + TX, methiocarb (530) + TX, pyridin-4-amine (IUPAC name) (23) + TX, salamine (804) + TX, trimethacarb (840) + TX, zinc cyclohexane [CCN] and ziram (856) + TX;

[0836] Virucidal agents selected from the group consisting of: imipenem (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX;

[0837] A wound protective agent selected from the group consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX;

[0838] Biologically active substances selected from 1,1-bis(4-chlorophenyl)-2-ethoxyethanol+TX, 2,4-dichlorophenylbenzenesulfonate+TX, 2-fluoro-N-methyl-N-1-naphthylacetamide+TX, 4-chlorophenylphenylsulfone+TX, acetofenapyr+TX, aldisulfonyl+TX, sirox+TX, fomanphos+TX, amitriptyline+TX, amitriptyline hydrogen oxalate+TX, amitraz+TX, cypermethrin+TX, arsenic trioxide+TX, azobenzene+TX, azophos+TX, benomyl+TX, benoxafos+TX, benzyl benzoate+TX, bixafenthion+TX, bromethrin+TX, bromothiophene+TX, bromophos+TX , bromocriptine + TX, buprofezin + TX, butanone carbendazim + TX, butanone carbendazim + TX, butylpyridaben + TX, calcium polysulfide + TX, octachlorocamphene + TX, chlormethoxam + TX, trithion + TX, cypermethrin + TX, cypermethrin + TX, cypermethrin + TX, chlordimeform + TX, chlordimeform hydrochloride + TX, chlorfenapyr + TX, chlorfenapyr + TX, chlorfenapyr + TX, dimethoate + TX, ethyl chlorfenapyr + TX, chlormebuform (chloromebuform) + TX, chlorfenapyr + TX, propyl chlorfenapyr + TX, chlorfenapyr + TX, chlorfenapyr + TX, chlorfenapyr I + TX, chlorfenapyr II + TX, chlorfenapyr + TX, closantel + TX, coumaphos + TX, crotamiton + TX, Toxop + TX, Thiamin + TX, Fructofos + TX, DCPM + TX, DDT + TX, Fenapth + TX, Fenapth-O + TX, Fenapth-S + TX, Demeton-methyl + TX, Demeton-O + TX, Demeton-O-methyl + TX, Demeton-S + TX, Demeton-S-methyl + TX, Demeton-S-methyl + TX, Demeton-S-methyl + TX, Demeton-S-methyl + TX, Dichlorvos + TX, Dimethoate ... TX, anthelmintic+TX, nitropentyl+TX, nitrobenzene acaricide+TX, nitrobutyl+TX, dithiophos+TX, sulfodiphenyl+TX, disulfiram+TX, DNOC+TX, dofenapyn+TX, doramectin+TX, fenoxaphos+TX, eprinomectin+TX, thiophos+TX, ethiopthion+TX, anti-mite+TX, fenbutatin+TX, fenthiocarb+TX, fenpyrad+TX, fenpyroximate+TX, anthracene+TX, fentrifanil+TX, fluazifop+TX, flufenoxuron+TX, diflubenzuron+TX, fluazifop+TX, FMC 1137+TX, fluazifop+TX, fluazifop hydrochloride+TX, formparanate+TX, γ-HCH+TX, fenoxadone+TX, benzylpezil+TX,Hexadecylcyclopropanecarboxylate + TX, isocarbophos + TX, jasmonate I + TX, jasmonate II + TX, iodonium + TX, lindane + TX, propanil + TX, cypermethrin + TX, dithiophos + TX, methylthiophene + TX, cypermethrin + TX, methylbromide + TX, methicillin + TX, chlorpyrifos + TX, milbemid + TX, propylamine + TX, monocrotophos + TX, maogu + TX, moxidectin + TX, naled + TX, 4-chloro-2-(2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one + TX, fluazifop + TX, nikkomycin + TX, penbufenac + TX, penbufenac 1:1 zinc chloride complex + TX, omethoate +TX, isothiophos+TX, sulfone+TX, pp'-DDT+TX, parathion+TX, permethrin+TX, fenthion+TX, phosalone+TX, thiophanate+TX, phosphamidon+TX, polychloroterpenes+TX, polynactins+TX, prochlorperazine+TX, cypermethrin+TX, propoxur+TX, ethidium+TX, pyrethrin I+TX, pyrethrin II+TX, pyrethrin+TX, pyrimethanthiophos+TX, pyrimithiophos+TX, quinalphos+TX, quintiofos+TX, R-1492+TX, glycine Sulfur + TX, rotenone + TX, octamidine + TX, clomartin + TX, thiophos + TX, SSI-121 + TX, sulfluramid + TX, sulfotep + TX, sulfur + TX, fluazifop + TX, τ-fluvalinate + TX, TEPP + TX, terbucarb + TX, tetrachlorvinphos + TX, thiafenox + TX, pyrimidine + TX, long-lasting cypermethrin + TX, methyl sulfophos + TX, chlorpyrifos + TX, thiophanate-methyl ... +TX, chlorpyrifos +TX, copper dioctanoate +TX, copper sulfate +TX, cybutryne +TX, dichloronaphthoquinone +TX, dichlorophen +TX, endoxan +TX, triphenyltin +TX, slaked lime +TX, sodium mancozeb +TX, quinone +TX, quinone +TX, simazine +TX, triphenyltin acetate +TX, triphenyltin hydroxide +TX, fusulin +TX, piperazine +TX, thiophanate +TX, chloralose +TX, fenthion +TX, pyridin-4-amine +TX, strychnine +TX, 1-hydroxy-1H-pyridine-2-thione +TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide +TX, 8-hydroxyquinoline sulfate +TX, bronopol +TX, copper hydroxide +TX, cresol +TX,Dipyrithione + TX, dodixin + TX, sodium disulfate + TX, formaldehyde + TX, mercurophen + TX, kasugamycin + TX, kasugamycin hydrochloride hydrate + TX, nickel bis(dimethyldithiocarbamate) + TX, trichloromethylpyridine + TX, octhiazide + TX, oxolinic acid + TX, oxytetracycline + TX, potassium hydroxyquinoline sulfate + TX, thiabendazole + TX, streptomycin + TX, streptomycin sesquisulfate + TX, chlorothiazol + TX, thimerosal + TX, cotton brown-banded tormenter GV + TX, Agrobacterium radiobacterium + TX, Amblyseius species + TX, celery budworm NPV + TX, original cherry-winged tassel wasp + TX, short-spurred aphid wasp + TX, cotton aphid parasitic wasp + TX, aphid-eating gall midge + TX, lucerne budworm NPV + TX, Bacillus sphaericus + TX, Beauveria bassiana + TX, Common lacewings + TX, Cryptochilus mongolianus + TX, Codling moth GV + TX, Siberian lacewings + TX, Pea leafminer + TX, Aphididae sibiricus + TX, Aphididae horned + TX, Bacteriotrophic Heterorhabditis elegans and Heterorhabditis magna + TX, Long-legged ladybird + TX, citrus mealybug parasitoid + TX, Misty bug + TX, Cabbage looper NPV + TX, Yellow-stalked jumping wasp + TX, Metarhizium anisopliae + TX, Metarhizium anisopliae microspore variant + TX, New European pine sawfly NPV and New red-headed pine sawfly NPV + TX, Microsporum fumosorum + TX, Chilean phytoseiid mite + TX, Trichoderma nematode + TX, Steinernema spp. + TX, Steinernema spp. + TX, Steinernema spp. + TX, Steinernema spp. + TX, Steinernema spp. riobravis+TX, mole cricket Steinernema+TX, Steinernema species+TX, Trichogramma species+TX, western blind mite+TX, Verticillium lecanii+TX, oxazolidinone+TX, bis(aziridine)methylaminophosphonium sulfide+TX, busulfan+TX, dimethivin+TX, hexamethylmelamine+TX, hexamethylphosphonium+TX, methyl tibazol+TX, methylthiotibazol+TX, methyloxazolidinone+TX, infertilil+TX, thiofluanid+TX, tibazol+TX, hexamethylphosphonium thioate+TX, thiotibazol+TX, trothamide+TX, urethaneimide+TX, (E)-dec-5-en-1-yl acetate and (E)-dec-5-en-1-ol +TX, (E)-tridec-4-en-1-yl acetate +TX, (E)-6-methylhept-2-en-4-ol +TX, (E,Z)-tetradec-4,10-dien-1-yl acetate +TX, (Z)-dodec-7-en-1-yl acetate +TX, (Z)-hexadec-11-enal +TX, (Z)-hexadec-11-en-1-yl acetate +TX, (Z)-hexadec-13-en-11-yn-1-yl acetate +TX, (Z)-eicos-13-en-10-one +TX, (Z)-tetradec-7-en-1-al +TX, (Z)-tetradec-9-en-1-ol +TX,(Z)-tetradec-9-en-1-yl acetate + TX, (7E,9Z)-dodec-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradec-9,11-dien-1-yl acetate + TX, (9Z,12E)-tetradec-9,12-dien-1-yl acetate + TX, 14-methyloctadec-1-ene + TX, 4-methylnon-5-ol and 4-methylnon-5-one + TX, α-polystyrene + TX, western pine beetle gathering pheromone + TX, dodecadienol + TX, caldoxime + TX, pyrrolidone + TX, epoxynonadecane + TX, dodec-8-en-1-yl acetate + TX, dodecadienol + TX, caldoxime + TX, pyrrolidone + TX, epoxynonadecane + TX, dodec-8-en-1-yl acetate + TX, dodec -9-en-1-yl acetate + TX, dodecan-8 + TX, 10-dien-1-yl acetate + TX, dominicalure + TX, 4-methyloctanoic acid ethyl ester + TX, eugenol + TX, southern pine beetle gathering pheromone + TX, trapping ene mixture + TX, trapping ene mixture I + TX, trapping ene mixture II + TX, trapping ene mixture III + TX, trapping ene mixture IV + TX, hexane attractant + TX, tooth beetle dienol + TX, small beetle alcohol + TX, scarab sex attractant + TX, trimethyldioxytricyclononane + TX, litlure + TX, cabbage looper sex attractant + TX, trapping ester + TX, megatomoic acid+TX, entophore+TX, entophore+TX, octadec-2,13-dien-1-yl acetate+TX, octadec-3,13-dien-1-yl acetate+TX, Hekangbi+TX, coconut rhinoceros beetle aggregation pheromone+TX, feilekang+TX, entophore+TX, sordidin+TX, fungivorous acetic acid+TX, tetradec-11-en-1-yl acetate+TX, Mediterranean fruit fly attractant+TX, Mediterranean fruit fly attractant A+TX, Mediterranean fruit fly attractant B1+TX, Mediterranean fruit fly attractant B2+TX, Mediterranean fruit fly attractant C+TX, trunc-call+TX, 2-(octylthio)-ethanol+TX, dimethoate+TX, butoxy(polypropylene glycol)+TX, dibutyl adipate+ TX, dibutyl phthalate + TX, dibutyl succinate + TX, DEET + TX, mosquito repellent + TX, dimethyl phthalate + TX, ethyl hexanediol + TX, hexyl urea + TX, mequindine + TX, methyl neodecylamide + TX, oxamate + TX, picaridin + TX, 1-dichloro-1-nitroethane + TX, 1,1-dichloro-2,2-bis(4-ethylphenyl)-ethane + TX, 1,2-dichloropropane and 1,3-dichloropropylene + TX, 1-bromo-2-chloroethane + TX, 2,2,2-trichloro-1-(3,4-dichloro-phenyl)ethyl acetate + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate + TX, 2-(1,3-dithiolan-2-yl)phenyl dimethylcarbamate + TX,2-(2-Butoxyethoxy)ethyl thiocyanate + TX, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenylmethylcarbamate + TX, 2-(4-chloro-3,5-xylyloxy)ethanol + TX, 2-chlorovinyldiethyl phosphate + TX, 2-imidazolidinone + TX, 2-isovalerylindan-1,3-dione + TX, 2-methyl(prop-2-ynyl)aminophenylmethylcarbamate + TX, 2-thiocyanatoethyl laurate + TX, 3-bromo-1-chloroprop-1-ene + TX, 3-methyl-1-phenylpyrazol-5-yldimethyl-amino TX, 4-methyl (prop-2-ynyl) amino-3,5-dimethylphenylmethylcarbamate + TX, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate + TX, acethion + TX, acrylonitrile + TX, aldrin + TX, aloamicin + TX, chlorpyrifos + TX, α-deceprin + TX, aluminum phosphide + TX, chlorpyrifos + TX, neonicotinoids + TX, ethylthiothion (athidathion) + TX, methylpyrifos + TX, Bacillus thuringiensis δ-endotoxin + TX, barium hexafluorosilicate + TX, barium polysulfide + TX, Permethrin + TX, Bayer 22 / 190 + TX, Bayer 22408 + TX, β-cyfluthrin + TX, β-cypermethrin + TX, bioethanomethrin + TX, biopermethrin + TX, bis(2-chloroethyl) ether + TX, borax + TX, bromopheniramine + TX, bromo-DDT + TX, cypermethrin + TX, butathiofos + TX, butyl phosphate + TX, calcium arsenate + TX, calcium cyanide + TX, carbon disulfide + TX, carbon tetrachloride + TX, batan hydrochloride + TX, Cevadine + TX, Borneol + TX, Chlordane + TX, Chlordecone + TX, Chloroform + TX, Chloropicrin + TX, Chloranilide + TX, Chlorprazophos + TX, Cis-resmethrin + TX, Cis-resmethrin + TX, Clocythrin (alias) + TX, Copper acetylarensite + TX, Copper arsenate + TX, Copper oleate + TX, Coumithoate + TX, Cryolite + TX, CS 708+TX, benzonitrile+TX, cypermethrin+TX, cypermethrin+TX, cypermethrin+TX, d-cypermethrin+TX, DAEP+TX, dazomethon+TX, decarbofuran+TX, cypermethrin+TX, isochlorvinphos+TX, cypermethrin+TX, dicresyl+TX, cypermethrin+TX, dieldrin+TX, diethyl 5-methylpyrazol-3-yl phosphate+TX, dior+TX, tetrafluthrin+TX, dimethoate+TX,Permethrin + TX, methyl chlorpyrifos + TX, difenocarb + TX, propanol + TX, pentanophenol + TX, dinoseb + TX, fenpyroxen + TX, vegetable phosphate + TX, thiopyraphos + TX, DSP + TX, ecdysterone + TX, EI 1642 + TX, EMPC + TX, EPBP + TX, etaphos + TX, ethiofencarb + TX, ethyl formate + TX, dibromoethane + TX, dichloroethane + TX, ethylene oxide + TX, EXD + TX, fenpyroxen + TX, ethiofencarb + TX, fenitrothion + TX, fenoxacrim + TX, cypermethrin + TX, fenthion + TX, ethylfenthion + TX, flucofuron + TX, butylfenthion + TX, phosphamidon + TX, butylfenthion + TX, furathiocarb + TX, pyrethroid +TX, biguanide salt +TX, biguanide acetate +TX, sodium tetrathiocarbonate +TX, benzyl chlorpyrifos +TX, HCH +TX, HEOD +TX, heptachlor +TX, cypermethrin +TX, HHDN +TX, hydrogen cyanide +TX, quinolinic acid +TX, IPSP +TX, chlorfenapyr +TX, carbofuran +TX, isodrin +TX, isofenol +TX, transplanting spirit +TX, rice blast +TX, oxazophos +TX, juvenile hormone I +TX, juvenile hormone II +TX, juvenile hormone III +TX, chlorpentyl +TX, methoprene +TX, lead arsenate +TX, bromophenylphos + TX, acetamiprid + TX, thiamethoxam + TX, m-isopropyl methylcarbamate + TX, magnesium phosphide + TX, phosphorus azide + TX, methyl azoxystrobin + TX, chlorpyrifos + TX, mercurous chloride + TX, methyl sulfoxide + TX, metamifop + TX, metamifop potassium + TX, metamifop sodium + TX, methylsulfonyl fluoride + TX, butenamidophos + TX, methoprene + TX, methoxythrin + TX, methoxychlor + TX, methyl isothiocyanate + TX, methyl chloroform + TX, dichloromethane + TX, oxadiazine + TX, mirex + TX, naphthiophos + TX, naphthalene + TX, NC-1 70+TX, Nicotine+TX, Nicotine sulfate+TX, Nithiothiazine+TX, Pronicotine+TX, O-5-dichloro-4-iodophenyl O-ethylethylphosphonothioate+TX, O,O-diethyl O-4-methyl-2-oxo-2H-benzopyran-7-ylphosphonothioate+TX, O,O-diethyl O-6-methyl-2-propylpyrimidin-4-ylphosphonothioate+TX, O,O,O',O'-tetrapropyl dithiopyrophosphate+TX, Oleic acid+TX, p-dichlorobenzene+TX, Methyl parathion+TX, Pentachlorophenol+TX, Pentachlorophenyl laurate+TX, PH 60-38+TX, fenthion+TX, parachlorothion+TX, phosphine+TX, methyl phoxim+TX, methamidophos+TX, polychlorinated dicyclopentadiene isomers+TX, potassium arsenite+TX, potassium thiocyanate+TX, precocious I+TX, precocious II+TX,Precocious hormone III + TX, amimidophos + TX, fluthrin + TX, fenvalerate + TX, prothiophos + TX, pyraclostrobin + TX, anti-pyrethroid + TX, quassia extract + TX, quinalphos-methyl + TX, fenvalerate + TX, iodoxamide + TX, resmethrin + TX, rotenone + TX, thiamethoxam + TX, ryanodine + TX, sabadilla + TX, octamethrin + TX, clostridium + TX, SI-0009 + TX, thiaprolin + TX, sodium arsenite + TX, sodium cyanide + TX, sodium fluoride + TX, sodium hexafluorosilicate + TX, sodium pentachlorophenol + TX, sodium selenate + TX, sodium thiocyanate + TX, sulfofensulfuron (su TX, sulcofuron-sodium + TX, sulfuryl fluoride + TX, thiopromide + TX, tar + TX, thiabendazim + TX, TDE + TX, butylpyrimidophos + TX, temephos + TX, cyclopentylthrin + TX, tetrachloroethane + TX, thiochlorfos + TX, cyclohexane + TX, cyclohexane oxalate + TX, cypermethrin + TX, cypermethrin + TX, cypermethrin sodium + TX, tralomethrin + TX, permethrin + TX, triazolam + TX, trichlormetaphos-3 + TX, chlorpyrifos + TX, tolprocarb + TX, chlorpyrifos-methyl + TX X, methoprene + TX, veratridine + TX, veratridine + TX, XMC + TX, zetamethrin + TX, zinc phosphide + TX, tolfenphos + TX, chlorfluanidine + TX, tetrafluanidine + TX, bis(tributyltin) oxide + TX, bromoacetamide + TX, iron phosphate + TX, niclosamide-ethanolamine + TX, tributyltin oxide + TX, pyrimorph + TX, snail killer + TX, 1,2-dibromo-3-chloropropane + TX, 1,3-dichloropropylene + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 5-methyl-6-thioxo-1,3,5-thiadiazin-3-yl acetic acid + TX, 6-isopentenyl Aminopurine + TX, anisiflupurin + TX, phenylchlorothiazide + TX, cytokinin + TX, DCIP + TX, furfural + TX, isoamidophos + TX, kinetin + TX, verrucous myristic fungus composition + TX, tetrachlorothiophene + TX, xylenol + TX, zeatin + TX, potassium ethylxanthate + TX, acibenzolar + TX, acibenzolar-S-methyl + TX, giant knotweed extract + TX, α-chlorohydrin + TX, anto + TX, barium carbonate + TX, bismuth urea + TX, brodifacoum + TX, bromadiolone + TX, bromodiolone + TX, chlorofacitin + TX, cholecalciferol + TX, chlorfenapyr + TX, ratfighting + TX, ratfighting naphthalene + TX, cypermethrin + TX, ratfighting + TX,Thiazide + TX, diphacin + TX, calciferol + TX, fludioxaline + TX, fluoroacetamide + TX, fludioxidine + TX, fludioxidine hydrochloride + TX, fosfomycin + TX, phosphorus + TX, warfarin + TX, warfarin + TX, scillarin + TX, sodium fluoroacetate + TX, thallium sulfate + TX, warfarin + TX, 2-(2-butoxyethoxy)ethyl piperonate + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone + TX, farnesol with nerolidol + TX, synergistic alkynyl ether + TX, MGK 264+TX, piperonyl butoxide+TX, synergistic aldehyde+TX, propyl isomer+TX, S421+TX, synergistic powder+TX, sesamelin+TX, sulfoxide+TX, anthraquinone+TX, copper naphthenate+TX, copper oxychloride+TX, dicyclopentadiene+TX, salamine+TX, zinc naphthenate+TX, ziram+TX, imanin+TX, ribavirin+TX, chloroinconazide+TX, mercuric oxide+TX, thiophanate-methyl+TX, azaconazole+TX, triaconazole+TX, oxadiazole+TX, cyproconazole+TX, difenoconazole +TX, diniconazole +TX, fluepiconazole +TX, fenbuconazole +TX, fluquinconazole +TX, flusilazole +TX, flutriafol +TX, furopyram +TX, hexaconazole +TX, imazalil +TX, imidazole +TX, ipconazole +TX, metconazole +TX, myclobutrazol +TX, paclobutrazol +TX, blastifoglu +TX, penconazole +TX, prothioconazole +TX, pyrifenox +TX, prochloraz +TX, propiconazole +TX, pyraconazole +TX, simeconazole +TX, tebuconazole +TX, fluconazole +TX , triadimefon + TX, triadimenol + TX, triflumizole + TX, triclosan + TX, pyrimidine + TX, chlorfenapyr + TX, flufenapyr + TX, bupirimate + TX, dimethirimol + TX, ethirimol + TX, dodecacyclic morpholine + TX, fenpropidine + TX, fenpropimorph + TX, spiroxazoline + TX, tridecazoline + TX, cyprodinil + TX, pyrimidine + TX, pyrimethanil (pyrimethan) il) + TX, fenpiclonil + TX, fludioxonil + TX, benalaxyl + TX, furalaxyl + TX, metalaxyl + TX, R-metalaxyl + TX, furamide + TX, oxadixyl + TX, carbendazim + TX, debacarb + TX, oxadixyl + TX, thiabendazole + TX, chlozolinate + TX, dichlozoline + TX, myclozoline + TX,Procymidone + TX, vinclozoline + TX, boscalid + TX, carboxin + TX, furamide + TX, flutolanil + TX, mefenamic acid + TX, oxycarboxin + TX, penthiopyrad + TX, thiofuran + TX, dodine + TX, biguanide + TX, azoxystrobin + TX, enestroburin + TX, enestroburin + TX, flutoxanil + TX, fluoxastrobin + TX, kresoxim-methyl + TX, oxathiostrobin + TX, trifloxystrobin + TX, trifloxystrobin + TX, Picoxystrobin + TX, pyraclostrobin + TX, pyraclostrobin + TX, pyraclostrobin + TX, ferbam + TX, mancozeb + TX, maneb + ​​TX, maneb + ​​TX, maneb + ​​TX, maneb + ​​TX, captol + TX, captan + TX, pyraclostrobin + TX, folpet + TX, tolylfluanid + TX, Bordeaux mixture + TX, copper oxide + TX, mancozeb + TX, quinoline copper + TX, phthalostrobin + TX, kefansan + TX, pyraclostrobin + TX, chlorfenapyr + TX, tolclofos-methyl + TX, captazole + TX, benthistrobin + TX, blasticidin + TX, chloroneb + ​​TX, chlorothalonil + TX, cyfluanid +TX, cymoxanil+TX, cyclobutrifluram+TX, diclocymet+TX, diclomezine+TX, dicloran+TX, diethofencarb+TX, dimethomorph+TX, flumorph+TX, dithianon+TX, ethaboxam+TX, etridiazole+TX, famoxadone+TX, fenamidone+TX, fenoxanil+TX, ferimzone+TX , fluazinam + TX, flumetylsulforim + TX, fluopicolide + TX, fluoxytioconazole + TX, flusulfamide + TX, flupyraclostrobin + TX, fenhexamid + TX, fosetyl-aluminium + TX, hymexazol + TX, propineb + ​​TX, cyazofamid + TX, methasulfocarb + TX, mefenamic acid + TX, pencycuron + TX, phthalide + TX,Polyoxins + TX, propamocarb + TX, pyrimidine + TX, proquinazid + TX, pyroquilon + TX, pyriofenone + TX, quinoxyfen + TX, pentachloronitrobenzene + TX, thiazolin + TX, triazoxide + TX, tricyclazole + TX, triamcinol + TX, validamycin + TX, valosin + TX, zoxamide + TX, mandipropamid + TX, flubeneteram + TX, isopyrazam + TX, thiazolin + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone + TX, oxazolidinone yrazam) + TX, sedaxane + TX, benzovinflumizone + TX, fluopicolide + TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide + TX, isoflurane + TX, isothianid + TX, dipymetitrone + TX, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1,4]dithia[1,2-c]isothiazole-3-carbonitrile + TX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, 4-(2,6-difluorophenyl)-6-methyl 1-Methyl-5-phenyl-pyridazine-3-carbonitrile + TX, (R)-3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine + TX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine + TX, fluindapyr + TX, Jiaxiangjunzhi + TX, lvbenmixianan + TX, dichlobentiazox + TX, Mandesbin (mande strobin)+TX, 3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone+TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolinyl)oxy]phenyl]propan-2-ol+TX, oxathiapiprolin+TX, N-[6-[[[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridinyl]carbamic acid tert-butyl ester+TX, pyraziflumid+TX, inpyrfluxam+TX, trolprocarb+TX, chlorfluanidazole+TX, ipfentrifluconazole+TX,2-(Difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine + TX, [2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro-phenyl] Methanesulfonate + TX, N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridinyl]carbamic acid but-3-ynyl ester + TX, N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamic acid methyl ester + TX, 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine + TX, pyridachlometyl + TX, 3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one+TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one+TX, aminopyrifen+TX, pyraclostrobin+TX, indazolesulfamide+TX, fluopicolide+TX, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamine+TX, f Lorylpicoxamid + TX, fenpicoxamid + TX, metarylpicoxamid + TX, tebufloquin + TX, ipflufenoquin + TX, quinofumelin + TX, isofetamido + TX, 1-[[4-[[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy]phenyl]methyl]pyrazole-3-carboxylic acid ethyl ester + TX (which can be prepared by the method described in WO 2020 / 056090), 1-[[4-[(Z)-2-ethoxy-3,3,3-trifluoro-prop-1-enyloxy]phenyl]methyl]pyrazole-3-carboxylic acid ethyl ester + TX (which can be prepared by the method described in WO 2020 / 056090),Methyl N-[[4-[1-(4-cyclopropyl-2,6-difluoro-phenyl)pyrazol-4-yl]-2-methyl-phenyl]methyl]carbamate+TX (can be prepared by the method described in WO 2020 / 097012), Methyl N-[[4-[1-(2,6-difluoro-4-isopropyl-phenyl)pyrazol-4-yl]-2-methyl-phenyl]methyl]carbamate+TX (can be prepared by the method described in WO 2020 / 097012), 6-chloro-3-(3-cyclopropyl-2-fluoro-phenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoro-ethyl]-5-methyl-pyridazine-4-carboxamide+TX (can be prepared by the method described in WO 2020 / 109391), 6-chloro-N-[2-(2-chloro-4-methyl-phenyl)-2,2-difluoro-ethyl]-3-(3-cyclopropyl-2-fluoro-phenoxy)-5-methyl-pyridazine-4-carboxamide + TX (can be prepared by the method described in WO 2020 / 109391), 6-chloro-3-(3-cyclopropyl-2-fluoro-phenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoro-ethyl]-5-methyl-pyridazine-4-carboxamide + TX (can be prepared by the method described in WO 2020 / 109391), N-[2-[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide+TX, N-[2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide+TX, benzathiostrobin+TX, cyproconazole+TX, 5-amino-1,3,4-thiadiazole-2-thiol zinc salt (2:1)+TX, fluopyram+TX, flufenoxadiazam+TX, fluthiazolinone+TX, fluoxathiocarbamide+TX, pyrapropoyne+TX, picarbutrazox+TX, 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indane- 4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, metyltetraprole + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, α-(1,1-dimethylethyl)-α-[4'-(trifluoromethoxy)[1,1'-diphenyl]-4-yl]-5-pyrimidinemethanol + TX, fluoxapiprolin + TX, enoxastrobin + TX,Methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate + TX, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-propyltriazol-2-yl]phenoxy]prop-2-enoate + TX, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate + TX, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy] Methyl prop-2-enoate + TX, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate + TX (these compounds can be prepared by the method described in WO2020 / 079111), (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate + TX, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate + TX (these compounds can be prepared by the method described in WO 2020 / 193387), 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfanyl-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, anti-invertase + TX, syringostyrin + TX, Zhongshengmycin + TX, thiophanate-methyl + TX, thiophanate-copper + TX, thiazole zinc + TX, benzopyrimidine amectotractin + TX, iprodione + TX, seboctylamine + TX; N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX,N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds can be prepared by WO 2015 / 155075); N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX (this compound can be prepared by the method described in IPCOM000249876D); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine + TX, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds can be prepared by the method described in WO 2018 / 228896); N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine + TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine + TX (these compounds can be prepared by WO 2019 / 110427); N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[(1S)-1 -benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide + TX, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide + TX,N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide + TX (these compounds can be prepared by the method described in WO 2017 / 153380); 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline + TX, 4,4-difluoro-3,3-dimethyl -1-(6-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline+TX, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline+TX, 1-(6-chloro-7-methyl-pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline+TX (these compounds can be prepared by WO 2017 / 025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline+TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline+TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline+TX, 4,4-difluoro-1-(5-fluoro-4-methyl-benzimidazol-1-yl)-3,3-dimethyl-isoquinoline+TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole+TX (these compounds can be prepared by WO 2016 / 156085); N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide+TX, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide+TX, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide+TX, 1-methoxy-3-methyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea+TX, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea+TX, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea+TX, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide+TX,4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one+TX, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one+TX, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester+TX, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine+TX. The compounds in this paragraph can be prepared by WO 2017 / 055473, WO 2017 / 055469,Prepared by the method described in WO 2017 / 093348 and WO 2017 / 118689; 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol+TX (this compound can be prepared by the method described in WO 2017 / 029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol+TX (this compound can be prepared by the method described in WO 2017 / 029179); 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile+TX (this compound can be prepared by the method described in WO 2016 / 156290); 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile + TX (this compound can be prepared by the method described in WO 2016 / 156290); 2-amino-6-methyl-pyridine-3-carboxylic acid (4-phenoxyphenyl) methyl ester + TX (this compound can be prepared by the method described in WO 2014 / 006945); 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']bipyrrole-1,3,5,7(2H,6H)-tetraone + TX (this compound can be prepared by the method described in WO2011 / 138281); N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]thiobenzamide + TX; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX (this compound can be prepared by the method described in WO2011 / 138281); 2018 / 153707); N'-(2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX; N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine + TX (this compound can be prepared by the method described in WO 2016 / 202742); 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX (this compound can be prepared by the method described in WO 2014 / 095675); (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + TX,(3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + TX (these compounds can be prepared by the method described in WO 2017 / 220485); 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide + TX (this compound can be prepared by the method described in WO 2018 / 065414); 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylic acid ethyl ester + TX (this compound can be prepared by the method described in WO 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide+TX, N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide+TX, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide+TX, N-[N-methoxy-C-methyl-carbonimido]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide+TX (these compounds can be prepared by the method described in WO 2018 / 202428);

[0839] Microorganisms including: Acinetobacter lwoffii + TX, Acremonium alternatum + TX + TX, Acremonium cephalosporium + TX + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) +TX, Agrobacterium radiobacter strain K84 +TX, Alternaria alternate +TX, Alternaria cassia +TX, Alternaria destruens +TX, Ampelomyces quisqualis +TX, Aspergillus flavus AF36 +TX, Aspergillus flavus NRRL 21882 +TX, Aspergillus species +TX, Aureobasidium pullulans +TX, Azospirillum +TX, ( +TX、TAZO )+TX, Azotobacter+TX, Azotobacter chroocuccum +TX, Azotobacter cysts (Bionatural Blooming )+TX, Bacillus amyloliquefaciens+TX, Bacillus cereus+TX, Bacillus chitinosporus strain CM-1+TX, Bacillus strain AQ746+TX, Bacillus licheniformis strain HB-2 (Biostart TM )+TX, Bacillus licheniformis strain 3086 ( +TX、Green )+TX, Bacillus circulans+TX, Bacillus firmus ( +TX, +TX, )+TX, Bacillus firmus strain I-1582+TX, Bacillus macerans+TX, Bacillus marismortui+TX, Bacillus megaterium+TX, Bacillus mycoides strain AQ726+TX, Bacillus papillae (Milky Spore )+TX, Bacillus pumilus spp.+TX, Bacillus pumilus strain GB34 (Yield )+TX, Bacillus pumilus strain AQ717+TX, Bacillus pumilus strain QST 2808( +TX, Ballad )+TX, Bacillus spahericus +TX, Bacillus spp. +TX, Bacillus strain AQ175 +TX, Bacillus strain AQ177 +TX, Bacillus strain AQ178 +TX, Bacillus subtilis strain QST 713 ( +TX, +TX, )+TX, Bacillus subtilis strain QST714 +TX, Bacillus subtilis strain AQ153+TX, Bacillus subtilis strain AQ743+TX, Bacillus subtilis strain QST3002+TX, Bacillus subtilis strain QST3004+TX, Bacillus subtilis variant Bacillus amyloliquefaciens strain FZB24 ( +TX, )+TX, Bacillus thuringiensis Cry 2Ae+TX, Bacillus thuringiensis Cry1Ab+TX, Bacillus thuringiensis aizawai GC 91 +TX, Bacillus thuringiensis israelensis ( +TX, +TX, )+TX, Bacillus thuringiensis kurstaki ( +TX, +TX, +TX, +TX, Scutella +TX, Turilav +TX, +TX、Dipel +TX, +TX, )+TX, Bacillus thuringiensis kurstaki BMP 123 +TX, Bacillus thuringiensis subsp. Kurstaki HD-1 +TX, Bacillus thuringiensis strain BD#32+TX, Bacillus thuringiensis strain AQ52+TX, Bacillus thuringiensis var.aizawai ( +TX, )+TX, bacterial species ( +TX, +TX, )+TX, bacteriophage of Clavipacter michiganensis +TX, +TX, Beauveria bassiana ( +TX, Brocaril )+TX, Beauveria bassiana GHA (Mycotrol +TX, Mycotrol +TX, )+TX, Beauveria brongniartii ( +TX, Schweizer +TX, )+TX, Beauveria spp.+TX, Botrytis cineria+TX, Bradyrhizobium japonicum +TX, Brevibacillus brevis +TX, Bacillus thuringiensis tenebrionis +TX, BtBooster+TX, Burkholderia cepacia ( +TX, +TX、Blue )+TX, Burkholderia gladii+TX, Burkholderia gladioli+TX, Burkholderia spp.+TX, Canadian thistle fungus (CBH Canadian )+TX, Candida butyri+TX, Candida famata+TX, Candida fructus+TX, Candida glabrata+TX, Candida guilliermondii+TX, Candida melibiosica+TX, Candida oleophila strain O+TX, Candida parapsilosis+TX, Candida pelliculosa+TX, Candida pulcherrima+TX, Candida reukaufii+TX, Candida saitoana( +TX, )+TX, Candida sake+TX, Candida spp.+TX, Candida tenius+TX, Cedecea dravisae+TX, Cellulomonas flavigena+TX, Chaetomium cochliodes +TX, Chaetomium globosum +TX, Chromobacterium subtsugae strain PRAA4-1T +TX, Cladosporium cladosporioides +TX, Cladosporium oxysporum +TX, Cladosporium chlorocephalum +TX, Cladosporium spp. +TX, Cladosporium tenuissimum +TX, Clonostachys rosea +TX, Colletotrichum acutatum +TX, Coniothyrium minitans (Cotans )+TX, Coniothyrium spp.+TX, Cryptococcus albidus +TX, Cryptococcus humicola +TX, Cryptococcus infirmo-miniatus +TX, Cryptococcus laurentii +TX, Cryptophlebia leucotreta granulovirus +TX, Cupriavidus campinensis+TX, Cydia pomonella granulovirus +TX, codling moth granulosis virus ( +TX, Madex +TX, Madex )+TX、Cylindrobasidium laeve +TX, Cylindrocladium +TX, Debaryomyceshansenii +TX, Drechslera hawaiinensis +TX, Enterobacter cloacae +TX, Enterobacteriaceae +TX, Entomophtora virulenta +TX, Epicoccum nigrum +TX, Epicoccum purpurascens +TX, Epicoccum species +TX, Filobasidium floriforme +TX, Fusarium acuminate +TX, Fusarium chrysosporium +TX, Fusarium oxysporum ( / Biofox )+TX, Fusarium spp.+TX, Fusarium spp.+TX, Galactomyces geotrichum+TX, Gliocladium catenulatum ( +TX, )+TX, Gliocladium roseum+TX, Gliocladium species +TX, Gliocladium virens +TX, granulovirus +TX, Halobacillus halophilus +TX, Halobacillus litoralis +TX, Halobacillus trueperi +TX, Halomonas species +TX, Halomonas subglaciescola +TX, Halovibrio variabilis +TX, Hansenula vitis +TX, Helicoverpa armigera nuclear polyhedrosis virus +TX, Spodoptera nucleus polyhedrosis virus +TX, isoflavone-formononetin +TX, Kloeckneria citrifolia +TX, Kloeckneria species +TX, Lagenidium giganteum +TX, Lecanicillium longisporum +TX, Lecanicillium muscarium +TX, Lymantria dispar nuclear polyhedrosis virus +TX, Halococcus halophilus +TX, Meira geulakonigii +TX, Metarhizium anisopliae +TX, Metarhizium anisopliae (Destruxin )+TX, Metschnikowia fruticola +TX, Metschnikowia pulcherrima+TX, Microdochium dimerum +TX, Micromonospora coerulea +TX, Microsphaeropsis ochracea +TX, Muscodor albus 620 +TX, Muscodor roseus strain A3-5+TX, Mycorrhizae spp. ( +TX、Root )+TX, Myrotheca verrucosa strain AARC-0255 +TX、BROS +TX, Ophiostoma piliferum strain D97 +TX, Paecilomyces farinosus +TX, Paecilomyces fumosorum +TX, )+TX, Paecilomyces lilacinus (Biostat )+TX, Paecilomyces lilacinus strain 251 (MeloCon )+TX, Paenibacillus polymyxa+TX, Pantoea agglomerans (BlightBan )+TX, Pantoea species+TX, Pasteurella species +TX, Pasteuria nishizawae+TX, Penicillium chrysogenum+TX, Penicillium billai ( +TX, )+TX, Penicillium breviscompactum+TX, Penicillium spp.+TX, Penicillium chrysogenum+TX, Penicillium purpurogenum+TX, Penicillium species+TX, Penicillium viridiflorum+TX, Phlebiopsis gigantean +TX, phosphate-solubilizing bacteria +TX, Cryptophyton+TX, Phytophthora palmatum +TX, Pichia anomala +TX, Pichia guilermondii +TX, Pichia membranaceus +TX, Pichia nail +TX, Pichia stipitis +TX, Pseudomonas aeruginosa +TX, Pseudomonas aureofasciens (Spot-Less )+TX, Pseudomonas cepacia+TX, Pseudomonas chlororaphis +TX, Pseudomonas corrugate +TX, Pseudomonas fluorescens strain A506 (BlightBan )+TX, Pseudomonas putida+TX, Pseudomonas reactans+TX, Pseudomonas species+TX, Pseudomonas syringae +TX, Pseudomonas aureus +TX, Pseudomonas fluorescens +TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex )+TX、Puccinia canaliculata+TX、Puccinia thlaspeos(Wood )+TX、Pythium oligandrum+TX、Pythium oligandrum +TX, )+TX, Pythium+TX, Rhanella aquatilis+TX, Rhanella spp.+TX, Rhizobia ( +TX, )+TX, Rhizoctonia+TX, Rhodococcus globerulus strain AQ719+TX, Rhodosporidiumdiobovatum+TX, Rhodosporidium toruloides+TX, Rhodotorula spp.+TX, Rhodotorula glutinis+TX, Rhodotorula graminis+TX, Rhodotorula mucilagnosa+TX, Rhodotorula rubra+TX, Saccharomyces cerevisiae+TX, Salinococcus roseus+TX, Sclerotinia minor+TX, Sclerotinia minor +TX, Scytalidium spp.+TX, Scytalidium uredinicola+TX, Spodoptera exigua nuclear polyhedrosisvirus ( +TX, )+TX, Serratia marcescens+TX, Serratia plymuthica+TX, Serratia spp.+TX, Sordaria fimicola+TX, Spodoptera littoralis nuclear polyhedrovirus +TX, Sporobolomyces roseus +TX, Stenotrophomonas maltophilia +TX, Streptomyces ahygroscopicus +TX, Streptomyces albaduncus +TX, Streptomyces exfoliates +TX, Streptomyces galbus +TX, Streptomyces griseoplanus +TX, Streptomyces griseoviridis +TX, Streptomyces lydicus +TX, Streptomyces lydicus WYEC-108 +TX, Streptomyces violaceus +TX, Tilletiopsis minor +TX, Tilletiopsis spp. +TX, Trichoderma asperellum (T34 )+TX, Trichoderma gamsii +TX, Trichoderma atroviride +TX, Trichoderma hamatum TH 382+TX, Trichoderma harzianum rifai +TX, Trichoderma harzianum T-22 ( +TX, PlantShield +TX, +TX, )+TX, Trichoderma harzianum T-39 +TX, Trichoderma mainhamatum +TX, Trichoderma koningii +TX, Trichoderma spp. LC 52 +TX, Trichoderma lignorum +TX, Trichoderma longibrachiatum +TX, Trichoderma polysporum (Binab )+TX, Trichoderma taxi+TX, Trichoderma virens+TX, Trichoderma virens (formerly known as Gliocladium virens GL-21) +TX, Trichoderma viride +TX, Trichoderma viride strain ICC 080 +TX, Trichosporon pullulans +TX, Trichosporon spp. +TX, Trichothecium spp. +TX, Trichothecium roseum +TX, Typhula phacorrhiza strain 94670 +TX, Typhula phacorrhiza strain 94671 +TX, Ulocladium atrum +TX, Ulocladium oudemansii +TX, Ustilago maydis +TX, various bacteria and supplemented micronutrients (Natural )+TX, various fungi (Millennium )+TX, Verticillium chlamydosporium+TX, Verticillium lecanii ( +TX, )+TX、Vip3Aa20 +TX, Virgibaclillus marismortui +TX, Xanthomonas campestris pv.Poae +TX, Xenorhabdus burnetii +TX, Xenorhabdus nematophila;

[0840] Plant extracts including: pine oil +TX, Azadirachtin (Plasma Neem +TX, +TX, +TX, +TX, plant IGR ( +TX, )+TX, canola oil (Lilly Miller )+TX, Chenopodium ambrosioides near ambrosioides +TX, chrysanthemum extract +TX, neem oil extract +TX, Labiatae essential oil +TX, clove-rosemary-peppermint and thyme oil extracts (Garden insect )+TX, betaine +TX, garlic +TX, lemongrass oil +TX, neem oil +TX, catnip (Nepeta cataria) (catnip oil) +TX, nepeta (Nepeta catarina) +TX, nicotine +TX, oregano oil +TX, Pedaliaceae oil +TX, Pyrethrum+TX, Soapbark Tree (Quillaja saponaria) +TX, Reynoutria sachalinensis ( +TX, )+TX, rotenone (Eco )+TX, Rutaceae plant extract +TX, soybean oil (Ortho )+TX, tea tree oil (Timorex )+TX, thyme oil+TX, MMF+TX, +TX, Rosemary-Sesame-Peppermint-Thyme and Cinnamon Extract Blend (EF )+TX, clove-rosemary and peppermint extract mixture (EF )+TX, Clove-Peppermint-Garlic Oil and Mint Blend (Soil )+TX, kaolin +TX, storage glucan of brown algae

[0841]

[0842] Pheromones including: 3M Sprayable Blackheaded Fireworm )+TX, Codling moth pheromone (Paramount dispenser-(CM) / Isomate )+TX, Grape Leaf Roller Pheromone (3MMEC-GBM Sprayable )+TX, leaf roller pheromone (3M MEC-LR Sprayable )+TX, housefly pheromone (Muscamone)(Snip7Fly +TX、Starbar Premium Fly )+TX, 3M oriental fruit moth sprayable )+TX, Peachtree Borer pheromone +TX, Tomato Pinworm Pheromone (3M Sprayable )+TX, Entostat powder (from palm tree extract) (Exosex )+TX、(3E,8Z,11Z)-3,8,11-tetradecatriene acetate+TX、(7Z,11Z,13E)-7,11,13-hexadecatrienal+TX、(E,Z)-7,9-dodecadien-1-yl acetate+TX、2-methyl-1-butanol+TX、calcium acetate+TX、 +TX, +TX, +TX, Lavandulyl senecioate+TX;

[0843] Macrobial agents, including: Aphidius ervi + TX, Aphidius ervi +TX, Acerophagus papaya+TX, Coccinella bispot +TX, Coccinella bispotata +TX, Coccinella bispotata +TX, Ageniaspis citricola+TX, Amblyseius andersoni ( +TX, )+TX, Amblyseius californicus ( +TX, )+TX, Amblyseius cucumber mite ( +TX, Bugline )+TX, Pseudo-Amblyseius +TX, Bugline +TX, )+TX, Amblyseius osbornei +TX, Amitus hesperidum +TX, Anagrus atomus +TX, Anagyrus fusciventris +TX, Anagyrus kamali +TX, Anagyrus loecki +TX, Anagyrus pseudococci +TX, Red wax scale flat-horned jumping wasp (Anicetus benefices) +TX, Golden wasp (Anisopteromalus calandrae) +TX, Woodland flower stink bug (Anthocoris nemoralis) +TX, Short-spur Aphid Wasp ( +TX, )+TX, Aphelinus asychis+TX, Aphidius colemani +TX, Alphididae +TX, tobacco aphid wasp+TX, peach red aphid wasp +TX, aphid-eating gall midge +TX, aphid-eating gall midge +TX, Lingnan yellow aphid wasp +TX, Indian yellow aphid wasp +TX, Aprostocetus hagenowii +TX, Atheta coriaria +TX, Bombus species +TX, European bumblebee (Natupol )+TX, European Bumblebee ( +TX, )+TX, Cephalonomiastephanoderis+TX, Black-backed Ladybird (Chilocorus nigritus)+TX, Common Lacewing (Chrysoperlacarnea) +TX, Common Lacewing +TX, Chrysoperlarufilabris+TX, Cirrospilus ingenuus+TX, Cirrospilusquadristriatus+TX, Citrostichus phyllocnistoides+TX, Closterocerus chamaeleon+TX, Closterocerus species+TX, Coccidoxenoidesperminutus +TX, Coccophagus cowperi+TX, Coccophagus lycimnia+TX, Coccophagus lutescens+TX, Coccophagus rapae+TX, Coccophagus moniliformis+TX, Coccophagus spp. +TX, )+TX、Japanese square-headed beetle+TX、Siberian jawed braconid wasp+TX、Siberian jawed braconid wasp +TX, Pea leafminer +TX, small black ladybug (Delphastuscatalinae) +TX, Delphastus pusillus+TX, Diachasmimorpha krausii+TX, Long-tailed fly miner+TX, Diaparsis jucunda+TX, Diaphorencyrtusaligarhensis+TX, Pea leafminer+TX, Pea leafminer +TX, )+TX, Siberian Braconid Wasp ( +TX, )+TX, Encarsia species+TX, Encarsia long-tasseled aphid wasp+TX, Encarsia +TX, +TX, )+TX, Eretmocerus eremicus +TX, Encarsia guadeloupae +TX, Encarsia haitiensis +TX, Slender Hoverfly +TX, Eretmoceris siphonini+TX, Eretmocerus californicus+TX, Eretmocerus eremicus ( +TX, Eretline )+TX, Eretmocerus eremicus +TX, Heinrich's aphid wasp+TX, Monterey's aphid wasp ( +TX, Eretline )+TX, Eretmocerussiphonini+TX, Four-spotted Ladybird (Exochomus quadripustulatus)+TX, Feltiella acarisuga +TX, Acarina +TX, Alishan fly miner +TX, Fopius ceratitivorus +TX, Wirless )+TX, thrips slender waist +TX, Galendromus occidentalis +TX, Goniozus legneri +TX, Echinops serratus +TX, Harmonia axyridis +TX, Heterorhabditis species (Lawn )+TX, Heterorhabditis elegans (NemaShield +TX, +TX, +TX, +TX, +TX, +TX, +TX, )+TX, Heterorhabditis megidis (Nemasys +TX, BioNem +TX、Exhibitline +TX, )+TX, Hippodamia convergens+TX, Hypoaspis aculeifer ( +TX, )+TX、Hypoaspis miles(Hypoline +TX, )+TX, Lbalia leucospoides+TX, Lecanoideus floccissimus+TX, Lemophagus errabundus+TX, Leptomastidea abnormis+TX, Leptomastix dactylopii +TX, Leptomastix epona+TX, Lindorus lophanthae+TX, Lipolexis oregmae+TX, Lucilia caesar +TX, Lysiphlebus testaceipes +TX, Macrolophus caliginosus ( +TX、Macroline +TX, )+TX, Mesoseiulus longipes+TX, Metaphycus flavus+TX, Metaphycus lounsburyi+TX, Micromus angulatus +TX, Microterys flavus +TX, Muscidifurax raptorellus and Spalangiacameroni +TX, Neodryinus typhlocybae+TX, Neoseiulus californicus+TX, Neoseiulus cucumeris +TX, Neoseiulus fallacis+TX, Nesideocoris tenuis( +TX, )+TX, bronze black fly (Ophyra aenescens) +TX, Orius insidiosus ( +TX, Oriline )+TX, Orius laevigatus ( +TX, Oriline )+TX、Orius majusculus(Oriline )+TX, small black stink bug (Orius strigicollis) +TX, Pauesia juniperorum+TX, Pediobius foveolatus+TX, Phasmarhabditis hermaphrodita +TX, Phymastichus coffea+TX, Phytoseiulus macropilus+TX, Phytoseiulus persimilis ( +TX、Phytoline )+TX, Podisus maculiventris +TX, Pseudacteon curvatus+TX, Pseudacteon obtusus+TX, Pseudacteon tricuspis+TX, Pseudaphycus maculipennis+TX, Pseudleptomastix mexicana+TX, Psyllaephagus pilosus+TX, Psyttalia concolor (complex)+TX, Quadrastichus spp.+TX, Rhyzobius lophanthae+TX, Rodolia cardinalis+TX, Rumina decollate+TX, Semielacher petiolatus+TX, Sitobion avenae +TX, Steinernema carpocapsae (Nematac +TX, +TX, BioNem +TX, +TX, +TX, )+TX, Steinernema carinata ( +TX, Nemasys +TX, BioNem +TX, +TX, +TX, +TX、Exhibitline +TX, +TX, )+TX, Steinernema kraussei (Nemasys +TX, BioNem +TX、Exhibitline )+TX, Steinernema riobrave ( +TX, )+TX, Steinernema scapterisci (Nematac )+TX、Steinernema spp.+TX、Steinernematid spp. )+TX, Stethorus punctillum +TX, Tamarixia radiate +TX, Tetrastichus setifer +TX, Thropobius semiluteus +TX, Torymus sinensis +TX, Tricholine )+TX, Trichogramma brassicae +TX, Trichogramma evanescens+TX, Trichogramma minutum+TX, Trichogramma ostriniae+TX, Trichogramma platneri+TX, Trichogramma pretiosum+TX, Xanthopimpla stemmator+TX;

[0844] Other biological agents, including: abscisic acid + TX, +TX, Chondrostereum purpureum (Chontrol )+TX, Colletotrichum spondyloticum +TX, copper octanoate +TX, Delta trap (Trapline )+TX, Erwinia amylovora (Harpin) ( +TX、Ni-HIBIT Gold )+TX, fatty acids derived from natural by-products of extra virgin olive oil +TX, ferric phosphate +TX, Funnel trap (Trapline )+TX、 +TX, Grower's +TX, Homo-brassonolide +TX, Ferric Phosphate (Lilly Miller Worry Free Ferramol Slug & Snail )+TX、MCP hail trap (Trapline )+TX, parasitic insect Microctonus hyperodae+TX, Mycoleptodiscus terrestris +TX, +TX, +TX, +TX, Pheromone Net (Thripline )+TX, potassium bicarbonate +TX, potassium salt of fatty acids +TX, potassium silicate solution +TX, potassium iodide + potassium thiocyanate +TX, +TX, spider venom +TX, locust microsporidia (Semaspore Organic Grasshopper )+TX, Trapline +TX, Rebell )+TX and capture (Takitrapline )+TX;

[0845] (1) An antibacterial agent selected from the group consisting of:

[0846] (1.1) Bacteria, examples of which are Bacillus mojavensis strain R3B (accession number NCAIM (P) B001389) (WO 2013 / 034938), from Certis USA LLC +TX, a subsidiary of Mitsui & Co.; Bacillus pumilus, in particular strain BU F-33, with NRRL accession number 50185 (available as Parts of the product were obtained from BASF, EPA registration number 71840-19) + TX; Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP in the United States, with NRRL registration number B21661, U.S. Patent No. 6,060,051) + TX; Bacillus subtilis strain BU1814, (available as PLUS, FLEX and EXTRA obtained from BASF SE) + TX; Bacillus subtilis var. amyloliquefaciens strain FZB24, with accession number DSM 10271 (available as or ECO (EPA registration number 70127-5) obtained from Novozymes) + TX; Bacillus subtilis CX-9060, obtained from Sertis America, Inc., a subsidiary of Mitsui & Co., Ltd. + TX; Bacillus species, specifically strain D747 (available as DOUBLE obtained from Kumiai Chemical Industry Co., Ltd.) with accession number FERM BP-8234, U.S. Patent No. 7,094,592+TX; Paenibacillus sp. strains with accession number NRRL B-50972 or accession number NRRL B-67129, WO 2016 / 154297+TX; Paenibacillus polymyxa, particularly strain AC-1 (e.g., from Green Biotech Company Ltd.) ) + TX; Pantoea agglomerans, in particular strain E325 (accession number NRRL B-21856) (available as BLOOMTIME BIOLOGICAL TM FD BIOPESTICIDE (from Northwest AgriProducts) + TX; Pseudomonas proradix (e.g., from Sourcon Padena) )+TX; and

[0847] (1.2) Fungi, examples of which are Aureobasidium pullulans, in particular blastospores of strain DSM 14940, blastospores of strain DSM 14941 or a mixture of blastospores of strains DSM 14940 and DSM 14941 (e.g., blastospores from bio-ferm, Switzerland). and BLOSSOM )+TX; Pseudozyma aphidis (as disclosed in WO 2011 / 151819 by Yissum Research Development Company of the Hebrew University of Jerusalem)+TX; Saccharomyces cerevisiae, in particular strains CNCM No. 1-3936, CNCM No. 1-3937, CNCM No. 1-3938 or CNCM No. 1-3939 (as disclosed in WO 2010 / 086790, from Lesaffre et Compagnie, France)+TX;

[0848] (2) Biofungicides selected from the group consisting of:

[0849] (2.1) Bacteria, an example of which is Agrobacterium radiobacterium strain K84 (e.g., from AgBioChem, California) )+TX; radiobacterium strain K1026 (e.g. NOGALL from BASF TM )+TX; Bacillus subtilis variant amyloliquefaciens strain FZB24, with accession number DSM10271 (available as or ECO (EPA registration number 70127-5) obtained from Novozymes) + TX; Bacillus amyloliquefaciens, specifically strain D747 (available as Double Nickel TM obtained from Kumihiko Chemical Industries, Ltd., with accession number FERM BP-8234, U.S. Patent No. 7,094,592) + TX; Bacillus amyloliquefaciens strain F727 (also known as strain MBI110) (NRRL accession number B-50768, WO 2014 / 028521) (from Marrone Bio Innovations )+TX; Bacillus amyloliquefaciens strain FZB42, registration number DSM 23117, (can be used as from ABiTEP, Germany) + TX; Bacillus amyloliquefaciens isolate B246 (e.g., AVOGREEN from the University of Pretoria); TM )+TX; Bacillus licheniformis, in particular strain SB3086, having accession number ATCC 55406, WO 2003 / 000051 (available as Biofungicides and Green Release TM Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (from FMC Corporation) (WG) and (WP)) + TX; Bacillus methylotrophicus strain BAC-9912 (from the Institute of Applied Ecology, Chinese Academy of Sciences) + TX; Bacillus mojavensis strain R3B (accession number NCAIM(P)B001389) (WO 2013 / 034938), from Sertis America, Inc., a subsidiary of Mitsui & Co., Ltd. + TX; Bacillus mycoides isolate with accession number B-30890 (available as BMJ or WG and LifeGard TM obtained from Surtice America, Inc., a subsidiary of Mitsui & Co., Ltd.) + TX; Bacillus pumilus, specifically strain QST2808 (available as obtained from Bayer CropScience, USA, with registration number NRRL B-30087 and described in US Pat. No. 6,245,551) + TX; Bacillus pumilus, in particular strain GB34 (available as Yield pumilus, in particular strain BU F-33, having NRRL accession number 50185 (available as part of the CARTISSA product from BASF, EPA accession number 71840-19) + TX; Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP in the United States, having NRRL accession number B21661, and described in U.S. Pat. No. 6,060,051) + TX; Bacillus subtilis Y1336 (available as WP was obtained from Bion-Tech, Taiwan, China, and registered as a biofungicide in Taiwan under registration numbers 4764, 5454, 5096, and 5277) + TX; Bacillus subtilis strain MBI 600 (available as SUBTILEX from BASF, with registration number NRRL B-50595, U.S. Patent No. 5,061,495) + TX; Bacillus subtilis strain GB03 (available as obtained from Bayer AG, Germany) + TX; Bacillus subtilis strain BU1814, (available as PLUS, FLEX and EXTRA obtained from BASF) + TX; Bacillus subtilis CX-9060, obtained from Sertis America, a subsidiary of Mitsui & Co., Ltd. + TX; Bacillus subtilis KTSB strain (obtained from Donaghys )+TX; Bacillus subtilis IAB / BS03 (AVIV from STK Bio-Ag Technologies) TM , from Idai Nature )+TX; Bacillus subtilis strain Y1336 (can be used as WP was obtained from Biotech, Taiwan, China, and registered as a biofungicide in Taiwan under registration numbers 4764, 5454, 5096, and 5277) + TX; Paenibacillus epiphyticus (WO 2016 / 020371) from BASF + TX; Paenibacillus polymyxa plantarum species (WO 2016 / 020371) from BASF + TX; Paenibacillus species strains with registration number NRRL B-50972 or registration number NRRL B-67129, WO 2016 / 154297 + TX; Pseudomonas chlororaphis strain AFS009 with registration number NRRL B-50897, WO 2017 / 019448 (e.g., HOWLER from AgBiome Innovations, USA). TM and ) + TX; Pseudomonas chlororaphis strains, in particular strain MA342 (e.g., by Bioagri and Koppert and )+TX; Pseudomonas fluorescens strain A506 (e.g., from NuFarm A506) + TX; Pseudomonas proradix (e.g., from Soconpadna) ) + TX; Streptomyces griseoviridis strain K61 (also known as Streptomyces luteus strain K61) (accession number DSM7206) (from Verdera BioWorks See Crop Protection 2006, 25, 468-475) + TX; Streptomyces lydicus strain WYEC108 (also known as Streptomyces lydicus strain WYCD108US) (from Novozymes and )+TX; and

[0850] (2.2) Fungi, an example of which is Pseudomonas aeruginosa, in particular strain AQ 10 (e.g. AQ 10 from IntrachemBio Italia). ) + TX; Pseudomonas aeruginosa strain AQ10, with accession number CNCM1-807 (e.g., AQ10 obtained from Intrachem Biologia Italia S.A. )+TX; Aspergillus flavus strain NRRL 21882 (as a Syngenta / ChemChina and known products) + TX; budding mold, especially the spores of strain DSM14940 + TX; budding mold, especially the spores of strain DSM 14941 + TX; budding mold, especially the mixture of spores of strains DSM14940 and DSM 14941 (for example, from Bio-Philippe Co., Ltd., Switzerland )+TX; Chaetomium cupreum (accession number CABI 353812) (e.g., BIOKUPRUM by AgriLife TM )+TX; Chaetomium globosum (can be used as from Rivale) + TX; Cladosporium cladosporioides, strain H39, with accession number CBS122244, US2010 / 0291039 (from Wageningen Research Foundation (Stichting Dienst Landbouwkundig Onderzoek)) + TX; Coniothyrium minitans, in particular strain CON / M / 91-8 (accession number DSM9660, e.g., from Bayer CropScience Biologics GmbH) + TX; )+TX; Cryptococcus flavescens, strain 3C (NRRL Y-50378), (B2.2.99)+TX; Dactylaria candida+TX; Dilophosphora alopecuri (can be used as TW...

Claims

1. A compound having formula (I) in: A 1 , A 2 and A 3 N or CR independently of each other Y ;or A 1 =A 2 -A 3 Together they are NR-C(=X)-N; wherein X is O or S; A 4 and A 5 N or CR independently of each other Y ; Q is wherein the staggered lines represent the connection of Q to the remainder of the compound of formula (I); R is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy; R 1 is hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, aminocarbonyl C1-C6 alkyl, hydroxycarbonyl C1-C6 alkyl, C1-C6 nitroalkyl, trimethylsilyl C1-C6 alkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl C 1-C2 alkyl-, C3-C4 cycloalkyl C1-C2 alkyl- wherein the C3-C4 cycloalkyl is substituted by 1 or 2 halogen atoms, oxetan-3-yl-CH2-, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl, benzyl or benzyl substituted by 1 to 3 substituents independently selected from halogen, C1-C6 alkoxy and C1-C6 haloalkyl; R 2a and R 2b each independently selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, one to three independently selected from R x C3-C6 cycloalkyl, C3-C6 cycloalkylcarbonyl, phenyl, substituted by one to three independently selected from R x substituted phenyl, heteroaryl, substituted by one to three independently selected from R x Substituents substituted heteroaryl, OR 6 , piperidin-2-one-1-yl, one to two independently selected from R x Substituents substituted with piperidin-2-one-1-yl, pyridin-2-one-1-yl, substituted with one or two independently selected from R x substituted pyridin-2-one-1-yl, azetidin-1-yl, substituted by one to two independently selected from R x substituted azetidin-1-yl, pyrrolidin-1-yl, substituted by one or two independently selected from R x substituted pyrrolidin-1-yl, C3-C6 cycloalkyl, C1-C4 alkyl, substituted by one or two independently selected from R z C3-C6 cycloalkyl C1-C4 alkyl, C3-C6 cycloalkyl C1-C3 alkoxy, substituted by one or two independently selected from R x C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, substituted by one to three independently selected from R x C1-C4 alkylsulfanyl, C1-C4 alkylsulfonyl, substituted by one to three independently selected from R x C1-C4 alkylsulfonyl, C1-C4 alkylsulfinyl, and substituted by one to three independently selected from R x C1-C4 alkylsulfinyl substituted with a substituent; R 3 is C1-C3 alkyl or C1-C3 haloalkyl; R 4 yes The staggered lines represent R 4 With Q a or Q b connection; A 14 , A 24 and A 34 are independently N or CH; R 4c is C1-C3 alkyl, C1-C3 haloalkyl, allyl, propargyl or C3-C6 cycloalkylC1-C4 alkyl; R 5 is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, C3-C4 alkoxy C(O)-, (C1-C3 alkoxy)2CH-, halogen, CN, NH2C(O), amino (i.e., NH2), (C1-C3 alkyl)amino, di(C1-C3 alkyl)amino, hydroxy, C3-C4 halocycloalkyl, C3-C4 cyanocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C3 alkyl Oxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)sulfonylamino, (C1-C3 alkyl)sulfonyl(C1-C3 alkyl)amino, (C1-C3 alkyl)NHC(O), (C1-C3 alkyl)2NC(O), (C1-C3 cycloalkyl)NHC(O), (C1-C3 cycloalkyl)(C1-C3 alkyl)NC(O), (C1-C3 alkyl)C(O)(C1-C3 alkyl)N, (C1-C3 alkyl)C(O)NH, (C1-C3 alkyl)C(O), (C1-C3 alkoxy)C(O), HC(O), diphenylmethanimine, C1-C3 haloalkoxy, phenyl, or a 5-membered heteroaromatic ring; or R 5 is phenyl substituted with one to three substituents selected from the group consisting of C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN and hydroxy; or R 5 is a 5-membered heteroaromatic ring substituted with one to three substituents selected from the group consisting of C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN and hydroxy; R 5a and R 5b are independently selected from hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, and C1-C3 haloalkoxy; R 6 is phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl; or R 6 is phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl, each of which is independently selected from one to three R x Substituents are substituted; R x independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, NO2, SF5, CN, C(O)NH2, C(S)NH2, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl and C1-C4 alkylsulfonyl; R Y is selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, hydroxy, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, CN and cyclopropyl; and R Z is selected from the group consisting of oxo, halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy and CN; or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer and N-oxide of the compound of formula I.

2. The compound according to claim 1, wherein A 1 and A 3 is N and A 2 Yes CR Y ; and R Y is hydrogen, chlorine, methyl, trifluoromethyl or methoxy.

3. The compound according to claim 1, wherein A 1 =A 2 -A 3 together are NR-C(=O)-N; and R is hydrogen, methyl, ethyl, 2,2-difluoroethyl or 2,2,2-trifluoroethyl.

4. The compound according to any one of claims 1 to 3, wherein A 4 and A 5 are independently N or CH.

5. The compound according to any one of claims 1 to 4, wherein A 4 and A 5 All are CH.

6. The compound according to any one of claims 1 to 5, wherein -When R 4 YesR 4a Time: A 14 Yes N, A 24 is N or CH, and A 34 is N or CH; or A 14 Yes N, A 24 is N or CH, and A 34 is CH; or A 14 Yes N, A 24 is CH, and A 34 is N or CH; or A 14 Yes N, A 24 is CH, and A 34 is CH; and -When R 4 YesR 4b Time: A 14 is N; or A 14 It is CH.

7. The compound according to any one of claims 1 to 6, wherein R 4c It is methyl, ethyl, propyl, difluoromethyl, trifluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, allyl, propargyl, cyclopropylmethyl, cyclobutylmethyl, 2-cyclopropylethyl, or 3-cyclopropylpropyl.

8. A compound according to any one of claims 1 to 7, wherein: -A 14 is N, and when R 4 YesR 4a When A 24 and A 34 is CH; and -R 4c It is methyl or ethyl.

9. The compound according to any one of claims 1 to 8, wherein X 0 It's O.

10. The compound according to any one of claims 1 to 9, wherein R 1 is hydrogen, methyl, ethyl, cyanomethyl, methoxymethyl, cyclopropyl-methyl, allyl, propargyl, benzyloxycarbonyl, or benzyl.

11. The compound according to any one of claims 1 to 10, wherein R 2a is halogen, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 haloalkoxy, C3-C6 cycloalkyl optionally substituted by one or two substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C3-C6 cycloalkyl optionally substituted by one to three substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C1-C4 alkyl, C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkylsulfinyl, or C3-C6 cycloalkylsulfonyl.

12. The compound according to any one of claims 1 to 11, wherein R 2b It is halogen, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 haloalkylsulfonyl, C1-C3 haloalkylsulfonyl, C1-C3 alkoxy, C1-C3 haloalkoxy, or CN.

13. The compound according to any one of claims 1 to 12, wherein R 2a and R 2b Independently selected from chloro, bromo, iodo and trifluoromethyl.

14. A compound according to any one of claims 1 to 13, wherein R 3 It is a C1-C3 alkyl group.

15. The compound according to any one of claims 1 to 14, wherein R 3 It's methyl.

16. A compound according to any one of claims 1 to 15, wherein: -When Q is Q a Time: R 5 is hydrogen, methyl, trifluoromethoxy, methoxy, cyclopropyl, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, difluoromethoxy, 2,2,2-trifluoroethyl, chloro, bromo, methoxyethoxy, methylcarbonyl or methoxycarbonyl; and -When Q is Q b Time: R 5a is hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; and R 5b It is hydrogen, halogen, CN, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy.

17. A composition comprising a compound as defined in any one of claims 1 to 16, one or more adjuvants and diluents, and optionally one or more other active ingredients.

18. A method comprising: (i) a method for combating and controlling insects, acarines, nematodes or molluscs, which method comprises applying an insecticidal, acaricidal, nematicidal or molluscicidal effective amount of a compound as defined in any one of claims 1 to 16 or a composition as defined in claim 17 to the pest, the locus of the pest, or a plant susceptible to attack by the pest; or (ii) a method for protecting plant propagation material from attack by insects, mites, nematodes or molluscs, which method comprises treating the propagation material or the site where the propagation material is planted with an effective amount of a compound as defined in any one of claims 1 to 16 or a composition as defined in claim 17; or (iii) A method for controlling parasites in or on an animal in need thereof, the method comprising administering an effective amount of a compound as defined in any one of claims 1 to 16 or a composition as defined in claim 17.

19. A plant propagation material, such as a seed, comprising, or treated with, or having adhered thereto, a compound as defined in any one of claims 1 to 16 or a composition as defined in claim 17.

20. A compound of formula XII(i) or a tautomer thereof, Among them A 14 , A 24 , A 34 and R 4c is as defined in any one of claims 1, 6, 7 and 8, provided that the compound is not 6-Hydrazino-2-methyl-3(2H)-pyridazinone, nor its tautomers; nor 6-Hydrazino-2-ethyl-3(2H)-pyridazinone, nor its tautomers.

21. A compound having the formula XX(i), XXI(i) or XXII(i) Where R 4a is as defined in any one of claims 1, 6 and 7; and wherein X - is an anion selected from the group consisting of: - a conjugate base of an inorganic acid selected from hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide and sulfuric acid; and - the conjugate base of an organic acid selected from carboxylic acids and sulfonic acids.

Citation Information

Cited By

  • Triazole compound and preparation method therefor, insecticidal composition, and use thereof

    WO2026184576A1